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ABSTRACT 
TAL effectors, from the plant-pathogenic bacterial genus Xanthomonas, are DNA binding 
proteins that can be engineered to bind to almost any sequence of interest.  The DNA target of 
the TAL effector is encoded by a modular central repeat region, with each repeat specifying a 
single binding site nucleotide.  TAL effectors can be targeted to novel DNA sequences by 
assembling the corresponding repeat sequence.  Therefore, custom TAL effectors have become 
important tools for manipulating gene expression and creating site-specific DNA modifications.  
This dissertation explores TAL effector-DNA binding through computational and experimental 
analyses. 
I identified positional and composition biases in known TAL effector-target pairs and 
proposed guidelines for designing custom TAL effectors and TAL effector nucleases (TALENs).  
Using these guidelines, I created a software tool for TAL effector design. We expanded this tool 
into a suite of tools for TAL effector/TALEN design and target site prediction.  Target site 
predictions can be used to estimate potential off-target binding of custom TAL effector 
constructs or to identify unknown targets of natural TAL effectors. 
Next, I present a case study in engineering disease resist rice plants.  Inserting multiple TAL 
effector binding elements (EBEs) into the promoter of a rice resistance gene conferred 
resistance to diverse strains of Xanthomonas oryzae.  Analysis of the EBE sequences revealed 
that TAL effectors have evolved to target specific host regulatory sequences, and caution is 
warranted when introducing such sequences into the promoter of an executor resistance gene. 
Finally, I examine the role of the TAL effector N terminus in DNA binding.  Most natural TAL 
effector binding sites are preceded by a T at the 5’ end (T0).  Structural data suggests T0 is 
encoded by tryptophan 232 (W232) in the cryptic -1st repeat.  We show that substitutions for 
W232 alter TAL effector activity and specificity for T0.  However, we find that the TAL effector-
T0 interaction is complex and may depend on other residues in the -1st repeat, the 0th cryptic 
repeat, or repeat sequence context.  Better understanding of TAL effector-DNA binding will 
improve TAL effector design and target prediction and enhance understanding of the role of TAL 
effectors in plant disease.
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CHAPTER 1. GENERAL INTRODUCTION 
Abbreviations 
CRR: central repeat region 
dTALE: designer TAL effector 
EBE: effector binding element 
R gene: resistance gene 
RTL: Ralstonia TAL-like effector 
RVD: repeat variable diresidue 
S gene: susceptibility gene 
TAL effector: transcription activator-like effector 
TALEN: TAL effector nuclease 
T3SS: type three secretion system 
 
Introduction 
Transcription activator-like (TAL) effectors are a class of transcriptional activators found 
primarily in the plant pathogenic bacterial genus Xanthomonas.  During infection, they are 
secreted by the bacterium directly into the host plant cell and subsequently localized to the 
nucleus where they bind to effector-specific DNA targets and activate transcription of host 
genes.  Many TAL effectors activate host genes known as susceptibility (S) genes, whose 
expression is necessary for bacterial spread and multiplication and/or for the development of 
disease symptoms.  A few TAL effectors bind to and activate genes that trigger disease 
resistance (known as resistance or R genes) (1,2). 
In 2009, the mechanism by which TAL effectors bind to their specific DNA targets was 
discovered independently by two different labs. The TAL effector’s central repeat region (CRR) 
consists of a variable number of tandem, nearly identical repeats of 33-34 amino acids in length.  
Repeat-to-repeat variation occurs primarily at amino acids 12 and 13, which are together known 
as the repeat variable diresidue, or RVD.  Computational and experimental analysis revealed a 
one-to-one correspondence between binding site nucleotides and repeats, such that the 
sequence of RVDs “encodes” the binding site (3,4).  Solved structures of two different TAL 
effectors bound to their DNA targets later confirmed that each RVD interacted with and specified 
a single binding site nucleotide (5,6)  
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Discovery of this RVD-nucleotide binding code has led to increasing interest in TAL 
effectors, both for their role in plant disease and their potential as research tools.  Knowledge of 
RVD-nucleotide specificity makes it possible to predict previously unknown TAL effector binding 
sites, potentially leading to the discovery of novel S or R genes and opening up novel paths for 
engineering disease resistant plants (7-9).  Additionally, RVDs specifying each of the four 
nucleotides have been identified, making it possible to design custom TAL effectors to target a 
given DNA sequence by assembling a TAL effector CRR with the appropriate sequence of 
repeats/RVDs. These custom TAL effectors and TAL effector-based constructs have been used 
in a variety of applications, including targeted gene activation (using the native TAL effector 
activation domain or replacing it with another activation domain) targeted gene repression 
(typically by replacing the TAL effector activation domain with a repressor domain), and targeted 
genome modifications (by using TAL effector-endonuclease fusion proteins known as TAL 
effector nucleases or TALENs to create targeted double strand breaks in the DNA) (10-17).  
TAL effector-based constructs have been demonstrated to work effectively in a wide variety of 
tissue and cell types. TALENs in particular have become a widely used research tool, with 
potential uses ranging from creating gene knockouts in model and non-model organisms to 
disease therapies in humans (18).   
Rationale 
This dissertation focuses on computational and experimental analysis of TAL effector-DNA 
binding.  I begin by analyzing known TAL effector-target pairs from nature and applying the 
results to create computational tools to design custom TAL effectors and TALENs.  The design 
of maximally efficient TAL effector-based constructs is an important consideration for 
researchers.  Because I reasoned that TAL effectors in nature had likely evolved to have 
maximum binding affinity for their targets, this set of computational tools focused on selecting 
target sites and corresponding RVD sequences that were similar in sequence composition to 
natural TAL effectors and known TAL effector targets.  Later, I altered these initial design 
guidelines to reflect accumulating data on the activity of custom TAL effector-based constructs 
as well as information from the structures of two TAL effectors bound to their targets.   
 An additional concern when designing custom TAL effector constructs is their specificity 
for their intended target sequence.  Because the RVD-nucleotide binding code is not absolute, a 
custom TAL effector can bind to sites other than the intended target but with sufficiently similar 
sequence.  Such off-target binding is especially problematic in applications using TALENs, 
where it may result in the unintended cleavage and subsequent disruption of non-target genes.  
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I extended my TAL effector and TALEN design software to include tools to predict potential off-
target binding sites based on a mathematical scoring function.  In addition to aiding researchers 
in designing highly specific custom TAL effectors, target prediction tools can also be used to 
identify previously unknown targets of natural TAL effectors, leading to the identification of novel 
plant disease S or R genes (a case study using TAL effector target prediction tools to discover a 
previously unknown S gene is included in the Appendix).  I also show that TAL effectors may 
have evolved to target specific sequences under selection, which has important implications for 
the use of TAL effectors in engineered plant disease resistance. 
 Finally, I examine the role of a specific region of the TAL effector’s N terminus in DNA 
binding.  Although the work described above is based primarily on the repeat/RVD sequence of 
the TAL effector, This N-terminal region located outside of the CRR may also play a role in 
defining the binding site and in nucleating TAL effector-DNA binding.  Understanding the role of 
this region may lead to the design of more efficient TAL effectors for biotechnology applications 
and may improve DNA targeting by custom TAL effectors.    
Dissertation Organization 
This dissertation is organized into five parts.  Chapter 2 presents a review of TAL effector 
literature. Chapters 3 and 4 describe the creation and development of a suite of software tools 
for designing and predicting targets for TAL effectors and TALENs.  Chapter 5 is a case study in 
engineering plant disease resistance based on naturally occurring TAL effectors, including 
computational analysis showing that TAL effectors have evolved to target specific gene 
sequences under selection.  Finally, Chapter 6 details experiments to study the role of the TAL 
effector’s cryptic –1st repeat region in TAL effector-DNA binding.  The Appendix presents an 
additional case study which verifies the functionality and utility of the target prediction tools by 
using them to identify novel plant disease S genes.  My contributions to the individual chapters 
were as follows: 
 
 For the literature review in Chapter 2, I was responsible for conducting the literature 
search, outlining the article, writing the majority of the text, and designing the figures.  Co-
author Barry Stoddard contributed to the section “TAL effector structure and function” and 
also created Figure 1, co-author Daniel Voytas contributed to the section “TAL effector 
fusions for genome editing”, and co-author Adam Bogdanove edited the paper. 
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 Chapter 3 describes a novel method for the rapid construction of custom TAL effectors and 
TALENs.  Additionally, it presents guidelines for designing TAL effectors/TALENs and a 
software tool to assist users in designing constructs that conform to these guidelines.  My 
role in this chapter was analysis of known TAL effector-target pairs to develop the design 
guidelines, creation of the TAL effector design software and website, design of TALENs 
targeting genes from a variety of organisms (activity of these TALEN pairs are reported in 
the manuscript), and writing all of the related sections of the manuscript.  Tomas Cermak 
and I were designated co-first authors of this manuscript. 
 
 Chapter 4 discusses a complete suite of software tools that I created for designing custom 
TAL effector constructs and predicting TAL effector binding sites.  I was responsible for the 
original design and coding of all software tools, overseeing development of the web 
interface, drafting the manuscript, and preparing the supplementary materials.   
 
 Chapter 5 presents a case study in which multiple TAL effector binding sites were inserted 
into the promoter of rice disease resistance gene Xa27, broadening the plants’ resistance to 
include multiple strains of Xanthomonas oryzae.  For this chapter, I designed and conducted 
the analysis of TAL effector binding site representation in the rice genome, wrote the related 
sections of the manuscript, and prepared Figure 6. 
 
 Chapter 6 details a set of experiments to characterize the role of tryptophan 232 and the 
cryptic -1st repeat in TAL effector-DNA binding.  I was responsible for the conception and 
initial design of the study, as well as data interpretation, preparing figures (except Figure 5), 
and writing and assembling the manuscript.  I also conducted all of the GUS experiments for 
TAL effectors PthXo1 and TAL868, and the RTL secondary structure analysis.  
 
 The study presented in the Appendix represents part of a larger study currently in 
preparation for publication.  I created the computational tools for target prediction, generated 
the initial TAL effector target predictions, cross-referenced the predicted target lists with 
microarray data to identify candidate target genes, and analyzed the confirmed target genes 
to identify characteristics of TAL effector targets.  I also wrote all of the related sections of 
the manuscript describing the larger study, and modified and compiled relevant sections 
from the longer manuscript into the Appendix. 
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Abstract 
Transcription activator-like (TAL) effectors are specific, customizable DNA binding proteins. 
DNA recognition occurs via a polymorphic repeat region that encodes the target sequence 
through a one-to-one correspondence between repeats and nucleotides. TAL effectors are 
transkingdom transcription factors, injected into plant cells by plant pathogenic bacteria in the 
genus Xanthomonas. They can act as virulence factors by activating host “susceptibility” genes 
important for disease, or as avirulence factors by turning on a gene that confers resistance. 
Understanding TAL effector DNA recognition has facilitated identification of targets and opened 
new avenues for engineering disease resistance. The customizability of TAL effectors has made 
them transformative tools for applications such as targeted control of gene expression and 
genome editing in a variety of organisms. This review discusses the structural basis for TAL 
effector-DNA specificity, the role of TAL effectors in plant pathology, engineered plant disease 
resistance, TAL effector-based DNA targeting applications, and future challenges.  
Introduction 
TAL (transcription activator-like) effectors are transcriptional activators injected into plant 
cells by plant pathogenic members of the bacterial genus Xanthomonas. In the plant nucleus, 
TAL effectors act as virulence factors by turning on genes necessary for disease susceptibility 
(S genes), or in a few cases, as avirulence factors by activating a gene that confers resistance 
(an R gene) [1, 2]. TAL effectors recognize their targets via a polymorphic repeat region that 
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encodes a specific nucleotide sequence through a one-to-one correspondence between repeats 
and consecutive bases on one strand of the DNA [3-6]. The modularity of this mechanism 
facilitates target identification and allows customization to generate DNA binding proteins with 
specificities of choice. Target identification is improving understanding of the role of TAL 
effectors in plant diseases and is informing efforts to develop more effective means to control 
those diseases. The customizability of TAL effectors has led to widely enabling TAL effector-
based tools for systems biology and genome engineering, advancing fundamental research, 
crop and livestock improvement, and medicine [1, 7]. 
The TAL effector-DNA recognition mechanism hinges on a central protein domain that is 
composed of a variable number of tandem, 33-34 amino acid repeats. The repeats are nearly 
identical, with variation occurring primarily at amino acids 12 and 13. These two positions are 
known as the repeat variable diresidue (RVD). The sequence of RVDs has been shown both 
computationally and experimentally, and more recently structurally, to “encode” the TAL effector 
binding site on the DNA, with each RVD specifying a single binding site nucleotide through 
direct interaction [3-6].  
This means of protein-DNA recognition and the functions it enables are so far unique. From 
the remarkable targeted effects these proteins have on plant cell biology to the transformative 
effects they are having on the field of cell biology itself, TAL effectors are a fascinating and 
useful invention of nature. TAL effector research is moving fast. Since publication in 2009 of the 
discovery of the RVD-nucleotide code that governs TAL effector-DNA recognition, the number 
of papers related to TAL effector function and application has risen sharply and steadily, from 
fewer than ten in 2009 to over 110 in 2012 [8]. In this review, we discuss highlights concerning 
the structural basis for TAL effector-DNA binding and specificity, the roles of TAL effectors in 
plant pathology and engineered plant disease resistance, TAL effector-based applications, and 
future challenges for TAL effector research.  
TAL effector structure and function 
The four most common RVDs, HD, NG, NN, and NI, respectively specify C, T, G or A, and 
A. Other RVDs of interest for DNA targeting include NS and N* (the asterisk represents a gap at 
position 13, resulting in a 33 amino acid repeat), which have lax specificity, and the less  
common NH, which has stringent specificity for G [9]. Two recent crystallization studies provided 
a clear view of the structural basis and context for all but one of these interactions. One 
illustrated the free and DNA-bound forms of an artificially engineered TAL effector termed 
'dHAX3', that contains 11 canonical TAL repeats and three of the most common RVDs (HD, NG 
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and NS) [6]. The other presented the DNA-bound structure of the naturally occurring TAL 
effector PthXo1 from X. oryzae [5] (Figure 1). That structure contained over 20 repeats bound to 
two full turns of DNA and six RVDs (HD, NG, NN, NI, N*, and the rare RVD HG), as well as a 
portion of a positively charged N-terminal region that interacts nonspecifically with the 5’ DNA 
region preceding the target site. 
  
Each TAL repeat forms a two-helix bundle, in which the RVD forms a well-ordered loop. The 
individual repeats self-associate to wrap around along the entire length of the unbent DNA 
target site. Unbound dHAX3 displays a slightly unwound, but still helical structure [6]. Thus, a 
significantly more extended effector conformation appears to be required for DNA target 
acquisition (a hypothesis that agrees with published small angle X-ray scattering data on the
 
Figure 1.  Structure of the TAL effector-DNA association and the basis of specificity.  At top, the 
structure of PthXo1 bound to its DNA target site [5] is shown (left) from the side of the DNA duplex and 
(right) looking down the axis of the DNA. The effector contains 22.5 repeat modules each colored 
separately. In the side view, the N-terminal end of the protein, containing two cryptic repeats that engage the 
DNA backbone via a series of basic residues, and that also capture the strongly conserved thymine (5’ T) at 
position 'zero' of the binding site, is leftmost. The labeled repeats (14, 15, and 16) are shown in detail at 
bottom. Bottom left illustrates the contacts made by the ‘HD’ RVD (residues 12 and 13) in repeat number 14. 
The histidine at position 12 in the repeat forms a hydrogen bond to the backbone carbonyl oxygen of residue 
8 in the first alpha-helix, while the aspartate at position 13 forms a hydrogen bond to the extracyclic amino 
nitrogen of the cytosine base.  Bottom right shows repeats 14, 15, and 16 interacting with the DNA, 
illustrating that consecutive RVDs (HD, NG and NN, respectively in these repeats) contact consecutive 
bases (cytosine, thymine, and guanine in this case) on the same DNA strand. 
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full-length PthA TAL effector [10]). 
The first residue in each RVD (at position 12) forms a structural interaction with the protein 
backbone carbonyl in the preceding helix of the same repeat, while the second residue makes 
sequence-specific contacts in the major groove to a single nucleotide base; all such contacts 
are made to a single DNA strand. The majority of observed contacts between the RVDs and 
DNA bases correspond to (i) directional hydrogen-bonds (observed for ‘HD’ RVDs in contact 
with cytosine, or for ‘NN’ RVDs in contact with purines), (ii) highly complementary steric packing 
in the absence of hydrogen bonds (such as between NG or HG RVDs and thymine), or (iii) 
interactions that appear to achieve reduced (but not completely negligible) specificity through 
steric exclusion of alternate bases (in particular, the ‘NI’ RVD). The 'N*' RVD, in which the RVD 
loop is truncated by one residue, appears to accommodate any base with little or no contribution 
to overall affinity. These observations agree with a recent study that examined artificial TAL 
effectors with blocks of homopolymeric repeats to determine the specificity and contribution to 
activity, as a proxy for binding affinity, of the most common RVDs and several rare RVDs. This 
study demonstrated that 'HD' and 'NN' (or 'HN') repeats provide a significant contribution to 
overall TAL effector activity (and therefore, presumably binding affinity), whereas strings of ‘NI’ 
or ‘N*’ repeats result in considerably lower activity and reduced specificity [9]. 
The pattern of contacts and specificity described above can be extended to the recognition 
of modified bases: the presence of an NG or HG repeat (which are specific for thymine in an 
unmodified target) can accommodate similar interactions with a 5-methyl-cytosine, thus making 
it possible to identify or design potential TAL effectors that can discriminate between target sites 
that contain methylated CpG sequences and those that are unmodified [11]. A more recent 
study indicates that TAL effectors can also recognize RNA-DNA hybrids by recognizing the 
sequence of the deoxynucleotide-containing strand [12].  
The structure of PthXo1 [5] and the relative performance of artificial TAL constructs 
containing a variety of N- and C-terminal truncations [13, 14] appear to indicate that an N-
terminal region immediately preceding the beginning of the canonical TAL repeats forms a 
highly basic region of the protein that is critical for high affinity DNA binding, and also engages a 
thymine base found at position zero of nearly all TAL binding sites via contacts with a single 
tryptophan residue that is found in all Xanthomonas TAL effectors. A detailed analysis of an 
extended N-terminal region of dHax3 indicates that as many as four additional cryptic repeats 
are formed immediately upstream of the central repeat region, and that this region provides the 
bulk of binding energy required for high affinity target binding and sequence-specific recognition 
[15]. 
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Finally, comparisons of the structures and individual repeats of dHAX3 and PthXo1 indicates 
that these proteins display extraordinarily slight structural differences from one another (r.m.s.d. 
~0.8 angstroms across all repeats) despite comprising distinct strings of RVDs that target 
completely different DNA target sites. This observation provides structural confirmation of the 
modular nature of DNA recognition by TAL effectors, which enables the prediction of targets in 
plant disease, the manipulation of targets for disease resistance, and the customization of TAL 
effectors for DNA targeting applications. 
The natural role of TAL effectors  
Different Xanthomonas species collectively infect a wide range of economically important 
crops and ornamentals. Sequenced Xanthomonas genomes typically encode zero to six TAL 
effectors, with some encoding upwards of thirty [16]. These have from 1.5-33.5 repeats in their 
DNA recognition domains, with an average of 17.5 [2]. The final repeat is the “half repeat”, but, 
truncated at 20 amino acids and containing an RVD, it is functional. Despite the natural variation 
in numbers of repeats in naturally occurring TAL effectors, experimental evidence suggests that 
a minimum of 10 repeats is necessary for TAL effector activity [3]. TAL effector genes encoding 
fewer repeats likely exist as remnants of, or raw material for, adaptations in TAL effector gene 
content through recombination. 
 Delivery of TAL effectors into plant cells takes place through the bacterial type III secretion 
system within hours of inoculation [17]. The type III secretion signal resides N terminal to the 
repeat region. C-terminal, the proteins display a highly conserved trio of nuclear localization 
signals, and the acidic activation domain that confers the namesake function of these proteins. 
Many TAL effectors activate susceptibility (S) genes, whose expression facilitates bacterial 
multiplication and spread, or the development of symptoms, or both [1, 2] (Figure 2). TAL 
effector AvrBs3, from Xanthomonas campestris pv. vesicatoria (a pepper pathogen) targets the 
cell size regulator UPA20. The cell hypertrophy triggered by UPA20 activation is hypothesized 
to contribute to bacterial exudation to the leaf surface for dissemination [18, 19]. Several 
Xanthomonas oryzae TAL effectors target a family of genes encoding sugar exporters known as 
SWEET proteins [20-23]. Inducing expression of these genes would ostensibly shunt energy-
rich photosynthate into the extracellular space for consumption by the bacteria [24], though this 
explanation has not yet been tested experimentally. At least one TAL effector induces a host 
transcription factor, indicating that individual TAL effector contributions to virulence may involve 
broad and indirect alterations to host transcription [25]. 
Plants have evolved resistance mechanisms to thwart TAL effector-wielding pathogens 
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Figure 2.  TAL effectors in plant disease, natural disease resistance, and engineered resistance.  
Following delivery into the host plant cytoplasm via the bacterial type III secretion system (T3SS) and 
translocation to the nucleus, TAL effectors activate host susceptibility (S) genes that contribute to disease. 
Resistant plants may harbor a mutation in a TAL effector binding site in a major S gene that blocks 
activation, or they may harbor an S gene mimic called an executor resistance (R) gene that triggers a 
localized cell death and limits the infection when activated by a TAL effector.  Strategies for engineered 
resistance to pathogens that depend on TAL effectors as virulence factors include (bottom left) site-directed 
mutagenesis of TAL effector binding sites sites in major S genes, using engineered nucleases such as 
TALENs (see also Figure 3), (bottom right) R genes with multiple TAL effector binding sites added to their 
promoters to provide greater durability in the face of possible TAL effector loss by the pathogen, and to 
broaden specificity, and (bottom middle) an S gene RNA silencing construct driven by one or more TAL 
effectors. In this last example, the context for the TAL effector binding site in the silencing construct should 
be different from that of the S gene to avoid silencing any endogenous expression of the S gene in the 
absence of the TAL effector. 
 
 (Figure 2). These mechanisms include adaptations that prevent key S genes from being 
activated. The rice resistance gene xa13 is an allele of the major S gene SWEET13 that harbors 
a short deletion in its promoter that destroys the binding site for the corresponding TAL effector 
PthXo1 [20]. The rice resistance gene xa5 encodes the gamma subunit of the general 
transcription factor TFIIA but harbors a mutation that results in a single amino acid substitution. 
This substitution is thought to disrupt the presumed association of TAL effectors with the host 
transcriptional machinery, and prevent activation of S genes [26]. Resistance mechanisms also 
include S gene mimics, in which a TAL effector target site resides in the promoter of a so-called 
“executor resistance (R) gene” [1]. Activation of such genes (including Bs3 and Bs4c in pepper 
and Xa27 in rice) by corresponding TAL effectors results in a localized host cell death and 
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blocks infection [27-29]. In yet another form of resistance, the Xanthomonas campestris TAL 
effector AvrBs4 is recognized prior to nuclear import by the cytoplasmic host protein Bs4, and 
this recognition triggers a plant immune response [30]. 
Though the distribution of TAL effectors in nature appears largely confined to Xanthomonas, 
TAL effector-like proteins are found in another plant pathogenic bacterium, the soil borne 
species Ralstonia solanacearum. These Ralstonia TAL like-effectors (RTLs) harbor repeats of 
35 amino acids and contain RVDs rarely or not observed in Xanthomonas. The RTL repeats 
were recently shown to mediate specific DNA binding [31], with binding sites determined by their 
RVD sequence. The specificity of RTL RVDs that differ from a Xanthomonas RVD only in the 
12th position are consistent with what one would predict from the Xanthomonas structures, 
strongly suggesting a conserved overall protein topology. No RTL activity has yet been 
demonstrated or RTL-targeted genes identified, so the role of these proteins in plant disease 
remains unknown. 
TAL effectors and improving plant disease resistance  
Discovery of the TAL-DNA binding code is advancing not only our understanding of TAL 
effector-dependent mechanisms in disease and defense, but also our ability to identify new 
sources of resistance. For example, knowledge of S genes allows breeders to search for 
alternate alleles that lack the TAL effector binding site. New S gene candidates can be identified 
by scanning the promoters of all genes in a plant genome for matches to TAL effectors that are 
important for virulence [32] and selecting from among them ones that are upregulated during 
infection. These candidates are then examined individually for dependence on the 
corresponding effector for expression, and for a role in disease. Genome wide predictions 
combined with TAL effector dependent expression data can also expedite the molecular 
identification of new executor R genes when the corresponding TAL effector is known [33].  
The TAL-DNA code also can be used to engineer altogether new types of resistance (Figure 
2). Identification of TAL effector binding sites in S gene promoters has enabled targeted 
mutagenesis of these sites (e.g., by using engineered nucleases; see next section) to generate 
plants that resist infection [34]. However, such resistance may not prove to be durable; it could 
be overcome by the evolution of an alternative TAL effector that binds to the new promoter or to 
an alternate S gene. Likewise, executor R genes might be broken by pathogen loss or 
modification of the activating TAL effector. For more durable resistance, binding sites for 
multiple TAL effectors might be added to an executor R gene promoter, selecting sites for TAL 
effectors that are important for virulence. This site stacking strategy can also broaden the 
14 
 
specificity of an R gene. For example, it was used to generate rice plants resistant to multiple 
strains of the two pathogenic variants of Xanthomonas oryzae [35]. However, that same study 
showed that TAL effector binding sites likely overlap endogenous cis regulatory elements; 
adding such elements to the promoter of a cell death-triggering executor R gene could cause 
unintended activation under unforeseeable conditions, leading to aborted development or death 
of the plant [35]. Therefore, alternative strategies should also be explored. One possibility is a 
TAL effector-activated S gene silencing construct. Using a promoter identical to that of the S 
gene to drive expression of the silencing construct might seem a desirable failsafe against 
evolution of alternate TAL effectors that activate the S gene, but it could be problematic since it 
would lead to silencing of any endogenous expression of the S gene. Using the promoter of an 
alternate target with a different context for the TAL effector binding site might solve the problem, 
provided the expression pattern of the target in the absence of the TAL effector has no overlap 
with that of the S gene. Or, as with the stacked R gene promoter, a construct that contains 
multiple TAL effector binding sites could be used. 
TAL effectors as customizable DNA targeting proteins  
Fusions for targeted gene activation and repression 
TAL effectors can be easily targeted to desired DNA sequences by assembling the 
corresponding sequence of repeats. Custom TAL effectors have been shown to be effective for 
targeted gene activation in a variety of cell types, often increasing gene expression by more 
than 20-fold. In plant cells, high levels of gene activation have been achieved using the native 
TAL effector activation domain [36]. In human and other mammalian cells, activation of target 
genes was highest when the native activation domain was replaced by the VP16 activation 
domain from the herpes simplex virus or its tetrameric derivative VP64 [37, 38]. Similarly, 
targeted gene repression in plant and animal cells has been achieved using custom TAL 
effectors in which the activation domain is replaced by a repressor domain, or, in yeast, when it 
is simply removed [39-41]. Custom TAL effectors (as activators) can fail in the face of epigenetic 
silencing of the target locus [42], though as described in the structure section above, 
substituting NG for HD should accommodate cytosine methylation. Despite this limitation, TAL 
effector-based gene regulation has potential in synthetic biology, in which the ability to tightly 
control components of novel genetic circuits is critical [39, 43]. TAL effector-based gene 
activators and repressors may also be useful for treating diseases related to gene expression 
defects. In a proof of concept study, a custom TAL effector was used to increase transcription of 
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the human frataxin gene. Low expression of frataxin causes Friedreich ataxia, a disease 
characterized by progressive nervous system damage [44].  
TAL effector fusions for genome editing 
Custom TAL effector domains were rapidly adopted to create sequence specific nucleases – 
so-called TAL effector nucleases or TALENs [45, 46]. A TALEN comprises a TAL effector repeat 
array that recognizes a specific target sequence, fused to the catalytic domain of the 
endonuclease FokI. FokI functions as a dimer, so two TAL effector arrays are engineered to 
bind sites on opposing strands of DNA that are separated by a short spacer (typically 15-20 bp). 
The binding of the TAL effector domains brings the FokI monomers into proximity, resulting in 
DNA cleavage within the spacer sequence. The double strand break (DSB) activates cellular 
DNA repair pathways, which can be harnessed to achieve desired DNA sequence modifications 
at or near the break site (Figure 3).  
Non-homologous end-joining (NHEJ), which involves the rejoining of the broken ends of the 
chromosome, is one of the primary means by which DSBs are repaired in eukaryotes [47-49]. 
NHEJ is sometimes imprecise, and occasionally small deletions or insertions are introduced at 
the break site. If imprecise repair of a TALEN-induced DSB occurs in a coding sequence, 
mutations are introduced that can knock out gene function. Alternatively, if two or more breaks 
are introduced simultaneously in the genome, then a variety of chromosomal rearrangements 
can result, including large-scale deletions, inversions or translocations. Targeted mutagenesis  
 
Figure 3.  TALEN-mediated genome editing.  Double strand breaks introduced by TALENs are repaired 
by non-homologous end joining (NHEJ), leading to short insertions or deletions, or by homologous 
recombination (HR), which can be used to replace or insert new DNA. TALENs are shown as TAL effector 
fusions to the catalytic domain of the type IIS restriction endonuclease FokI, which cuts as a dimer. 
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achieved through NHEJ facilitates the study of gene function or enables creation of organisms 
or cell lines of novel genetic composition.  
Another means by which DSBs can be repaired is through homologous recombination (HR), 
also referred to as gene targeting [47-49]. HR is achieved by introducing into cells a DNA 
fragment encoding a variant of a sequence of interest. Once in the cell, HR between the 
incoming DNA and the native locus at the cut site results in an exchange of genetic information, 
thereby incorporating the sequence alterations at the locus. Sequence alterations can range 
from single base pair substitutions to large DNA insertions. The diversity of DNA sequence  
modifications enabled by HR, as well as the ability to target DSBs to any chromosomal locus, 
provides unprecedented control over the genetic material in a variety of organisms.  
The field of targeted genome modification using TALENs has advanced rapidly since the 
first TALENs were reported three years ago [45, 46]. Whereas the TAL effector repeat array  
mediates DNA recognition, sequences flanking the array (the so-called TALEN backbone) also 
influence TALEN activity in vivo. Although targeted chromosome breaks can be achieved using 
TALEN backbones that include most or all of the N- and C-terminal regions flanking the DNA 
binding domain [45, 46], several groups reported enhanced activity for TALENs with truncations 
of the N- and C-termini [13, 14, 50]. For example, truncated backbone architectures in plants 
result in more than a 25-fold increase in mutagenesis of endogenous targets [51]. We speculate 
that removal of N- and C-terminal sequences stabilizes the TALEN protein or facilitates folding.  
In the short time since the first TALENs were reported, they have proven powerful reagents 
for reverse genetics in multiple experimental systems. Although not comprehensive, the 
pantheon of experimental models whose genome has been manipulated by TALENs already 
includes C. elegans [52], Drosophila [53], zebrafish [54], Xenopus [55], mice [56], rats [57], and 
various plant [46, 58, 59] and livestock species [60]. TALEN-mediated genome modification has 
been accomplished in human differentiated cell lines [13] as well as embryonic stem and 
induced pluripotent stem cells [61], and they are rapidly being deployed to ameliorate genetic 
diseases through gene therapy  and to help solve challenges in agriculture [34, 50, 60, 62-64]. 
Although TALENs have quickly become the genome editing tool of choice, another 
potentially powerful approach is the use of TAL effector targeted recombinases. Recombinases 
(e.g. Cre) mediate recombination between specific DNA recognition sites (e.g. LoxP) and 
enable a diverse array of genome modifications including deletions, insertions and inversions. 
TAL effector recombinases (“TALER”s) have recently been engineered that recognize novel 
sites in genomes and thereby obviate the need to integrate recognition sites such as LoxP [65]. 
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Despite the growing popularity of TAL effector based tools for genome editing, particularly 
TALENs, a newly developed platform based on the bacterial CRISPR/Cas system for defense 
against phage may have significant relative advantages. This system relies on a guide RNA to 
direct the Cas9 nuclease to cleave a target DNA sequence [66]. Where TALENs function as 
dimers, requiring construction and delivery of two large proteins, Cas9 functions as a monomer 
and requires only a single RNA of about 75 bases to direct cleavage. Multiple targets can be 
encoded into longer RNAs [67]. The CRISPR/Cas9 system has been used to mediate HR and 
NHEJ in human and mouse cells, with activity comparable to that of TALENs [67, 68]. Targeting 
specificity of the CRISP/Cas system, which depends on RNA-DNA hybridization, has not yet 
been examined in depth however. 
Design and construction 
Several online tools that aid users in designing custom TAL effectors and TALENs are freely 
available, including ZiFiT (http://zifit.partners.org/ZiFiT/Introduction.aspx), Mojo Hand 
(http://www.talendesign.org/mojohand_main.php), and TALE-NT 2.0 (https://tale-
nt.cac.cornell.edu) [32, 69, 70]. For construction, modular assembly methods that rely on 
Golden Gate cloning have been developed that enable individual researchers to make dozens 
of constructs in a few days [31, 38, 59, 71, 72]. Reagents for many of these methods are 
available as kits from the non-profit plasmid repository Addgene (www.addgene.org). Solid state 
synthesis methods that allow high throughput, automatable assembly of custom TAL effector 
constructs have also been developed [73-75]. Custom TAL effectors and TALENs are available 
commercially as well. 
Future challenges  
Although custom TAL effectors and TALENs have proven to be powerful tools for a variety 
of applications, challenges and questions remain. Custom TAL effector-based constructs 
function with varying degrees of efficiency. Despite the modularity of the repeats, as noted 
above, RVDs differ in their apparent affinities for their preferred nucleotides. Thus, variation may 
simply relate to RVD (and target site) composition. Effects of binding site context and chromatin 
status are still largely unexplored however, and may also play a significant role. Better 
understanding of these effects combined with the identification of any high affinity RVDs or 
repeat types that could be used to replace those with lower affinities will be necessary to 
maximize and standardize the efficiency of TAL effectors and TALENs. 
Specificity is also important, and sometimes critical. In nature, all known TAL effector and 
target alignments contain positions where an RVD associates with a non-preferred nucleotide, 
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and most contain one or a few RVDs that lack specificity. This degeneracy may be the product 
of selection for a binding mechanism that can accommodate minor genetic changes in the host 
before adaptation through effector recombination restores optimal binding. Whether this 
degeneracy is based in evolution or simple biochemistry, it presents a challenge for designing 
custom TAL effector-based DNA targeting proteins with perfect specificity, even when using the 
most specific RVDs. There is some evidence that TAL effector tolerance for mismatches varies 
depending on the type, position, and context of the mismatch, but this tolerance has not been 
studied systematically, making it difficult to predict off-targeting. Activity at off-target sites has 
been documented for both custom TAL effectors and TALENs [14, 71, 76]. Overall, TAL 
effectors appear to target with very good specificity [reviewed in 7]. But for applications such as 
human disease therapy, absolute specificity is paramount [63]. Better understanding of 
mismatch tolerance, and continued identification of any additional RVDs that can be used to 
replace less stringent ones, such as NH in place of NN for guanine, will aid in designing highly 
specific constructs [9, 41]. 
Because of their large size and repeat structure, delivery and integrity of TAL effector 
proteins or expression constructs might present a challenge, depending on cell type or method. 
For viral delivery of TAL expression constructs to mammalian cells, for example, size may be 
limiting. The repeats might also render constructs unstable. Advances in protein and nucleic 
acid delivery are an important technical frontier for further improving the utility of TAL effector-
based DNA targeting tools. For TALENs, the use of a monomeric nuclease domain would 
decrease complexity [77]. Where possible, incorporating a nuclease domain with inherent 
specific DNA binding properties might also reduce the number of repeats needed, allowing 
smaller constructs. 
 Another future challenge is the continued development of new TAL effector-based tools 
(Figure 4). Closest on the horizon are probably TAL effector targeted DNA methylases (or 
demethylases) and histone modifiers for chromatin remodeling, and targeted cytosine 
deaminases or other mutagens for single base pair editing without recombination. One could 
also imagine using TAL effectors for DNA labeling or diagnostics, or even as organic linker 
molecules for DNA based materials [78].  Questions about native TAL effectors also remain. 
Determining their evolutionary origins and the selective forces acting on them may shed light on 
their uneven distribution across Xanthomonas species, and their limited distribution outside 
Xanthomonas. Probing the diversity and functions of TAL effector activated S and R genes is 
essential to expand our knowledge of disease and defense mechanisms, and to exploit that  
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Figure 4.  Applications of custom TAL effectors.  FokI, FokI endonuclease catalytic domain. AD, 
activation domain. RD, repressor domain. HDAC, histone deacytelase. DNMT, DNA methyltransferase. Gin, 
Gin recombinase. CD, cytosine deaminase. 
 
knowledge for effective disease control. Advances in both fields of inquiry into natural TAL 
effectors will undoubtedly also further improve our understanding of TAL effector DNA 
interaction and our ability to continue to use that understanding in creative and robust ways to 
investigate and manipulate cell biology. 
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Abstract 
TALENs are important new tools for genome engineering. Fusions of transcription activator-
like (TAL) effectors of plant pathogenic Xanthomonas spp. to the FokI nuclease, TALENs bind 
and cleave DNA in pairs. Binding specificity is determined by customizable arrays of 
polymorphic amino acid repeats in the TAL effectors. We present a method and reagents for 
efficiently assembling TALEN constructs with custom repeat arrays. We also describe design 
guidelines based on naturally occurring TAL effectors and their binding sites. Using software 
that applies these guidelines, in nine genes from plants, animals, and protists, we found 
candidate cleavage sites on average every 35 bp. Each of 15 sites selected from this set was 
cleaved in a yeast-based assay with TALEN pairs constructed with our reagents. We used two 
of the TALEN pairs to mutate HPRT1 in human cells and ADH1 in Arabidopsis thaliana 
protoplasts. Our reagents include a plasmid construct for making custom TAL effectors and one 
for TAL effector fusions to additional proteins of interest. Using the former, we constructed de 
novo a functional analog of AvrHah1 of X. gardneri. The complete plasmid set is available 
through the non-profit repository AddGene, and a web-based version of our software is freely 
accessible online. 
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Introduction 
Transcription activator-like (TAL) effectors are a newly described class of specific DNA 
binding protein, so far unique in the simplicity and manipulability of their targeting mechanism. 
Produced by plant pathogenic bacteria in the genus Xanthomonas, the native function of these 
proteins is to directly modulate host gene expression. Upon delivery into host cells via the 
bacterial type III secretion system, TAL effectors enter the nucleus, bind to effector-specific 
sequences in host gene promoters, and activate transcription (1). Their targeting specificity is 
determined by a central domain of tandem, 33-35 amino acid repeats, followed by a single 
truncated repeat of 20 amino acids (Figure 1a). The majority of naturally occurring TAL effectors 
examined have between 12 and 27 full repeats (2). Members of our group and another lab 
independently discovered that a polymorphic pair of adjacent residues at positions 12 and 13 in 
each repeat, the “repeat-variable di-residue” (RVD), specifies the target, one RVD to one 
nucleotide, with the four most common RVDs each preferentially associating with one of the four 
bases (Figure 1a) (3,4). Also, naturally occurring recognition sites are uniformly preceded by a T 
that is required for TAL effector activity (3,4). These straightforward sequence relationships 
allow the prediction of TAL effector binding sites (3-6) and construction of TAL effector 
responsive promoter elements (7), as well as customization of TAL effector repeat domains to 
bind DNA sequences of interest (8-11). 
As a result, TAL effectors have attracted great interest as DNA targeting tools. In particular, 
we and other groups have shown that TAL effectors can be fused to the catalytic domain of the 
FokI nuclease to create targeted DNA double strand breaks (DSBs) in vivo for genome editing 
(8,10,12,13). Since FokI cleaves as a dimer, these TAL effector nucleases (TALENs; 8) function 
in pairs, binding opposing targets across a spacer over which the FokI domains come together 
to create the break (Figure 1b). DSBs are repaired in nearly all cells by one of two highly 
conserved processes, non-homologous end joining (NHEJ), which often results in small 
insertions or deletions and can be harnessed for gene disruption, and homologous 
recombination (HR), which can be used for gene insertion or replacement (14,15). Genome 
modifications based on both of these pathways have been obtained with high frequency in a 
variety of plant and animal species using zinc finger nucleases (ZFNs) and homing 
endonucleases. However, for each of these platforms, engineering novel specificities has 
generally required empirical and selection-based approaches that can be time and resource  
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Figure 1.  TAL effector and TALEN structure.  (a) Structure of a naturally occurring TAL effector. A 
consensus repeat sequence is shown with the repeat-variable di-residue (RVD) underlined. The sequence 
of RVDs determines the target nucleotide sequence. The four most common RVDs, on which our designs 
and plasmids are based, are shown with their most frequently associated nucleotide. Some evidence 
suggests that the less common RVD NK (not displayed) has greater specificity for G than NN does and for 
that reason our plasmid set also includes NK modules. (b) Structure of a TALEN. Two monomeric TALENs 
are required to bind the target site to enable FokI to dimerize and cleave DNA.  NLS, nuclear localization 
signal(s); AD, transcriptional activation domain; B, BamHI; S, SphI. 
 
intensive. And, despite a significant recent advance for ZFNs that takes finger context into 
account to achieve high success rates (16), targeting capacity (the diversity of sequences that 
can be recognized) still suffers limitations (17-19). TALENs thus far appear not to be subject to 
these constraints. In at least one study, mutagenesis frequency was estimated to be as high as 
25% of transfected cells, on par with or better than ZFNs (10)  
The TAL effector repeat domain also has been successfully customized to make targeted 
transcription factors, both in plants in the native protein context and in human cells with the TAL 
effector activation domain replaced by VP64 (9,11). Fusions to other protein domains for 
chromatin modification, gene regulation, or other applications can also be envisioned. Thus, an 
efficient method for assembling genetic constructs to encode TAL effectors and TAL effector 
fusions to other proteins, with repeat arrays of user-defined length and RVD sequence, is highly 
desirable. 
In our previous work, we constructed TALENs with customized repeat arrays through 
sequential cloning of sequence-verified single, double, and triple repeat modules (8). We sought 
a more rapid approach that would not rely on commercial synthesis, which is costly, or PCR- 
based methods, which can result in mutations or recombined repeats. We opted for Golden 
Gate cloning, a recently developed method of assembling multiple DNA fragments in an ordered  
a
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fashion in a single reaction (20,21). The Golden Gate method uses Type IIS restriction 
endonucleases, which cleave outside their recognition sites to create unique 4 bp overhangs 
(sticky ends) (Figure 2). Cloning is expedited by digesting and ligating in the same reaction 
mixture because correct assembly eliminates the enzyme recognition site. 
 We report here a complete set of plasmids for assembling novel repeat arrays for TALENs, 
 
 
Figure 2.  Golden Gate assembly of custom TAL effector and TALEN constructs using module, array, 
last repeat and backbone plasmids
1
.  By using the type IIS restriction endonucleases BsaI and Esp3I, 
modules containing the desired RVDs can be released with unique cohesive ends for ordered, single-
reaction assembly into array plasmids in a first step, and those arrays subsequently released and 
assembled in order in a second step into a backbone plasmid to create full length constructs with custom 
repeat arrays (see text for details). NLS, nuclear localization signal(s); AD, transcriptional activation domain; 
tet, tetracycline resistance; spec, spectinomycin resistance; amp, ampicillin resistance; attL1 and attL2, 
recombination sites for Gateway cloning; B, BamHI, and S, SphI, useful for subcloning custom repeat 
arrays. Unique restriction enzyme sites flanking the coding seqeunces, useful for subcloning the entire 
constructs into other vectors, are not shown but can be found in the sequence files (Supplementary Data). 
                                                          
1
 The marker in the Last Repeat plasmid has been changed to spec, according to the correction 
published in Nucleic Acids Res., 2011. 39(17), 7879.   
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TAL effectors, or TAL effector fusions to other proteins using the Golden Gate method in two 
steps. We also describe software for TALEN targeting based on guidelines we developed to 
reflect naturally occurring TAL effector binding sites and on our previous TALEN study. We 
show that TALENs targeted with this software and constructed using the plasmid set are active 
in a yeast DNA cleavage assay, and effective in gene targeting in human cells and Arabidopsis 
thaliana (hereafter Arabidopsis) protoplasts. Finally, we demonstrate successful construction of 
a functional analog of the avrHah1 TAL effector gene of Xanthomonas gardneri (22).  
Materials and Methods 
Protocol for assembly of custom TALEN, TAL effector or TAL effector fusion-ready 
constructs 
Assembly of a custom TALEN or TAL effector construct is accomplished in five days (Figure 
3) and involves two steps: (i) assembly of repeat modules into intermediary arrays of 1-10 
repeats, and (ii) joining of the intermediary arrays into a backbone to make the final construct. A 
schematic representation is shown in Figure 2 and the complete set of required plasmids is 
displayed in Supplementary Figure S1. Construction and features of the plasmids themselves 
are described in the following section. The assembly protocol differs slightly for arrays of 12-21 
modules versus arrays of 22-31 modules. We use as an example here construction of a TALEN 
monomer with a 16 RVD array and note differences in the protocol where they occur for making 
constructs with arrays of 22-31 RVDs. 
 
 
Figure 3.  TALEN or TAL effector construct assembly timeline. 
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30 
 
Day 1 
Consider the RVD array NI HD HD NN HD NI NI NG HD NG HD NI NI NG HD NG, targeting  
the sequence 5’- ACCGCAATCTCAATCT-3’.1 Note that the 5’-T preceding the RVD-specified 
sequence is not shown and need not be considered in the assembly, although based on 
evidence to date (3,4), it should be considered during site selection. Select from the module 
plasmids those that encode RVDs 1-10 in the array using plasmids numbered in that order. For   
example, the plasmid for the first RVD would be pNI1, the second pHD2, the third pHD3, etc. 
Modules from these plasmids will be cloned into array plasmid pFUS_A. Next, select modules 
for RVDs 11-15 in the 16 RVD array again starting with plasmids numbered from 1. Thus for 
RVD 11 pHD1 would be used, for RVD 12 pNI2, etc. Note that the sixteenth and last RVD is 
encoded by a different, last repeat plasmid and is added later, in the second step (see Day 3). 
Modules encoding RVDs 11-15 are cloned into a pFUS_B array plasmid. The pFUS_B plasmids 
are numbered 1-10 and should be selected according to the number of modules going in. Thus, 
in our example, pFUS_B5 should be used. If arrays of 22-31 modules are to be assembled, the 
first 10 modules are cloned into pFUS_A30A, the second 10 modules into pFUS_A30B, and the 
remaining modules into the appropriate pFUS_B plasmid, again according to the number of 
modules going in.  
The module and array plasmids (150 ng each) are subjected to digestion and ligation in a 
single 20 ml reaction containing 1 ml BsaI (10U, New England BioLabs), and 1 ml T4 DNA 
Ligase (2000U, New England BioLabs) in T4 DNA ligase buffer (New England BioLabs). The 
reaction is incubated in a thermocycler for 10 cycles of 5 min at 37˚C and 10 min at 16˚C, then 
heated to 50˚C for 5 min and then 80˚C for 5 min. Then, 1ml 25 mM ATP and 1 ml Plasmid Safe 
DNase (10U, Epicentre) are added. The mixture is incubated at 37˚C for 1 hr, then used to 
transform Escherichia coli cells. Cells are plated on LB agar containing 50 mg/ml spectinomycin, 
with X-gal and IPTG for blue/white screening of recombinants, as described (23). Treatment 
with Plasmid Safe DNase is an important step to prevent linear DNA fragments, including partial 
arrays, from recombining into and circularizing the linearized array plasmids following 
transformation, due to the presence of partial repeat sequences at the termini of the array 
plasmids. 
Day 2 
Pick up to three white colonies from each transformation and start overnight cultures.  
Day 3 
                                                          
1
 This sentence has been corrected to reflect the correction published in Nucleic Acids Res., 2011. 
39(17), 7879.   
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 Isolate plasmid DNA and identify clones with the correct arrays by restriction enzyme 
digestion and agarose gel electrophoresis. AflII and XbaI will release the repeat arrays, which 
will be 1048 bp for pFUS_A, 1052 bp for pFUS_A30A, 1040 bp for pFUS_A30B plasmids, and 
of varying sizes for pFUS_B plasmids.  
The next step is to join the intermediary arrays, along with a last repeat, into the desired 
context, usin
prepared as in the first step but with 150 ng each of the pFUS_A and pFUS_B plasmids 
containing the intermediary repeat arrays (or the pFUS_A30A, pFUS_A30B, and pFUS_B 
plasmids carrying the intermediaries for final arrays of 22-31 RVDs), 150 ng of the backbone 
plasmid, in this case pTAL3 or pTAL4 for constructing a TALEN monomer, and importantly, 150 
ng of the appropriate last repeat plasmid. In our example, pLR-NG, for the 16th and last RVD, 
would be used. The reaction is treated and used to transform E. coli as above, except that 
Plasmid Safe DNAse treatment is omitted because the backbone plasmid termini have no 
homology with the array. Also, in this step, ampicillin (100 
spectinomycin for selection of transformants. 
Day 4 
 Pick up to 3 white colonies from each transformation and start overnight cultures.  
Day 5 
Isolate plasmid DNA and identify clones containing the final, full-length repeat array. Array 
length can be verified by digestion with BstAPI (or StuI) and AatII, which cut just outside the 
repeats, or with SphI, which cuts farther out. Array integrity can be checked using BspEI, which 
cuts only in HD modules 2-10. The array can also be characterized by DNA sequencing. 
Construction of module, last repeat, array, and backbone plasmids 
Repeat modules with the RVDs HD, NG, NI, NK, and NN, across ten staggered positions 
and with a BsaI site added to each end, were synthesized. The modules were cloned between 
the unique XbaI and XhoI sites of pTC14, replacing the spectinomycin resistance gene in that 
plasmid, to create a set of 50 module plasmids (pHD1 through pHD10, pNG1 through pNG10, 
etc.). pTC14 is a derivative of the Gateway entry and TOPO cloning vector pCR8 (Invitrogen) in 
which the Gateway cassette was replaced with a gene for tetracycline resistance using the 
flanking EcoRV and HpaI sites. Aside from the RVD codons, the modules at each position are 
identical, except for a BspEI site introduced into HD modules 2-10 for testing full-length array 
integrity by digestion. The modules are based on the first repeat of tal1c of X. oryzae pv. 
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oryzicola strain BLS256 (3), which matches the consensus repeat and is made up of common 
codons.  
Similarly, one module for each of the five RVDs containing the last, truncated repeat of the 
TAL effector repeat domain was synthesized and cloned in plasmid pCR8 (carrying the 
spectinomycin resistance gene) using ApaI and XbaI and replacing the Gateway cassette, to 
create five last repeat plasmids (e.g., pLR-HD).  
Next, array plasmids pFUS_A, pFUS_A30A, and pFUS_A30B were created by cloning, 
using AflII and XbaI, synthesized fragments into pCR8 that contain two internal BsaI sites 
oriented to cut outward into flanking sequences such that linearizing the vector with the enzyme 
leaves the appropriate overhangs to accept an array of 10 repeat modules (i.e. complementary 
on one side to the 5’ end of position 1 modules and on the other to the 3’ end of position 10 
modules). The series of array plasmids pFUS_B1 through pFUSB10 were made similarly to be 
complementary on one side to the 5’ end of position 1 modules, but complementary on the other 
to the 3’ end of modules in position 1 through 10, respectively, to accept arrays ranging from 1 
to 10 modules. A DNA fragment containing the lacZ gene for blue/white screening (23) was 
cloned between the two BsaI sites. For this, the multiple cloning site between the HincII and 
Eco53kI sites in phagemid pBCSK+ (Stratagene) was deleted and the lacZ gene PCR amplified 
with primers carrying KasI and AgeI overhangs. These sites were included in the synthesized 
fragments, allowing the lacZ gene to be placed between the BsaI sites, maintaining the 
overhang sequences for accepting modules. The inserts in the array plasmids all contain 
terminal Esp3I (another type IIS enzyme) sites positioned to cut inward and release the arrays 
with appropriate overhangs for ordered ligation into a backbone plasmid for complete arrays of 
12-21 (a pFUS_A array with a pFUS_B array, plus a last repeat) or 22-31 repeats (a 
pFUS_A30A with a pFUS_A30B and a pFUS_B array, plus a last repeat). These sites, or 
flanking AflII and XbaI sites in the vector (enzymes that are generally less expensive), can also 
be used to screen assembled clones for the correct size.  
Backbone plasmid pTAL3 was derived from pFZ85, a precursor to the TALEN yeast 
expression vector we created previously (8). Derived from pDW1789 (24), pFZ85 contains the 
counterselectable ccdB gene flanked by BamHI sites downstream of the yeast TEF promoter 
and a sequence encoding a nuclear localization signal and upstream of a sequence encoding a 
linker and the FokI nuclease catalytic domain. For our previous TALEN constructs, we used 
tal1c as a context for custom repeat arrays. First, solely for expediency of later adding the lacZ 
gene, the SphI fragment of tal1c was replaced with the SphI fragment of TAL effector gene 
pthXo1 (25), which has minor polymorphisms flanking the repeat region that create convenient 
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restriction enzyme sites. The spanning BamHI fragment of the resulting gene was then cloned 
between the BamHI sites of pFZ85. Finally, the repeat region within the SphI fragment was 
deleted by digestion with BstAPI and AatII and replaced with a fragment carrying the lacZ gene 
for blue/white screening (cloned into this fragment as described above), flanked by outward 
cutting Esp3I sites and the necessary sequences to create a specific overhang on either end to 
accept final arrays and reconstitute a complete TAL effector domain. Importantly, the SphI sites, 
which are highly conserved among TAL effectors and are useful for swapping the entire repeat 
region into other TAL effector constructs, are preserved. The architecture of the constructs is 
the same as reported in our earlier work (8), encoding 287 and 230 amino-acids of the TAL 
effector upstream and downstream of the repeats, respectively, with an additional 6 amino acids 
linking the TAL effector and FokI domains. To create pTAL4, which is identical to pTAL3 except 
that it carries LEU2 in place of HIS3, first the LEU2 gene was PCR amplified using primers 
having 20 bp extensions with homology to the region at the 5’ end of the Bpu10I and 3’ end of 
the AfeI site in pDW1789. Then, pDW1789 was linearized with Bpu10I and AfeI (removing the 
HIS3 gene) and the PCR amplified LEU2 gene was inserted by in vivo recombination in E. coli 
(26). Finally, into this plasmid, the XbaI-SacI fragment of pTAL3 containing the TALEN 
backbone construct was introduced at the corresponding sites.  
pTAL1 was created by replacing the SphI fragment of tal1C in pCS691 with the 
corresponding SphI fragment of pTAL3, containing the lacZ gene and the Esp3I sites and 
flanking sequences for accepting final arrays. pCS691 is a derivative of Gateway entry vector 
pENTR-D (Invitrogen) containing between the attL sites the complete tal1c gene preceded by 
both Kozak and Shine-Dalgarno consensus sequences for efficient translation in eukaryotic or 
bacterial cells respectively. In pCS691, the kanamycin resistance gene of pENTR-D is replaced 
by the BspHI fragment of pBlueScript SK(-) (Stratagene) for ampicillin resistance. To create 
pTAL2, the stop codon of tal1c in pTAL1 was deleted using the QuickChange mutagenesis kit 
(Stratagene) to allow translational fusion to other protein domains following Gateway 
recombination into a destination vector. 
 A schematic of all modules, last repeat, array, and backbone plasmids (Supplementary 
Figure S1) and a folder containing complete sequences (Supplementary Data) are included in 
Supplementary Data. 
Software to identify candidate TALEN target sites 
The software used to design TALENs in this study was written in Python 2.6.4. and runs in 
Linux (Ubuntu 10.10). It is available for use as an online tool (TAL Effector-Nucleotide Targeter, 
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TALE-NT; http://boglabx.plp.iastate.edu/TALENT/). The tool provides a window to input DNA 
sequences (Supplementary Figure S2a), which are then scanned for sites based on TALEN 
design guidelines we established, described in the “Results” section. The software identifies 
sets of TALEN recognition sites between 15 and 30 bp in length and separated by a spacer. 
The default spacer lengths are 15 and 18-30 bp (8), but other lengths can be specified by the 
user. In addition, buttons allow users to exclude design guidelines individually. The output is 
tab-delimited text, which can be imported into standard spreadsheet software (Supplementary 
Figure S2b). It provides coordinates and sequences of identified targets indicating the 
recognition sites for the left and right TALEN monomers and the spacer sequence. Because 
naturally occurring TAL effector recognition sites are uniformly preceded by a T, which is 
required for TAL effector activity (3,4), only TALEN monomer recognition sites preceded by a T 
are included. The T itself is not part of the output. Finally, the software provides the RVD 
sequences needed to construct the corresponding custom TALENs.  
Testing TALEN function in yeast 
The yeast assay for TALEN function was adapted from one we developed previously for 
ZFNs (8,24) in which cleavage of the target, positioned between partially duplicated fragments 
of the lacZ gene, reconstitutes the gene via subsequent recombination to provide a quantitative 
readout (Supplementary Figure S3a). For typical heterodimeric target sites (i.e. such as would 
typically occur in a native DNA sequence), paired TALEN constructs, in pTAL3 and pTAL4, are 
 mating type) using histidine and leucine 
prototrophy for selection. Individual TALEN monomers can be tested on homodimeric sites 
using just one of these plasmids. The target is made using synthesized complementary 
oligonucleotides that produce BglII- and SpeI-compatible ends, and cloned between the lacZ 
fragments in the high copy DNA cleavage reporter plasmid pCP5 (24) cut with those enzymes 
(Supplementary Figure S3b). The target plasmid is transformed into yeast strain YPH499 (α 
mating type), using tryptophan prototrophy for selection, but also excluding uracil from the 
growth medium: in addition to the target cloning site, pCP5 carries also the URA3 gene between 
the lacZ fragments so that selection for URA3 ensures that the strain has not undergone 
spontaneous recombination (and loss of URA3) prior to the assay.  
Three transformants each of YPH500 carrying the TALEN construct(s) and of YPH499 
carrying the target plasmid are cultured overnight at 30°C, with rotary shaking at 800 rpm, in 
synthetic complete medium lacking histidine and/or leucine (TALENs), or tryptophan and uracil 
(target). TALEN and target transformants are next mated (3 pairs) by combining 200-
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the overnight cultures, adding 1 ml of YPD medium, and incubating for 4-6 hrs at 30°C, shaking 
at 250-300 rpm. Cells are harvested by centrifguation, washed in 1 ml synthetic complete 
medium lacking histidine and/or leucine and tryptophan, but now containing uracil, then 
resuspended in 5 ml of that medium and incubated overnight again at 30°C, with shaking (800 
rpm), to an OD600 between 0.1 and 0.9. Cells are harvested by centrifugation, then resuspended 
and lysed using YeastBuster Protein Extraction Reagent (Novagen) according to the 
-galactosidase activity measured and normalized as previously described (24). For 
high throughput, yeast may be cultured and mated (using a gas permeable seal) as well as 
lysed in 24 well blocks. We typically express activity relative to a Zif268 ZFN (24).  
Expression of custom TALENs in human cells and Arabidopsis protoplasts and detection 
of site-specific mutations 
One of the pairs of TALENs targeting the human HPRT1 gene was subcloned into the 
mammalian expression vector pCDNA3.1(-) (Invitrogen) using XhoI and AflII. These enzymes 
excise the entire TALEN from pTAL3 or pTAL4 and place the coding sequence under control of 
the CMV (cytomegalovirus) promoter. The resulting plasmids were introduced into HEK293T 
cells by transfection using Lipofectamine 2000 (Invitrogen) following the manufacturer’s 
protocol. Cells were collected 72 hours after transfection, and genomic DNA isolated and 
digested with Hpy188I, which cuts in the spacer sequence of the TALEN target site. After 
digestion, a chromosomal fragment encompassing the target site was amplified by PCR. Upon 
completion, the reactions were incubated for 20 min at 72°C with 4 µl of Taq DNA polymerase. 
PCR products then were digested with Hpy188I and cloned in a TOPO TA vector (Invitrogen). 
Independent clones containing the full-length PCR product were sequenced to evaluate 
mutations at the cleavage site. 
The TALENs targeting the Arabidopsis ADH1 gene were subcloned into the plant 
expression vector pFZ14 (27) using XbaI and SacI. These enzymes excise the entire TALEN 
from pTAL3 or pTAL4 and place the coding sequence under control of the CaMV (cauliflower 
mosaic virus) 35S promoter. Recombinant plasmids were transformed into Arabidopsis 
protoplasts as previously described (27). Forty-eight hours after transformation, DNA was 
prepared and digested with PflFI, which cuts in the spacer sequence of the TALEN target site. 
After digestion, a chromosomal fragment encompassing the target site was amplified by PCR 
and the reaction products were once again digested with PflFI and run on an agarose gel. The 
36 
 
band corresponding in size to undigested product was excised and cloned, and individual 
clones were sequenced to evaluate mutations at the cleavage site. 
Expression of a custom TAL effector in Xanthomonas and in planta activity assay 
An analog of avrHah1 was assembled into pTAL1 using the Golden Gate method with HD, 
NI, NG, and NN modules, ordered to match the AvrHah1 binding site in the promoter of the Bs3 
gene (22). A native avrHah1 construct was made by replacing the BamHI fragment of tal1c in 
pCS495 with that of avrHah1. pCS495 is tal1c preceded by Shine-Dalgarno and Kozak 
consensus sequences in pENTR-D (Invitrogen). The analog and native avrHah1 constructs and 
tal1c were moved into pKEB31 by Gateway cloning (LR reaction). pKEB31 Is a derivative of 
pDD62 (28) that contains a Gateway destination vector cassette (Invitrogen) between the XbaI 
and BamHI sites and a tetracycline resistance gene in place of the gene for gentamycin 
resistance. The resulting plasmids were introduced into X. campestris pv. vesicatoria strain 85-
10 by electroporation and transformants were inoculated to 6-week-old pepper plants by syringe 
infiltration, as described (22). After 48 hours, infiltrated leaves were cleared in 70% ethanol and 
10% glycerol and photographed.  
Results 
Efficient assembly of custom repeat arrays into TALEN and other TAL effector-based 
constructs 
Our implementation of the Golden Gate method accomplishes custom TAL effector 
construct assembly in two steps (Figure 2 and Supplementary Figure S1). In the first step, it 
uses five sets of 10 staggered repeat clones, one for each of the four most common RVDs HD, 
NI, NG, and NN, which associate most frequently with C, A, T, and G, respectively and one for 
the less common NK, which at least in some contexts appears to have higher specificity for G 
than NN does (9,10). Inserts in these “module” plasmids carrying the desired RVDs are 
released and assembled in order in one or two sets of 10 and one set of 1-10 into “array” 
plasmids, using a type IIS enzyme. In the second step, the resulting array fragments are joined, 
along with a final, truncated repeat from a collection of five “last repeat” plasmids (one for each 
RVD), into any of four different “backbone” plasmids, using a different type IIS enzyme, for a 
final array of 12 (10 + 1 + the last) to 31 (10 + 10 + 10 + the last) RVDs. Counting the 5’ T that 
precedes the RVD specified sequences in TAL effector binding sites, the corresponding target 
ranges from 13 to 32 nucleotides. 
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The backbone plasmids include (i) pTAL1 for assembling a custom TAL effector gene 
preceded by Shine-Dalgarno and Kozak sequences for efficient translation in bacteria and 
eukaryotes, respectively, (ii) pTAL2, identical to pTAL1, but without a stop codon so that the 
effector can be fused to other protein domains, (iii) pTAL3 for assembling a custom TALEN and 
expressing it in yeast using the selectable marker HIS and (iv) pTAL4, identical to pTAL3 but 
containing the marker LEU2, so that two TALEN monomers can be paired in the yeast assay 
(see below). The TAL effector constructs are flanked by attL sites for transfer by Gateway 
recombination (Invitrogen) into destination vectors of choice. The TALEN constructs, though not 
Gateway compatible, are flanked by restriction enzyme sites convenient for subcloning into 
different expression vectors. All constructs retain the internal SphI sites flanking the repeat 
domain as well as the BamHI sites farther out that are conserved in most TAL effectors and can 
be used to readily swap a custom array into other TAL effector based constructs. 
All of the array and backbone plasmids contain within the cloning site the lacZ gene for 
blue/white screening to identify recombinants (23). For the work presented here, we 
successfully assembled > 30 custom TALENs (Supplementary Table S1) and one custom 
TAL effector, ranging in array length from 15 to 30 RVDs. We never failed to obtain the correctly 
assembled array plasmid clone or the correctly assembled, final backbone plasmid clone for any 
of these by screening only three white colonies per cloning reaction transformed into E. coli. We 
routinely pick just two colonies, and usually both are correct (not shown). Assembly of one or 
more constructs takes just 5 days (Figure 3 and refer “Materials and Methods” section). 
Guidelines and software for TALEN site selection and repeat array design.  
To facilitate TALEN design for genome editing, we wrote a computer program that analyzes 
DNA sequences, identifies suitable, paired and opposing TAL effector target sites across a 
spacer, and generates corresponding RVD sequences using the four most common RVDs (see 
“Materials and Methods” section). The software uses guidelines for TAL effector targeting that 
reflect naturally occurring TAL effectors and their binding sites and spacer lengths that we 
observed to function well in our previous study using TALENs derived from naturally-occurring 
TAL effectors (8). We established the targeting guidelines by examining the 20 TAL effector-
target pairs identified by Moscou and Bogdanove (3). We looked for positional biases, neighbor 
effects and overall trends in nucleotide and RVD composition. To examine position effects for 
sequences of different lengths, we confined the analysis to the five positions at either end. We 
compared observed nucleotide and RVD frequencies to expected frequencies, taken as the 
frequencies in the entire set of sequences (Figure 4). The binding sites showed a strong bias  
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Figure 4.  Nucleotide and RVD frequencies at the termini of 20 target and TAL effector pairs.  RVDs 
that have a frequency of ≥20% at one or more of the positions are shown.  ‘XX’ represents all other RVDs. 
 
against T at position 1 (5’ end), a bias against A at position 2, biases against G at the last (3’) 
and next-to-last positions and a moderate bias for T at the last position. RVD sequences 
showed corresponding positional biases: NG was disfavored at position 1; NI was disfavored at 
position 2 and NG was favored and NN disfavored at the last position. The bias for NG at the 
last position was particularly striking: NG occurs at this position in 85% of the sequences 
compared to its overall observed frequency of 18%. No neighbor effects were detected in the 
binding sites or RVD sequences. Average nucleotide composition of the binding sites was 31 ±  
16% A, 37 ± 13% C, 9 ± 8% G, and 22 ± 10% T. To expand on this dataset, we used the weight 
matrix developed by Moscou and Bogdanove (3) to identify the best-scoring binding sites 
(preceded by a T) for each of 41 X. oryzae TAL effectors in each of approximately 57,000 rice 
promoters. We retained those in genes shown by microarray analysis (www.plexdb.org, 
experiment OS3) to be up-regulated during infection. This analysis yielded close to 100 putative 
additional TAL effector-target pairs. These reflected the same positional biases (data not 
shown). The guidelines are therefore as follows: (i) As noted previously for TAL effector binding 
sites (3,4), TALEN monomer binding sites should be preceded by a 5’ T, (ii) they should not 
have a T at position 1, (iii) they should not have an A at position 2, (iv) they should end with a T, 
so that the corresponding TALENs will reflect the strong bias for NG at this position and (v) they 
should have a base composition within two standard deviations of the averages we observed.     
We did not systematically test the guidelines, but data from intermediate constructs we 
obtained while building full-length TALENs with our earlier sequential ligation method provide 
some support (Supplementary Table S2). Of the four intermediate length TALEN-target pairs 
showing no detectable activity in the yeast assay for DNA cleavage (8), one did not match 
overall target nucleotide composition, one did not have an RVD sequence ending in NG, and 
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another did not meet either of these guidelines. Two out of seven with activity <25% of the 
Zif268 ZFN used as a control did not match overall target nucleotide composition. One of four 
with activity 25-50% of Zif268 did not have an RVD sequence ending in NG. TALENs with 50% 
or greater activity of Zif268 met all of the guidelines. The impact of the number of repeats in a 
TALEN was also considered. In general, longer TALENs that met all of the guidelines or 
medium-length TALENs that met all guidelines and had a high percentage of HDs showed the 
highest activity. Longer TALENs that failed to meet one or more guidelines showed reduced 
activity when compared to those of the same length that met all guidelines. Thus, in addition to 
providing preliminary support for the guidelines, the results also suggest that array length 
positively correlates with activity.  
Toward validating our method for making custom TAL effector arrays, we used the software 
to first identify candidate TALEN sites in seven plant (Arabidopsis, tobacco), animal (human, 
zebrafish, Drosophila) and protist (Plasmodium) genes as well as in GFP and eGFP. In these 
genes, the software found unique TALEN sites on average every 35 bp (range = 15-120 bp). 
Activity of custom TALENs in a yeast-based DNA cleavage assay 
Custom TALEN pairs for 15 target sites (30 TALENs total; SupplementaryTable S1) were 
made using the Golden Gate method and plasmids described above and tested in the yeast 
based DNA cleavage assay we described previously (8). All TALEN pairs showed significant 
activity above the target-only negative controls, and 14 of 15 showed activity ≥25% of our 
positive control, a Zif268 ZFN (Figure 5). We have generally found for ZFNs that this level of 
activity is sufficient for targeted mutagenesis of endogenous plant loci (24,27). 
Targeted mutagenesis in human cells and Arabidopsis protoplasts using custom 
TALENs 
To validate the activity of our custom TALENs outside of yeast, we used one of the TALEN 
pairs for the human HPRT1 gene (HPRT1 B in Figure 5) and the TALEN pair for the Arabidopsis 
ADH1 gene to carry out targeted mutagenesis in human embryonic kidney cells and Arabidopsis 
protoplasts, respectively. In both cases the custom TALENs generated mutations at the 
recognition site through imprecise repair of the cleaved chromosomes by non-homologous end-
joining (Figure 6). Our method of detection used an enrichment step, so it was not possible to 
quantify mutagenesis frequency. However, we obtained for HPRT1, 17 independent mutations  
including two single base pair substitutions and deletions ranging from 1-27 bp roughly centered 
on the spacer and for ADH1, 6 independent mutations consisting of deletions ranging from 4 to 
15 bp, also centered on the spacer.   
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Figure 5.  Activity of 15 custom TALEN pairs targeting diverse sequences in a reporter-based yeast 
assay.  TALENS were targeted to gene sequences from the indicated organisms and to GFP and eGFP 
using the software and constructed using the Golden Gate method and plasmids described in the text. 
Activity was measured in a yeast-based assay in which cleavage and recombination reconstitutes a 
functional lacZ gene (see text for details). Activity was normalized to a Zif268 ZFN positive control. Activity of 
target-only controls for each is plotted above the target-plus-TALEN values; in each case the activity was 
undetectable. Error bars denote s.d.; n = 3. 
 
Replication of AvrHah1 TAL effector activity with a Golden Gate assembled clone 
To assess our plasmids for construction of custom TAL effectors, we assembled an analog 
of the avrHah1 TAL effector gene of X. gardneri, which elicits a hypersensitive reaction in 
pepper by transcriptionally activating the Bs3 resistance gene (22). We chose AvrHah1 because 
it is highly divergent relative to other characterized TAL effectors, carrying predominantly 35 
amino acid repeats (in contrast to the more common 34 amino acid repeat on which our 
modules are based) as well as other deviations from the consensus sequences both within and 
outside the repeat region. Introduced into X. campestris pv. vesicatoria strain 85-10, which lacks 
AvrHah1, that was then inoculated into pepper leaves, the Golden Gate assembled clone 
triggered a Bs3 specific hypersensitive reaction indistinguishable from that elicited by the native 
effector (Figure 7). This recreation of AvrHah1 specificity using our modular reagents 
demonstrates their utility for making custom transcription factors and underscores the 
sufficiency of the RVD sequences for targeting. 
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Figure 6.  Site-directed mutagenesis in human embryonic kidney cells and Arabidopsis protoplasts 
using custom TALENs.  TALENS targeted to the human HPRT1 gene (pair HPRT1 B in Figure 5) and the 
Arabidopsis ADH1 gene (Figure 5) were transiently expressed in human embryonic kidney cells and in 
Arabidopsis protoplasts, respectively and the targets subsequently amplified and sequenced (see text for 
details). Prior to amplification, genomic DNA was digested with a restriction endonuclease having a site 
present in the TALEN target site to reduce amplification of wild type sequences and enrich the amplicon pool 
for mutated ones. Results for HPRT1 are shown in (a) and ADH1 in (b). For each, the schematic at the top 
shows the chromosomal locus, short arrows designate primers used for PCR amplification following TALEN 
transient expression, sequence of the wild type gene (top line) and unique mutated alleles obtained are 
shown below, binding sites for the TALEN monomers are underlined and the coincident restriction 
endonuclease site is indicated. 
 
Discussion 
The hallmark feature of TAL effectors that makes them such remarkably powerful tools for 
DNA targeting, their long arrays of 33-35 amino acid repeats that specify nucleotides in the 
recognition site in a straightforward and modular fashion, also make them challenging to 
engineer. Commercial synthesis is effective (10) but costly. PCR based methods (11) carry the 
risk of artifact and recombination.  Assembly by sequential ligation of sequence-verified 
modules (8) is inexpensive and assures array integrity but is time consuming. The Golden Gate  
a
b
PflFI 
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Figure 7.  Activity of an AvrHah1 analog created using the Golden Gate method and our plasmid set.  
Shown are leaves of pepper varieties ECW30R, carrying the Bs3 resistance gene and ECW, lacking it, 48 h 
following spot-infiltration with suspensions of X. campestris pv. vesicatoria strain 85-10 transformed to 
deliver (1) Tal1c (the effector used to make the backbone plasmids in this study), (2) native AvrHah1 or (3) 
an AvrHah1 analog encoded by a construct made using the Golden Gate method and our plasmid set. 
Leaves were cleared with ethanol to reveal the accumulation of phenolic compounds, visible as dark stained 
areas, indicative of the hypersensitive reaction induced by TAL effector driven transcriptional activation of 
Bs3. 
 
method using the reagents we describe here, provides a cost-effective, robust, and rapid 
solution. TAL effector constructs with arrays of up to 31 RVDs are assembled in just two cloning 
steps using a set of sequence-verified modules. Furthermore, the reagents provide great 
flexibility for cloning arrays in different contexts and expressing them in different organisms, 
either in our set of backbone plasmids for TALENs, TAL effectors, or TAL effector fusions to 
additional proteins, or by simple subcloning or Gateway recombination into other vectors. 
Zhang et al. (11) recently presented a protocol and set of templates for Golden Gate-like 
assembly that involves PCR amplification of modules, intermediary arrays, and full-length arrays 
to yield TAL effector DNA binding domains with 13 RVDs fused in a backbone vector to VP64 
(see also www.taleffectors.com). This marked a significant advance that enabled the authors to 
rapidly assemble custom arrays and demonstrate the utility of TAL effector-based proteins as 
custom transcription factors to activate endogenous genes in human cells. However, the 
method and plasmids we describe here offer more versatility for broader utility, not only with 
regard to the available contexts and portability of the arrays, as noted above, but also in array 
length. The ability with our reagents to construct arrays ranging from 12 to 31 RVDs allows fine-
tuning for targeting and will be important for testing the important outstanding question of the 
relationship of length to affinity and specificity. The broad range in array length also offers 
greater flexibility to systematically address other important questions including the contributions 
2
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of individual RVD-nucleotide associations to affinity and specificity, as well as the effect of 
position on mismatch tolerance (1). This could be accomplished, e.g. by starting with an array of 
minimal functional length and comparing the effects of adding or interspersing additional RVDs 
aligned to different nucleotides in the target.  
Our method has the technical advantage of involving no PCR. Although the Zhang et al. (11) 
repeat templates for different RVDs are codon engineered to guard against slippage and inter-
repeat recombination during PCR amplification, this strategy does not prevent recombination 
between repeats carrying the same RVD, particularly if they are present in tandem. Also, in part 
because our method involves no PCR, though it is 2 days longer it is less labor intensive and 
time consuming day to day. 
Though all of the custom arrays made for this study use just the four most common RVDs, 
our plasmids set includes modules with NK, which users might opt to substitute for NN to 
specify G, because NN sometimes associates with A. We note however, based on data 
presented by Miller et al. (Figure 2e in ref. 10), that NK also associates substantially with A in 
some contexts. Modules with yet additional RVDs can be generated readily by mutagenesis of 
an existing set. 
Among the genes we selected for targeting with TALENs, we deliberately chose some for 
which targeting with ZFNs has proven difficult. For example, one of the most common mutations 
in patients with cystic fibrosis is a deletion of three nucleotides (DF508) in CFTR; however, best 
efforts to engineer a ZFN for this position only succeeded in targeting a site ˃120 bp away, a 
distance that would likely compromise gene targeting efficiency (18). For our CFTR TALENs, 
the DF508 mutation resides within the spacer sequence at the site of TALEN cleavage. 
Similarly, we previously created herbicide resistant tobacco plants by gene targeting with ZFNs 
that recognize and cleave the acetolactate synthase gene (24). The nearest ZFN that could be 
engineered to the desired site of modification was 188 bp away, whereas our TALENs cleave 
within 10 bp of the desired sequence modification. Finally, AT-rich sequences have been 
difficult to target with ZFNs; we successfully targeted two sites in the AT-rich (75.5%) 
Plasmepsin V gene of Plasmodium falciparum, which has an overall genome content of 80.6% 
AT (29). Generally, the high success rate of TALENs designed using our software, which found 
sites in diverse sequences on average every 35 bp, suggests that targetability of TALENs will 
prove superior to the public ZFN platforms, which are estimated to be capable of targeting on 
average every 500 bp (16,18). Indeed, we anticipate our estimate of targeting range is 
conservative, as some TALENs that do not follow our design principles still recognize and 
cleave DNA efficiently (10; Supplementary Table S2). 
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Activity varied among the TALENs we tested in the yeast assay. The reason for this is not 
clear. It could relate to expression levels or variability in the assay itself, but more likely, the data 
reflect inherent differences in the DNA binding affinity of the arrays, possibly related to their 
length and composition. The relationship of array length and composition to overall affinity is still 
an open question that must be addressed. The important conclusion for this study is that all of 
the TALENs were active, demonstrating that the targeting approach as well as the Golden Gate 
methods and plasmids for assembly are robust. And, our results in Arabidopsis protoplasts and 
human cells, along with recent results from other groups (10,13), indicate that TALENs are likely 
to be broadly effective for genome engineering. 
We have deposited all of our plasmids for constructing and expressing TALENs, as well as 
TAL effectors with or without a stop codon in the non-profit clone repository AddGene 
(www.addgene.org). To complement our method and reagents we have also made our software 
for TALEN site selection and design freely accessible as an online tool, the TAL Effector 
Nucleotide Targeter at http://boglabx.plp.iastate.edu/TALENT/. Although our success rate was 
high with TALENs designed using the software, we have not shown that it is “necessary” to 
follow the guidelines on which the software is based. So, even though the guidelines place only 
relatively minor constraints on targeting, the online tool allows users to exclude them individually 
to increase candidate target site frequency. Also, because optimal spacing may differ for 
different TALEN architectures, the software provides the option to specify desired spacer 
lengths. In making these resources available, we hope to facilitate further characterization of 
TAL effector DNA targeting properties, broad adoption of TALENs and other TAL effector-based 
tools, and further development of the utility of these unique DNA binding proteins. 
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Supplementary Material 
Supplementary Table S1.  Custom TALENs and target sites. 
Gene Organism TAL1,TAL2 
Plasmids 
TAL1,TAL2 
Repeat 
number 
Spacer TAL1, TAL2 RVD Sequences DNA Target Sequence 
with Spacer (TAL1, TAL2 
underlined) 
HPRT1 A Human pTAL141N 
pTAL142N 
17,20 15 TAL1:  NN HD NI NG NI HD HD 
NG NI NI NG HD NI NG NG NI 
NG 
TAL2:  HD HD NI NG NN NI NN 
NN NI NI NG NI NI NI HD NI HD 
HD HD NG 
5’-
GCATACCTAATCATTAT 
GCTGAGGATTTGGAA 
AGGGTGTTTATTCCTC
ATGG 
HPRT1 B Human pTAL143N 
pTAL144N 
20,17 15 TAL1:   HD HD NI NG NG HD HD 
NG NI NG NN NI HD NG NN NG 
NI NN NI NG 
TAL2:   NI NG NI HD NG HD NI 
HD NI HD NI NI NG NI NN HD 
NG 
5’-
CCATTCCTATGACTGT
AGAT 
TTTATCAGACTGAAG 
AGCTATTGTGTGAGTA
T 
CFTR A Human pTAL148N 
pTAL149N 
29,30 28(25) TAL1:  NN NN NI NG NG NI NG 
NN HD HD NG NN NN HD NI HD 
HD NI NG NG NI NI NI NN NI NI 
NI NI NG 
TAL2:  NN NN HD NI NG NN HD 
NG NG NG NN NI NG NN NI HD 
NN HD NG NG HD NG NN NG NI 
NG HD NG NI NG 
5’-
GGATTATGCCTGGCAC
CATTAAAGAAAAT 
ATCATCTTTGGTGTTTC
CTATGATGAAT 
ATAGATACAGAAGCGT
CATCAAAGCATGCC 
CFTR B Human pTAL150N 
pTAL151N 
23,28 25(22) TAL1:  NN NN HD NI HD HD NI 
NG NG NI NI NI NN NI NI NI NI 
NG NI NG HD NI NG 
TAL2:  NN NN HD NI NG NN HD 
NG NG NG NN NI NG NN NI HD 
NN HD NG NG HD NG NN NG NI 
NG HD NG 
5’-
GGCACCATTAAAGAAA
ATATCAT 
CTTTGGTGTTTCCTAT
GATGAATAT 
AGATACAGAAGCGTCA
TCAAAGCATGCC 
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Supplementary Table S1. (continued) 
Gene Organism TAL1,TAL2 
Plasmids 
TAL1,TAL2 
Repeat 
number 
Spacer TAL1, TAL2 RVD Sequences DNA Target Sequence 
with Spacer (TAL1, TAL2 
underlined) 
gridlock Zebrafish pTAL112 
pTAL117 
17,16 18 TAL1:  NI NG NG NG HD NN NI 
HD NN HD  NG HD NI NG NG 
HD NG 
TAL2:  HD HD HD NN NN NI NI 
NN HD HD NN NI NG NN HD NG 
5’- 
ATTTCGACGCTCATTC
T 
CTGGCCATGGACTTCT
TG 
AGCATCGGCTTCCGG
G 
white Drosophila pTAL152N 
pTAL153N 
22,24 24 TAL1:  HD HD NG NN NI HD HD 
NI NG NG HD NI NG HD NI NN 
HD HD NN NG HD NG 
TAL2:  NN HD HD HD NG HD NN 
NN HD HD NI NG HD NI NN NI 
NI NN NN NI NG HD NG NG 
5’-
CCTGACCATTCATCAG
CCGTCT 
TCCGAGCTGTTTGAGC
TCTTTGAC 
AAGATCCTTCTGATGG
CCGAGGGC 
GFP Jelly Fish pTAL156N 
pTAL157N 
26,25 25 TAL1:  HD HD NI NG NN NN HD 
HD NI NI HD NI HD NG NG NN 
NG HD NI HD NG NI HD NG NG 
NG 
TAL2:  NN HD HD NN HD NG NG 
HD NI NG NI NG NN NI NG HD 
NG NN NN NN NG NI NG HD NG 
5’-
CCATGGCCAACACTTG
TCACTACTTT 
CTCTTATGGTGTTCAA
TGCTTTTCA 
AGATACCCAGATCATA
TGAAGCGGC 
eGFP Jelly Fish pTAL158N 
pTAL159N 
24,26 21 TAL1:  NI HD NI NI HD NG NI HD 
NI NI HD NI NN HD HD NI HD NI 
NI HD NN NG HD NG 
TAL2:  HD NG NG NN NI NI NN 
NG NG HD NI HD HD NG NG NN 
NI NG NN HD HD NN NG NG HD 
NG 
5’-
ACAACTACAACAGCCA
CAACGTCT 
ATATCATGGCCGACAA
GCAGA 
AGAACGGCATCAAGGT
GAACTTCAAG 
Plasmepsin A Plasmodium pTAL160N 
pTAL161N 
19,22 15 TAL1:  HD NN HD NI NI NI NN NI 
NI NG NG NG HD NG NG NG NI 
NI NG 
TAL2:  NI HD NI HD NN NN NN 
NI NI NI HD NG NG NI NI HD NN 
NI NI NN NI NG 
5’-
CGCAAAGAATTTCTTT
AAT 
TCTAGATACAGGTTC 
ATCTTCGTTAAGTTTCC
CGTGT 
Plasmepsin B Plasmodium pTAL162N 
pTAL163N 
23,24 15 TAL1:  NI NG NG NI NG NG NN 
NN HD HD NG NG NI NI HD HD 
NI NG NI HD NG HD NG 
TAL2:  HD HD NI NG NN NG NI 
NI NI NI HD NI NG NG NG NG 
NG HD NG NN NI HD NI NG 
5’-
ATTATTGGCCTTAACC
ATACTCT 
TATCTCTTATTCTTT 
ATGTCAGAAAAATGTT
TTACATGG 
TT4 A Arabidopsis pTAL164N 
pTAL165N 
19,22 15 TAL1:  HD HD NI NG HD NG HD 
HD NG HD NI NI NN NN NI NG 
NN NG NG 
TAL2:  HD NG NI NN NI HD NG 
HD NG NG HD NI HD NI NI NG 
NN NG NG HD NG NG 
5’-
CCATCTCCTCAAGGAT
GTT 
CCCGGCCTCATCTCC 
AAGAACATTGTGAAGA
GTCTAG 
TT4 B Arabidopsis pTAL166N 
pTAL167N 
15,16 15 TAL1:  NN NG HD NN NG HD 
NG NG HD NG NN HD NI HD NG 
TAL2:  NI NN NG HD NI NN HD 
NI HD HD NI NN NN HD NI NG 
5’-
GTCGTCTTCTGCACT 
ACCTCCGGCGTCGAC 
ATGCCTGGTGCTGACT 
ADH1 Arabidopsis pTAL69N 
pTAL74N 
15,15 18 TAL1:  HD HD NN NN NI NG NN 
HD NG HD HD NG HD NG NG 
TAL2:  NI NN NI HD NI NI NI HD 
HD NI HD NI NI HD NG 
5’- 
CCGGATGCTCCTCTT 
GACAAGGTCTGTATTG
TC 
AGTTGTGGTTTGTCT 
 
SuRB A Tobacco pZHY096 
pZHY106 
17,20 15 TAL1:  NI HD NG NN NI NI NG NI 
NI NG HD NI NI HD NI HD NG 
TAL2:  NI NG NI NN NI NI HD HD 
NN NI NG HD HD NG HD HD HD 
NI NG NG 
5’- 
ACTGAATAATCAACAC
T 
TGGGAATGGTGGTTC 
AATGGGAGGATCGGTT
CTAT 
SuRB B Tobacco pZHY108 
pZHY109 
19,19 15 TAL1:  NI HD HD NG HD NI NG 
HD NI NN NN NI NI HD NI NG 
NN NG NG 
TAL2:   HD NG NG NG NN NI NI 
NI NN HD HD HD HD NN HD HD 
NI HD NG 
5’- 
ACCTCATCAGGAACAT
GTT  
CTACCTATGATTCCC 
AGTGGCGGGGCTTTC
AAAG 
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Supplementary Table S2.  Activity, conformity to rules, and length of TALENs tested in the yeast 
assay.   
TALEN RVDS Activity
1 
% GATC Ends in NG RVD sequence 
ADH1_1R12 12 - y n HD HD HD NI NN NI NI NN NG NI NI NI 
ADH1_2R12 12 - n n NI NN NI HD NI NI NI HD HD NI HD NI 
tt4_1L15 15 - y y NN NN HD NI HD NG NN HD NG NI NI HD HD HD NG 
telo_1R15 15 - n y HD NN NN NG NG NG NN HD NG NI NG HD NN NG NG 
ADH1_R15 15 + y y HD HD HD NI NN NI NI NN NG NI NI NI HD NI NG 
ADH1_2L12 12 + y n HD HD NN NN NI NG NN HD NG HD HD NG 
grid_1R10 10 + n y NI HD HD HD HD NG HD NG HD HD  
telo_1L15 15 + y y HD NG NG NN NG HD HD NN HD NI NG NN NI NG NG  
telo_2L16 16 + y y NI NG NG HD HD HD HD NI HD NN NI NN HD NG HD NG 
telo_2R17 17 + n y NI NN NI HD NI NN NN NI NI NN NG NN NN NI NN HD NG 
ADH1_1L12 12 ++ y n NI NG HD NI NI NN NI NG NG HD NG HD 
ADH1_2R15 15 ++ y y NI NN NI HD NI NI NI HD HD NI HD NI NI HD NG 
grid_1R13 13 ++ y y NI HD HD HD HD NG HD NG HD HD NN HD NG 
ADH1_2L15 15 +++ y y HD HD NN NN NI NG NN HD NG HD HD NG HD NG NG 
grid_1L16 16 ++++ y y NI HD HD HD HD NG HD NG HD HD NN HD NG NG HD NG 
1. –  no activity, + activity less than 25% of ZFN Zif268, ++ activity 25-50% of ZFN Zif268, +++ activity 
50-75% ZFN Zif268, ++++ activity >75% ZFN Zif268. 
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Supplementary Figure S1.  Module, array, repeat, and backbone plasmids.  Overhangs left by BsaI 
digestion are shown in blue font and by Esp3I in green. HD modules 2-10 contain a BspEI site (not shown) 
not present in the the other modules. NLS, nuclear localization signal(s); AD, transcriptional activation 
domain; tet, tetracycline; spec, spectinomycin ; amp, ampicillin ; attL1 and attL2, recombination sites for 
Gateway cloning; B, BamHI, and S, SphI. Unique restriction enzyme sites flanking the entire coding 
sequences of the backbone constructs are not shown but can be found in the sequence files. 
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Supplementary Figure S2.  The TAL Effector-Nucleotide Targeter.  (a) Screenshot showing the DNA 
sequence input window and options to include or exclude specific guidelines and to specify spacer lengths. 
(b) Sample output for the human HPRT1 gene showing candidate target sequences and corresponding 
TALEN RVD sequences. Highlighted in the top row is the HPRT1 A (Figure 5) target site information. The 
targeter URL is boglabx.plp.iastate.edu/TALENT/. 
 
a
b
Fig. S2. The TAL Effector-Nucleotide Targeter. (a) Screenshot showing the DNA sequenc input window and options to
include or xclude specific guidelines and to specify spacer engths. (b) Sampl output for the human HPRT1 ene
showing candidat target sequences and corresponding TALEN RVD sequences. Highlighted in the top row is the HPRT1
A (Fig. 5) target site information. The tar et r URL is b glabx.plp.iastate.edu/TALENT/.
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Supplementary Figure S3.  The yeast assay for testing TALEN function.  (a) Schematic of the assay 
(see text for details).  SSA, single-strand annealing.  (b) Example of target site oligonucleotides that are 
synthesized, annealed and cloned into the target plasmid pCP5.  Arrows indicate the opposing TALEN 
monomer binding sites, separated by a spacer The T preceding each site is in bold. 
SSA
a/α diploid 
a strain a strain
la acZURA3
TRP12m or CEN
acZla
TRP12m or CEN
lacZ
CEN
TALEN
HIS3
CEN
TALEN
LEU2CEN
TALEN
target
a
b
5’- GATCTACACGTGCATCTCGATGGGGCCATTAGATTAAAGACCGTTTTAGATGTA
3’- ATGTGCACGTAGAGCTACCCCGGTAATCTAATTTCTGGCAAAATCTACATGATC
BglII
overhang
SpeI
overhang
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CHAPTER  4. TAL EFFECTOR-NUCLEOTIDE TARGETER (TALE-NT) 
2.0: TOOLS FOR TAL EFFECTOR DESIGN AND TARGET PREDICTION 
 
A paper published in Nucleic Acids Research1 
 
Erin L. Doyle2, Nicholas J. Booher3, Daniel S. Standage4, Daniel F. Voytas5, 
Volker P. Brendel6,7, John K. VanDyk3 and Adam J. Bogdanove2,8 
 
Abstract 
Transcription activator-like (TAL) effectors are repeat-containing proteins used by plant 
pathogenic bacteria to manipulate host gene expression. Repeats are polymorphic and 
individually specify single nucleotides in the DNA target, with some degeneracy. A TAL effector-
nucleotide binding code that links repeat type to specified nucleotide enables prediction of 
genomic binding sites for TAL effectors and customization of TAL effectors for use in DNA 
targeting, in particular as custom transcription factors for engineered gene regulation and as 
site-specific nucleases for genome editing. We have developed a suite of web-based tools 
called TAL Effector-Nucleotide Targeter 2.0 (TALE-NT 2.0; https://boglab.plp.iastate.edu/) that 
enables design of custom TAL effector repeat arrays for desired targets and prediction of TAL 
effector binding sites, ranked by likelihood, in a genome, promoterome or other sequence of 
interest. Search parameters can be set by the user to work with any TAL effector or TAL effector 
nuclease architecture. Applications range from designing highly specific DNA targeting tools and 
identifying potential off-target sites to predicting effector targets important in plant disease. 
Introduction 
Transcription activator-like (TAL) effectors from the plant pathogenic bacterial genus 
Xanthomonas represent a class of DNA binding proteins that can be readily engineered to 
                                                          
1
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University Press. Copyright The Authors. 
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target novel DNA sequences. During infection, TAL effectors are deployed by the bacteria to 
modulate host gene expression, with each effector directly binding an effector-specific DNA 
target (1,2). A central region in the protein, composed of a variable number of tandem, near-
identical, 33-35 amino acid repeats, determines the target(s) of each TAL effector. Repeat-to-
repeat variation occurs primarily at residues 12 and 13 (termed the repeat variable diresidue or 
RVD). The RVD sequence has been shown both computationally and experimentally to 
correspond directly to the DNA target site sequence; repeats with different RVDs recognize 
different nucleotides, in a code-like fashion, with some degeneracy (3,4). Custom TAL effectors 
can be targeted to novel DNA sequences by assembling an array of repeats that corresponds to 
the intended target site (5). Designing custom TAL effectors for DNA targeting has proved to be 
a much simpler and less labor-intensive process than the design of other customizable DNA 
binding proteins such as zinc fingers (6), and a variety of rapid construction methods for custom 
TAL effectors and TAL effector fusion proteins have recently been developed (7-12). 
Increasingly therefore, TAL effectors and TAL effector-based fusion proteins have been adopted 
as tools for DNA targeting applications (6).  
Site-specific DNA modification has been achieved using TAL effector-endonuclease fusion 
proteins (TAL effector nucleases or TALENs), which create targeted double-stranded breaks 
(DSBs) in DNA. TALEN architectures to date combine the central repeat region and some 
portion of the flanking parts of the TAL effector with the catalytic domain of FokI, which functions 
as a dimer. Thus, TALENs work in heteromeric pairs, with the monomers binding to opposing 
target sites oriented 5’ to 3’ on opposite strands across a spacer, allowing the C-terminal FokI 
domains to dimerize and create a DSB in that spacer (5,13-15). In eukaryotes, such breaks are 
repaired by either non-homologous end joining (NHEJ), which is prone to errors and useful for 
creating gene knockouts, or homologous recombination (HR), which replaces the sequences 
surrounding the break with a supplied template. TALEN-mediated NHEJ and HR have been 
demonstrated in a variety of cell types and organisms (7,8,13,14,16-20). TAL effectors have 
also been used as custom transcriptional activators, most effectively in plants in their native 
form and in mammalian cells with the native acidic activation domain replaced by the VP16 (or 
tetrameric derivative VP64) activation domain from Herpes Simplex Virus (10,21,22). The TAL 
effector targeting domain has also been fused to a repressor protein and used successfully for 
specific gene repression in plants (23). 
Custom TAL effector and TALEN architectures using different proportions of the flanking 
regions on either side of the repeat region have been reported. In the case of TALENs, the 
optimum spacer length between the TALEN monomers depends on the architecture used 
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(5,13,15,24). Additionally, different methods assemble different numbers of repeats in an array, 
with some allowing a wide range (7-12). Therefore, tools for designing custom TAL effectors 
and TALENs should allow for a range or a prescribed number of repeats and, for TALENs, 
various spacer lengths. Most TAL effector targets in nature are preceded by a T at the 5’-end 
(3), but at least one example of a TAL effector target preceded by a C has been identified (25), 
and some custom TAL effectors have been reported to be active on sites preceded by a C (13). 
The preference for T at this position is structurally specified by the region of the protein 
immediately N-terminal to the central repeat region (26,27). Accounting for the “-1 position” 
nucleotide is important for target prediction and custom TAL effector design as well.  
Because of the degeneracy in the TAL effector–DNA recognition code, off-targeting is a 
concern in the use of TAL effectors and TALENs. RVDs associate preferentially, but not 
exclusively, with specific nucleotides. TAL effector-target pairs in nature are observed to have 
up to 50% mismatches (positions at which the RVD is not aligned with its most frequently 
associated nucleotide) (3), and TAL effector-based custom transcription factors have been 
shown to activate transcription of off-target genes whose promoters contain sequences similar 
but not identical to the intended targets (21). If custom TAL effectors and TALENs are to be a 
widely adopted biotechnology, accurate prediction of potential off-target activity and design to 
minimize such activity will be crucial. Prediction of potential TAL effector binding sites that takes 
the degeneracy into account is also important for the identification of disease targets in plant 
hosts of Xanthomonas spp. 
To aid researchers in adopting TALENs as gene editing tools, we converted a computational 
script we had created for TALEN design, called “TALEN Targeter”, to a web-based tool and 
posted it on a site we called TAL Effector-Nucleotide Targeter (TALE-NT 1.0). The tool designed 
TALEN pairs according to five design guidelines based on positional and composition biases 
observed in known TAL effector-target pairs (7). Herein, we describe a new version of the web 
site, TALE-NT 2.0, that offers a suite of tools for TALEN and TAL effector design as well as 
target prediction. Since the publication of TALE-NT 1.0, it was shown that the design guidelines 
have little effect on TALEN efficiency (12). Therefore, for TALE-NT 2.0, we removed the 
guidelines from TALEN Targeter and instead allow users to search for TALENs targeting a 
specific base. We also updated TALEN Targeter to provide users with additional options for 
entering sequences, customizing their queries to accommodate different TALEN architectures 
and other preferences, searching for sites preceded by T or C and viewing output. We added 
two new tools: “TAL Effector Targeter”, for designing custom TAL effectors for single sites, and 
“Target Finder”, for predicting candidate TAL effector targets, ranked by likelihood, in the 
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genomes or gene promoteromes of several model organisms or in a sequence supplied by the 
user. The new web site (https://boglab.plp.iastate.edu/) makes this suite of tools freely available 
to the research community. Applications range from designing highly specific DNA targeting 
reagents and identifying potential off-target sites to predicting effector targets important in plant 
disease. 
Software and Algorithms 
Programming 
TALENT 2.0 tools other than Target Finder are written in the Python programming language 
and use Biopython libraries for parsing input DNA sequences and other sequence operations 
(28). Target Finder is written in C and uses Kseq.h 
(http://lh3lh3.users.sourceforge.net/parsefastq.shtml) for sequence parsing. 
Tools for designing custom TALENs and TAL effectors 
TALEN Targeter and TAL Effector Targeter design paired and single custom TAL effector 
repeat arrays, respectively, for targeting DNA sequences of interest. Both tools require one or 
more FASTA-formatted DNA sequences as input. TALEN Targeter identifies paired monomer 
(typically heteromeric) binding sites oriented 5’ to 3’ on opposite strands of the DNA and 
separated by a spacer. TAL Effector Targeter identifies single TAL effector binding sites; users 
have the option of searching the reverse complement in addition to searching the DNA 
sequence as entered. In either tool the number of TAL effector repeats can vary across a user-
specified range. TALEN Targeter allows users also to specify a range for the spacer length; all 
possible combinations of repeat numbers and spacer lengths are considered. Identified binding 
sites are converted into RVD sequences using the four most common RVD-nucleotide pairs (NI-
A, HD-C, NN-G and NG-T). Target sites, RVD sequences, and other information are returned to 
the user (the output for all tools is described more fully in the “Web Interface” section). Arrays 
designed with TAL Effector Targeter are by default designed to meet the five guidelines 
developed based on TAL effectors observed in nature, as the effect of these guidelines on TAL 
effector transcription factors has not been determined.  Users may choose not to enforce one or 
more guidelines.  
A tool for identifying candidate TAL effector targets 
Target Finder allows users to enter an RVD sequence and search for candidate targets in 
the genome or gene promoterome of any of several model organisms or in one or more user-
provided, FASTA-formatted DNA sequences. The tool may be used to identify and rank 
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candidate plant genomic targets of TAL effectors important for disease, or potential off-target 
binding sites of custom TAL effector proteins. 
To predict and rank sites, the tool uses a simple scoring function developed by Moscou and 
Bogdanove (3) based on RVD-nucleotide association frequencies found in a set of known TAL 
effector-target pairs us. We have used this scoring function to predict 21 previously unknown 
and subsequently experimentally verified plant targets for 14 TAL effectors (A. Cernadas, 
E.Doyle and A.Bogdanove, unpublished results). Briefly, for scoring, for each RVD in the set of 
TAL effector-target pairs, the frequency with which it pairs with each nucleotide was calculated 
and then converted to a weighted RVD-nucleotide association probability. For RVDs that are not 
observed in the set of pairs, each nucleotide association was given an equal probability. The 
score for a DNA/RVD sequence alignment is found by summing the negative logs of the 
appropriate RVD-nucleotide association probabilities, such that better alignments have lower 
scores. A detailed description of the scoring function, including weighted RVD-nucleotide 
association probabilities, is provided in the Supplementary Material. 
Target Finder returns a list of the lowest scoring (best) sites in the queried DNA sequence 
below a cutoff (discussed in the Web Interface section). Candidate binding sites are not required 
to conform to any of the design guidelines except that they must be preceded by a T, or C if that 
option is selected. The tool by default searches for binding sites on both strands of the DNA 
sequence(s), but users may opt to search only the forward strand. 
Web Interface 
Design and general features 
The TALE-NT 2.0 web site is powered by Drupal 7 on Red Hat Enterprise Linux 6. Job 
queuing is handled by Celery using Redis as a message broker. All features of the web site 
have been tested on common web browsers. 
TALE-NT 2.0 makes the three tools for design of TAL effectors and prediction of TAL 
effector targets freely available to all users, with no log-in requirement. Upon submitting a job, 
users are taken to a bookmarkable page updating them on the status of their query or supplying 
a link that will take them to their results when the query has finished processing. Processing 
times are not excessive: a search of the entire rice genome for possible targets of an average 
length TAL effector (18 RVDs) took less than three minutes. Nevertheless, users have the 
option to enter an address to receive email notification when their job finishes. Results for each 
tool are displayed in a sortable table by default. Users may also or instead download results as 
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a tab-delimited text file. For Target Finder users can download either or both of two formats, 
standard or GFF3, described further below. 
All tools allow users to design or search for TAL effector binding sites preceded by a 5’ T 
only, C only, or T or C. In our hands however, with either TALENS or TAL effectors, sites 
preceded by a C are significantly less active than those preceded by a T, so we suggest using 
T, which is the default selection. 
TALEN Targeter 
The TALEN Targeter web interface allows users to design custom TALENs to target one or 
more DNA sequences of interest. Users enter their sequence(s) in a text box or upload a file 
containing the sequence(s). Allowable file size is up to 2 MB. Users may select from four 
common TALEN architectures (7,13,15,24) with preselected ranges for spacer size and 
numbers of repeats or enter their own ranges for these parameters. Users may choose to allow 
binding sites to be preceded by a T only, C only, or by T or C.  In addition, users have the option 
to output just TALEN pairs targeting a specific base, a filtered list including up to one TALEN 
pair for each base, or the complete list of all TALEN pairs targeting anywhere in the sequence. 
The targeted base is defined as the base is in the center (or immediately to the left of the 
center) of the spacer. If users choose to return up to one TALEN pair per base, the pair with the 
smallest average number of RVDs and shortest spacer targeting a given base will be returned.  
Each line of the output describes a pair of monomers that will function together as a TALEN. 
Information provided includes the name of the input sequence (in case more than one sequence 
was entered), the starting position and number of repeats for each monomer, the target 
sequence including the -1 nucleotide and RVD sequences corresponding to each monomer. 
The output is ordered by sequence name, with TALENs for each sequence grouped by the 
start position of the first monomer. The order of TALENs in the output does not relate to how 
well they might function. No scoring or other prioritization method is used. Users should select 
TALENs closest to the site of desired cleavage that have the fewest or poorest predicted off-
target sites determined using Target Finder and further analysis. This analysis should take into 
account not only the heterodimer but both of the possible homodimers as well. Users may also 
wish to choose TALENs that straddle a spacer with a diagnostic restriction endonuclease site to 
facilitate detection of NHEJ-mediated mutation of the spacer sequence (such restriction 
endonuclease sites are indicated in the output table) or in the case of HR, a TALEN that 
uniquely binds the sequence to be replaced, so that following replacement it does not cut again. 
Users might opt to introduce silent mismatches in the HR template to facilitate this.  
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TAL Effector Targeter 
TAL Effector Targeter allows users to design a single custom TAL effector repeat array to 
target a DNA sequence of interest. The array may be used for the design of a TAL effector or 
any TAL effector-based fusion protein that functions as a monomer. As with TALEN Targeter, 
users enter sequence(s) in a text box or upload a FASTA-formatted file. Additional text boxes 
allow users to specify a range for the number of repeats in each TAL effector (default is 15-30). 
Checkbox options allow users to turn off individual design guidelines. By default, the tool 
searches only the sequence(s) as entered; a checkbox option includes also the reverse 
complement sequence(s). Users may also choose to search only for sites preceded by T at the 
5’ end, or to allow T and/or C. 
Each line of the output describes a single custom TAL effector repeat array.  Information 
returned includes the name of the input sequence (in case multiple sequences were entered), 
the strand and coordinates of the target, the target sequence including the -1 nucleotide, and 
corresponding RVD sequences. 
The output is ordered first by sequence name, with target sites for each sequence sorted by 
their position in the sequence. As with TALEN Targeter, arrays are not ranked or prioritized. 
Users should choose according to their own targeting criteria. If there are no target sites in a 
sequence or no sites in the desired region, users may be able to increase the number of sites 
by relaxing some of the design rules and/or changing the range for number of repeats. We 
recommend that users leave the percent composition rule enforced to better assure good 
overall affinity. Although data regarding relative affinities of different RVDs for their partner 
nucleotide(s) is lacking, based on the published structures (26,27) we predict that the highest 
affinity interactions are those that occur most frequently in nature. So, if a user chooses not to 
enforce the percent composition guideline, at a minimum, arrays should be selected that have 
overall higher numbers of HDs and NGs than NIs and NNs. Also, in most contexts tested, NN 
pairs with G or A, so we anticipate that minimizing NN content will maximize specificity. 
Target Finder 
Target Finder uses the scoring function of Moscou and Bogdanove (3) to identify the best-
scoring sites in a DNA sequence for a user-specified string of RVDs. Users input a TAL effector 
RVD sequence containing from 12 to 35 RVDs, each separated by a space, using single-letter 
amino acid abbreviations.  All possible RVDs constructed using the standard 20 amino acids 
and ‘*’ to indicate a missing 13th amino acid are allowed. Users may select a genome or gene 
promoterome from a drop-down list, or provide their own sequence of interest in a text box or as 
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a file upload. Promoterome is defined as the collection of sequences 1000 bp upstream of 
annotated translational start sites in a genome. Available genomes and promoteromes include 
those of rice (Oryza sativa), Arabidopsis thaliana, human (Homo sapiens), fruit fly (Drosophila 
melanogaster), mouse (Mus musculus), nematode (Caenorhabditis elegans), and zebra fish 
(Danio rario). Genome sequences were obtained from Ensembl (www.ensembl.org), except for 
the rice genome, which was downloaded from the MSU Rice Genome Annotation Project 
(http://rice.plantbiology.msu.edu, Version 6.1). Promoteromes were downloaded from the UCSC 
Genome Bioinformatics Site (http://genome.ucsc.edu/index.html), except for the rice 
promoterome, which was downloaded from the Rice Genome Annotation Project, and the 
Arabidopsis promoterome, which was downloaded from The Arabidopsis Information Resource 
(TAIR, http://www.arabidopsis.org/). By default, the tool searches both strands, but users may 
choose to search only the forward strand. Users may choose to search for sites preceded by a 
5’ T only, C only or T and C.  
Target Finder returns all targets scoring under a threshold cutoff defined as a ratio of 
observed score to best possible score of 3.0 or less. The best possible score is the score for the 
array aligned to its code-specified, perfect match DNA sequence. Users may relax the cutoff to 
4.0. The default threshold of 3.0 was selected because the naturally occurring TAL effector-
target site pairs we analyzed to decipher the TAL effector DNA binding code and develop the 
scoring matrix (3) typically had scores ˂3.0 times the best possible score for the TAL effector. In 
addition, for binding sites of naturally occurring TAL effectors predicted using the scoring 
function, experimentally verified sites also had scores ˂3.0 times the best possible score (A. 
Cernadas, E.Doyle and A.Bogdanove, unpublished results1). Users wishing to identify more 
sites should choose the less stringent cutoff. The best possible score for an array is included at 
the top of the output table or file. Information provided for each target in the output includes the 
coordinates, the DNA strand being targeted, the score for the target, and the target sequence. 
Targets in each DNA sequence are ordered from best (lowest scoring) to worst (highest 
scoring). For searches of genomes or promoteromes from the drop-down list, the output in the 
default displayed table includes a link for each target that configures a custom track to show the 
target location in a corresponding genome browser when available. The number of targets 
displayed in the table is set by default to a maximum of 10, though users can specify a different 
number. In the downloadable output, all targets below the threshold are included. As noted 
above, the downloadable output is available in two formats. The standard file includes the same 
                                                          
1
 These results are described in the Appendix. 
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information for each target as is displayed in the table. The GFF3 file contains gene feature 
coordinates and can be used in many genome browser and related applications. 
It is important to point out that the contributions of individual RVD-nucleotide associations to 
overall binding affinity are not yet worked out. Scoring based on RVD-nucleotide association 
frequencies provides only an estimate of relative affinities. Thus, not all sites returned may be 
efficiently bound by the TAL effector, irrespective of their score, and some biologically relevant 
targets may be missed if their scores rise above the arbitrary cutoff. Target Finder output should 
be considered a best estimate of the most probable binding sites for a given TAL effector based 
on available information. It represents a good starting point for further study to identify true 
targets or off-targets through experimentation, and a tool for initial assessment of probable 
relative specificities to choose among multiple arrays that might be available to target a 
sequence of interest.  
A final note about the web interface for Target Finder: TALE-NT 2.0 provides a convenient 
way to use the tool, but working through the web interface restricts users to the model organism 
sequences available on the site, or relatively short, user-provided sequences. To study large 
datasets not included on the site, users can download from TALE-NT 2.0 a C-coded version of 
Target Finder and run it locally under an open source license. 
Conclusion 
TALEN Targeter and TAL Effector Targeter are versatile tools that allow design of custom 
RVD arrays for gene editing, engineered gene regulation and other applications. Although other 
TALEN design tools exist (TALEN Hit, http://talen-hit.cellectis-bioresearch.com/search; ZiFit 
Targeter 4.0 (16), http://zifit.partners.org/ZiFiTBeta/Introduction.aspx and idTALE (29), 
http://idtale.kaust.edu.sa/index.html), TALEN Targeter is the only tool that works with any 
architecture by allowing users to specify ranges for both spacer size and number of repeats. 
TAL Effector Targeter is the only tool available that targets single custom TAL effector arrays. 
Although idTALE allows users to search a genome for paired TALEN sites, its search function 
identifies exact matches only. Target Finder uses a scoring function that allows a biologically 
relevant number of mismatches in the TAL effector-target alignment, useful for identifying 
candidate targets of naturally occurring TAL effectors, as well as potential off-targets for custom 
TAL effector-based proteins. 
In addition to these design and targeting tools, TALE-NT 2.0 also includes help pages and 
tutorials, with guides to interpretation of results. A “Protocols and Reagents” page provides 
useful links to other TAL effector and TALEN resources. With its wide range of capabilities and 
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content, TALE-NT 2.0 should be a valuable resource for anyone studying TAL effector function 
or using custom TAL effectors, TALENs, or other TAL effector-based proteins for DNA targeting 
applications.  A new tool, “Paired Target Finder”, that automates the identification of potential 
off-target sites for TALENs, as heterodimer or either homodimer, was recently added to the web 
site. 
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Supplementary Material 
The Target Finder scoring function 
To predict and rank sites, the tool uses a scoring function developed based on the RVD 
nucleotide association frequencies in known TAL effector-target pairs used by Moscou and 
Bogdanove to establish the RVD-nucleotide binding code (1). Precisely, if Fr n is taken as the 
observed frequency (percent) with which RVD r associates with nucleotide n in the set of 
identified pairs, then Pr n = w Fr n + (1-w) 0.25 estimates the probability of association of RVD r 
with nucleotide n in general. Here w is set to 0.9 and corrects for unobserved data (i.e. the 
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possibility of an RVD that occurs in the observed set participating in an unobserved RVD-
nucleotide pair). In this correction, any nucleotide is taken to occur with equal probability. For 
any RVD v not included in the set of known TAL effector-target pairs, Fvn is set so that Pvn is 0.25 
for all n. The score for an RVD sequence/DNA alignment with l RVDs aligned with l consecutive 
bases is then calculated as 
    ∑            
 
 
 
where Pr n (l) is the association probability of the RVD-nucleotide pair at position l in the 
alignment. 
Supplementary Table S1.  Target Finder RVD-nucleotide association probabilities. 
RVD 
Total 
Observations A C G T 
HD 107 0.084 0.858 0.025 0.033 
NI 64 0.841 0.109 0.025 0.025 
NG 70 0.102 0.102 0.038 0.758 
NN 57 0.357 0.151 0.436 0.057 
NS 30 0.625 0.205 0.145 0.025 
N* 20 0.070 0.520 0.070 0.340 
HG 18 0.075 0.125 0.025 0.775 
HA 6 0.175 0.625 0.175 0.025 
ND 4 0.025 0.925 0.025 0.025 
NK 2 0.025 0.025 0.925 0.025 
HI 1 0.025 0.925 0.025 0.025 
HN 1 0.025 0.025 0.925 0.025 
NA 1 0.025 0.025 0.925 0.025 
IG 1 0.025 0.025 0.025 0.925 
H* 1 0.025 0.025 0.025 0.925 
Other 0 0.250 0.250 0.250 0.250 
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CHAPTER 5.  ADDITION OF TRANSCRIPTION ACTIVATOR-LIKE 
EFFECTOR BINDING SITES TO A PATHOGEN STRAIN-SPECIFIC RICE 
BACTERIAL BLIGHT RESISTANCE GENE MAKES IT EFFECTIVE 
AGAINST ADDITIONAL STRAINS AND AGAINST BACTERIAL LEAF 
STREAK 
 
A paper published in New Phytologist1 
 
Aaron W. Hummel2, Erin L. Doyle2, and Adam J. Bogdanove2,3 
Summary 
• Xanthomonas transcription activator-like (TAL) effectors promote disease in plants by 
binding to and activating host susceptibility genes. Plants counter with TAL effector-activated 
executor resistance genes, which cause host cell death and block disease progression.  We 
asked whether the functional specificity of an executor gene could be broadened by adding 
different TAL effector binding elements (EBEs) to it. 
• We added six EBEs to the rice Xa27 gene, which confers resistance to strains of the 
bacterial blight pathogen Xanthomonas oryzae pv. oryzae (Xoo) that deliver the TAL effector 
AvrXa27. The EBEs correspond to three other effectors from Xoo strain PXO99A and three from 
strain BLS256 of the bacterial leaf streak pathogen Xanthomonas oryzae pv. oryzicola (Xoc). 
• Stable integration into rice produced healthy lines exhibiting gene activation by each TAL 
effector, and resistance to PXO99A, a PXO99A derivative lacking AvrXa27, and BLS256, as well 
as two other Xoo and 10 Xoc strains virulent toward wildtype Xa27 plants. Transcripts initiated 
primarily at a common site. Sequences in the EBEs were found to occur nonrandomly in rice 
promoters, suggesting an overlap with endogenous regulatory sequences. 
• Thus, executor gene specificity can be broadened by adding EBEs, but caution is 
warranted because of the possible coincident introduction of endogenous regulatory elements. 
Introduction 
Many crops, including rice, wheat, cotton, citrus, tomato, cassava, banana, soybean, 
sugarcane, and others, suffer losses as a result of infection by pathogenic members of the 
bacterial genus Xanthomonas.  Rice (Oryza sativa), a staple for more than half the world’s 
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population, is host to the xylem pathogen Xanthomonas oryzae pv. oryzae (Xoo),   which 
causes bacterial blight, and the leaf mesophyll  pathogen, Xanthomonas oryzae pv. oryzicola 
(Xoc), which causes bacterial leaf streak. These diseases reduce yields by up to 50 and 30%, 
respectively (Niño-Liu et al., 2006). Like several Xanthomonas species, Xoo relies on transcription 
activator-like (TAL) effectors to render the host susceptible to colonization (Bai et al., 2000; Yang 
& White, 2004; Yang et al., 2006; Sugio et al., 2007; Antony et al., 2010). Xoc also deploys TAL 
effectors, which, though less well studied, are presumed to contribute similarly to virulence 
(Makino et al., 2006; Bogdanove et al., 2011). 
Named for features shared with eukaryotic transcription factors (Yang et al., 2006), TAL 
effectors are secreted into host cells via the bacterial type III secretion system (T3SS), then 
directed to the host cell nucleus by C-terminal nuclear localization signals (Yang & Gabriel, 1995; 
Van den Ackerveken et al., 1996; Szurek et al., 2001, 2002). There they bind to cognate effector 
binding elements (EBEs) in specific host gene promoters to activate transcription of those genes 
using a C-terminal, acidic activation domain (Zhu et al., 1998, 1999; Kay et al., 2007; Ro¨mer et 
al., 2007; Boch et al., 2009; Moscou & Bogdanove, 2009). Binding specificity is dictated by a 
variable number of central, 33–35 amino acid repeats. In each repeat, a pair of variable residues 
at positions 12 and 13 (together called the repeat-variable diresidue (RVD)) preferentially 
associates with a different nucleotide to define the length and sequence of the EBE (Boch et 
al., 2009; Moscou & Bogdanove, 2009). With this modular protein-DNA recognition mechanism, 
the pathogen can activate multiple susceptibility (S) genes in the host by deploying different 
TAL effectors. Several bacterial blight S genes in rice that correspond to Xoo TAL effectors 
important for virulence have been identified (Yang et al., 2006; Sugio et al., 2007; Antony et al., 
2010), and several more S gene candidates for bacterial blight and bacterial leaf streak have 
been predicted computationally based on RVD sequences of uncharacterized Xoo and Xoc TAL 
effectors (Moscou & Bogdanove, 2009). 
Plants counter TAL effector-wielding pathogens with S gene mimics that cause host cell 
death and block disease progression when transcriptionally activated. Such normally silent, 
EBE- controlled ‘executor’  resistance  genes (Bogdanove et al., 2010) include the pepper 
(Capsicum annuum) Bs3 gene, which provides resistance against strains of  the  bacterial spot 
pathogen Xanthomonas  campestris pv. vesicatoria that express the TAL effector AvrBs3 (Bonas 
et al., 1989; Ro¨mer et al., 2007), and the rice bacterial blight resistance gene Xa27, which is 
activated by the Xoo TAL effector AvrXa27 (Gu et al., 2005). In addition to executor genes, 
alleles of major S genes that are immune to activation by the corresponding TAL effector, such 
as the rice xa13 and xa25 bacterial blight resistance genes, provide another form of defense 
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(Yang et al., 2006; Liu et al., 2011). A third type of resistance directed at TAL effectors, again 
exemplified by a rice bacterial blight resistance gene, xa5, is a polymorphism in the gamma 
subunit of general transcription factor TFIIA. A single amino acid substitution in the protein is 
thought to impair the ability of TAL effectors to recruit the transcriptional machinery to activate 
target genes (Iyer & McCouch, 2004; Sugio et al., 2007; Gu et al., 2009). Each of these types of 
resistance, however, is subject to defeat by adaptation of the pathogen TAL effector inventory. 
For example, executor genes can be defeated by mutation or loss of the corresponding TAL 
effector, provided the TAL effector is dispensable for virulence, as appears to be the case for 
AvrXa27 (Tian & Yin, 2009). S gene promoter polymorphisms that confer resistance can be 
overcome by TAL effectors that target the new sequence or an alternative S gene (Antony et al., 
2010). Also, the xa5 gene is rendered ineffective by a strain with two apparent adaptations, a TAL 
effector that activates the corresponding S gene particularly strongly such that the reduction in 
activity caused by xa5 might be inconsequential, and a TAL effector that induces expression of a 
TFIIA gamma paralog that may substitute for the allele found in susceptible plants (Yang et 
al., 2006; Sugio et al., 2007; B. Yang, unpublished). Furthermore, the latter two types of 
resistance are genetically recessive, rendering them less easily bred into elite hybrids. A 
genetically dominant, broad-spectrum, and durable form of resistance effective against 
pathogens that deploy TAL effectors would be beneficial, but none has been identified. 
In  an Agrobacterium-mediated  transient expression assay in Nicotiana benthamiana, 
Römer et al. (2009a) showed that amending the Bs3 gene promoter with the AvrXa27 EBE 
(which they call a ‘UPT box’, which stands for up-regulated by TAL effector) and an EBE matching 
an AvrBs3 variant called AvrBs3∆rep16 rendered the promoter responsive to all three TAL effectors. 
This pioneering study suggested that broad-spectrum and potentially durable resistance might be 
achieved by stable integration of an executor gene engineered in this way to respond to TAL 
effectors from multiple pathogen strains or even different pathogens. 
In previous studies, stable integration of Xa27 into rice under conditions in which it was 
expressed constitutively resulted in reduced tillering, delayed flowering, and stiff, early-
senescing leaves; nonetheless, the expression of the gene indeed conferred resistance to 
several  Xoo strains normally virulent on wildtype Xa27 lines, and partial resistance to a strain of 
Xoc  (Gu et al., 2005; Tian & Yin, 2009). We therefore chose Xa27 to test the notion suggested 
by Römer et al. (2009a) that functional specificity of an executor gene could be broadened, 
without deleterious effects associated with constitutive expression, by making its promoter 
responsive to several distinct TAL effectors. 
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We added to the Xa27 promoter EBEs corresponding to three additional TAL effectors each 
from the Xoo strain PXO99A, which harbors AvrXa27, and the Xoc strain BLS256, which does 
not.  Stable integration of this construct into rice produced healthy lines exhibiting gene 
activation by each of the TAL effectors, and resistance to PXO99A, a PXO99A derivative lacking 
AvrXa27, and BLS256, as well as two other Xoo and 10 Xoc strains from a diverse collection 
virulent toward wildtype Xa27 plants. Our results establish the efficacy of executor gene 
promoter engineering for broader specificity.  They also demonstrate that a rice gene for 
bacterial blight resistance can be readily modified to provide complete protection from bacterial 
leaf streak as well, a disease for which no major gene resistance in rice has been identified. 
Materials and Methods 
Modification of Xa27 
A 2.4 kb sequence including the Xa27 gene (AY986492.1) was PCR-amplified from rice 
cultivar IRBB27 (Gu et al., 2005) with primers P250 (CACCTGCAGCTGAACCAAACAGTTTTA- 
GC) and P251 (GGGCCCCACTTACTTATTTATTTATTTTTGCTGAC)  using the Phire Hotstart 
polymerase (Thermo Fisher Scientific, Waltham, MA, USA) and cloned into the Gateway entry 
vector pENTR ⁄ D-TOPO (Life Technologies, Grand Island, NY, USA). To modify the promoter, 
custom oligonucleotides (Integrated DNA Technologies, Coralville, IA, USA) were synthesized to 
generate double-stranded DNA fragments with appropriate overhangs that were then cloned into 
the unique SpeI site 100 bp upstream of the Xa27 coding sequence and 14 bp upstream of the 
AvrXa27 EBE. Oligonucleotides were designed such that EBEs are flanked by the weak 
consensus context of TAT at the 5’ end and CCC at the 3’ end (Moscou & Bogdanove, 2009) 
and such that EBEs for TAL effectors from Xoo alternate with those for TAL effectors from Xoc. 
The EBE and control constructs (Fig. 1) were transferred to the binary vector pTF101.1gw1 (Plant 
Transformation Facility, Iowa State University, http://www.agron.iastate.edu/ptf/),  which carries 
the bar gene for resistance to the herbicide phosphinothricin, using the Gateway LR II Clonase 
enzyme kit (Life Technologies). 
Plant transformation and growth 
Rice (Oryza sativa L. cv Kitaake) was transformed by the Iowa State University Plant 
Transformation Facility using Agrobacterium tumefaciens gene transfer in callus tissue, as   
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Figure 1.  Engineered Xa27 constructs used in this study.  A 2.4 kb region from rice variety IRBB27, 
including the Xa27 gene, its promoter and 3’ untranslated region (UTR) sequences (drawn to scale), was 
modified by inserting new sequences at an SpeI restriction enzyme site at position -100 relative to the 
coding sequence (CDS), 14 nucleotides upstream of the native AvrXa27 effector binding element (EBE). In 
the UXO (up-regulated by Xanthomonas oryzae) construct, EBEs corresponding to transcription activator-
like (TAL) effectors Tal4c, Tal2g, and Tal4a from Xanthomonas oryzae pv. oryzicola (Xoc) strain BLS256 
alternate with EBEs corresponding to TAL effectors PthXo1, PthXo6, and Tal9a from Xanthomonas oryzae 
pv. oryzae (Xoo) strain PXO99
A
. In the XOC construct, the EBEs for the three Xoo TAL effectors are 
substituted with internally randomized sequences. The inverse is true of the XOO construct. In the RAN 
construct, all six EBE sequences are substituted with the internally randomized ones. The native AvrXa27 
EBE (shown at bottom) is maintained in all constructs except XOC, in which the corresponding, 
nonfunctional sequence from the xa27 allele was substituted (differences are indicated above the EBE; ‘-’ 
indicates a deletion). The putative TATA box upstream of the AvrXa27 EBE is italicized. In all constructs, the 
nopaline synthase terminator (NOS-T) was included upstream of the Xa27 promoter to prevent read-through 
transcription by any neighboring promoter at the point of insertion into the genome. 
 
previously described (http://www.agron.iastate.edu/ptf/protocol/Rice.PDF). Herbicide-resistant 
lines were advanced to the T2 generation for characterization.  Presence of the transgene was 
assessed using the Kapa3G Plant PCR Kit (Kapa Biosystems, Woburn, MA, USA) with primers 
P664 (GGCATTCTTCCTTTCTTCAGC) and P352 (GGAGGCAGCTTCTTGGGTGTCTCAG). 
Transgenic and IRBB27 rice plants were grown in a growth chamber under cycles of  
12 h, 28°C : 12 h, 25°C; light : dark. Fertilizer for acid-loving plants (30-10-10; Earl May, 
Shenandoah, IA, USA) and iron chelate micronutrient (Becker Underwood,  Ames, IA, USA) 
were applied by watering twice a week at rates of 0.185 and 0.595 g l-1, respectively. 
TAL effector clones 
Clones  encoding PthXo1, PthXo6, Tal9a, AvrXa27,  and AvrXa10 were provided by B. 
Yang (Iowa State University), and clones encoding Tal2g, Tal4a, Tal4c, and Tal1c were from 
C. Schmidt (our laboratory). The SphI fragment of each TAL effector gene, encoding its central 
repeat region, was transferred into a functionally equivalent tal1c gene backbone (missing its 
own SphI fragment) in plasmid pCS466, a derivative of the pCR8 ⁄ GW ⁄ TOPO TA entry vector 
(Life Technologies, Grand Island, NY, USA). Each effector construct was then moved via the  
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Gateway LR II Clonase enzyme kit  (Life Technologies, Grand Island, NY, USA) into pKEB31, a 
derivative of the broad host range plasmid pDD62 (Mudgett et al., 2000) in which the nptII gene 
is replaced by the tetR gene of pBR322. pKEB31 places the effector gene under the control of the 
lac promoter, which is constitutive in Xanthomonas. 
Isolation and transformation of Xag EB08 and cultivation of Xanthomonas strains 
Xanthomonas axonopodis pv. glycines (Xag)  strain EB08 was isolated from diseased 
soybean (Glycine max L. Merr.) leaves that had been stored at -20°C after being collected in 
Iowa in 2008. Leaf tissue was ground in sterile water; an aliquot of supernatant was cultured on 
glucose yeast extract (GYE) agar amended with 150 µg ml -1 cyclohexamide, and a yellow, 
mucoid colony was isolated. The isolate was confirmed as the causal agent of bacterial pustule 
of soybean by reinoculation to healthy soybean plants. Xag EB08 was transformed by 
electroporation as previously described (Tsuge et al., 2001) and cultured  on  GYE agar 
amended with 10 µg ml -1   tetracycline for plasmid selection. X. oryzae strains were cultured on 
GYE. 
Plant inoculations, virulence assays, and qPCR 
Fresh (24–48 h) bacterial cultures were scraped from GYE plates and suspended in 10 mM 
MgCl2 to an optical density at 600 nm (OD600)  = 0.5 as inoculum for virulence assays, and 
OD600 = 0.9 as inoculum for quantitative real-time reverse-transcriptase PCR (qPCR) assays. 
For Xoc virulence assays, 6-wk old plants were inoculated by infiltration of leaves with inoculum 
using a needleless syringe (Schaad et al., 1996), and the length of water-soaked lesions was 
measured at 10 d. For Xoo, leaf tips of 6-wk-old plants were clipped with scissors dipped in 
bacterial suspension (Kauffman et al., 1973), and the length of leaf curl was measured at 14 d. 
For qPCR, bacteria were inoculated with a needleless syringe into the youngest, fully expanded 
leaf on 4-wk-old plants. Inoculated tissue was flash-frozen after 48 h, and total RNA was 
extracted with the RNeasy Mini Plant Kit (Qiagen, Hilden, Germany). qPCR was performed on 
an iCycler Thermo Cycler (Bio-Rad, Hercules, CA, USA) with 100 ng total RNA as template for 
cDNA synthesis and PCR amplification using the iScript One-Step  RT-PCR kit with SYBR 
Green (Bio-Rad). Gene-specific primers P772 (CCGTCATCCTCAT GCACATGCTCACCAC) 
and P771 (CACGGAGGAGAACTAGAGAGACCAGAGAC) were used for amplification of Xa27 
cDNA, and P787 (CCGGTGGATCTTCATGCTTACCTGG) and P788 
(CGACGAGTCTTCTGGCGAAACTGC) were used for amplification of Actin-6 (EU215044) 
cDNA for normalization. A minimum of three independent biological replicates, each with three 
qPCR technical replicates, were tested for each treatment. The 2 -∆∆Ct method (Livak & 
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Schmittgen, 2001) was used to quantify expression of Xa27 transcript for each treatment 
relative to mock-inoculated tissue. 
 
5’ RACE 
cDNA for 5’-RACE was produced from 1 µg total RNA with the SMARTer RACE cDNA 
amplification kit (Takara Bio, Inc., Otsu, Shiga, Japan) using the manufacturer’s protocol, from 
the same samples prepared for qPCR. Xa27 mRNA was amplified with the Universal forward 
primer (Takara Bio, Inc., Otsu, Shiga, Japan) and P771. For sequencing, PCR products were 
cloned using the pCR8 ⁄ GW ⁄ TOPO TA entry vector system (Life Technologies, Grand Island, 
NY, USA). 
Analysis of EBE sequence representation in rice promoters 
Rice promoters (defined as the sequences from 400 to 50 bases upstream of all 
translational start sites) were extracted from the MSU Rice Genome Annotation Project 
database (http://rice.plantbiology.msu.edu/), version 6.1, and concatenated into a single 
‘promoterome’. The promoterome was then randomized 5000 times. Next, all six-nucleotide 
sequences of each EBE were extracted using a sliding window. For each six-nucleotide 
sequence, the numbers of exact matches in the promoterome and in the 5000 randomized 
promoteromes were determined. To test if each six-nucleotide sequence occurred at higher- or 
lower-than-expected frequencies in the actual promoterome, P-values were estimated by 
dividing by 5000 the number of randomized promoteromes that contained more (or fewer) exact 
matches. To determine whether the observed numbers of six-nucleotide sequences that 
occurred at lower- or higher-than-expected frequencies were significant, the EBEs were 
randomized 100 times and the analysis was repeated for each randomization. P-values were 
estimated by dividing by 100 the number of EBE randomizations with more six-nucleotide 
sequences showing higher- or lower-than-expected  frequencies than those from the real EBEs. 
Results 
Stable integration of EBE-amended Xa27 constructs into rice 
We amplified Xa27 from rice variety IRBB27 (Gu et al., 2005) and amended its promoter 
with EBEs from target genes of three TAL effectors important for virulence of the Xoo strain 
PXO99A and EBEs found in rice for three TAL effectors of the Xoc strain BLS256, whose roles 
in virulence are as yet uncharacterized (Table S1). These include EBEs from rice genes 
8N3/Xa13 (Os08g42350), TFX1 (Os09g29820), and Hen1 (Os07g06970) that correspond to 
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virulence factors PthXo1, PthXo6, and Tal9a, respectively, from PXO99A (Yang et al., 2006; 
Sugio et al., 2007; Salzberg et al., 2008; Römer et al., 2010; B. Yang, unpublished), and EBEs 
from rice genes Os03g37840 (a putative potassium transporter), Os06g37080 (a putative L-
ascorbate oxidase precursor) and Os05g34600 (a putative NAC (which stands for NAM (no 
apical meristem), ATAF, CUC (cup-shaped cotyledon)) transcription factor), predicted to be 
bound by TAL effectors Tal4a, Tal4c and Tal2g, respectively, of BLS256 (Moscou & 
Bogdanove, 2009; Bogdanove et al., 2011; E. L. Doyle & A. J. Bogdanove, unpublished). The 
TAL effectors are reciprocally unique to each strain. The EBEs were inserted upstream of the 
native AvrXa27 binding site. To maximize space for simultaneous binding of multiple effectors 
from the same pathogen while keeping the length of the overall modification short, sites for Xoo 
were alternated with those for Xoc and further separated by 6 bp (Fig. 1 and Supporting 
Information, Fig. S1). The nopaline synthase terminator was placed upstream of the Xa27 
promoter to prevent read-through expression of the transgene should it insert downstream of an 
active endogenous promoter. This construct, containing all six EBEs, was designated as UXO 
(up-regulated by X. oryzae). Three other constructs were also made (Figs 1, S1). In the first, 
termed RAN (for randomized EBEs), sequences of all six EBEs were internally randomized, 
thereby maintaining the nucleotide composition and length of the UXO construct, but destroying 
the binding sites. In the second, termed XOO, the Xoo EBEs were kept intact but the Xoc EBEs 
were randomized as in the RAN construct. In the third, called XOC, the inverse was done to 
retain only the Xoc EBEs. The native AvrXa27 EBE was unchanged in all except the XOC 
construct, where, in order to generate strictly Xoc-specific resistance, it was converted to the 
corresponding sequence of the nonfunctional xa27 allele, which is not activated by AvrXa27 (Gu 
et al., 2005). None of the constructs contains any sequence that would be predicted to bind a 
PXO99A or BLS256 TAL effector other than those for which the constructs were designed. 
All four constructs were stably integrated into the readily transformed, short-season japonica 
rice cv. Kitaake. The xa27 allele in this variety is nonfunctional and identical in sequence to that 
(Os06g39810) in the reference japonica genome, Nipponbare. All recovered events were 
advanced for characterization. Of three lines from independent transformation events with the 
UXO construct that were advanced to the T2 generation, lines 1 and 3 were found by PCR 
amplification to contain the UXO construct, and were analyzed further. Similarly, two 
independent lines for each of the RAN and XOC constructs were confirmed by PCR and 
characterized. Only a single line with the XOO construct survived to the T2 generation, and this 
was also characterized. Finally, two events resulting from transformation with the wild type Xa27 
gene were advanced to the T2 generation. One, termed HRB, was found to contain the 
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herbicide resistance cassette but not the modified Xa27 gene. In the second, called AZY, 
neither the herbicide resistance cassette nor the Xa27 gene could be detected at T2. These two 
lines were retained as controls. Plants from all lines advanced to T2 were morphologically and 
developmentally indistinguishable from untransformed plants with the exception of the XOC lines, 
which were slightly reduced in stature. In leaves of the UXO and XOO lines, basal levels of expression 
of Xa27 were similar to that in IRBB27.  In the RAN lines and the one tested XOC line, basal 
expression was moderately elevated relative to that in IRBB27 (Table S2). 
EBE-amended Xa27 is activated by Xoo and Xoc independent of AvrXa27 
To examine responsiveness of the UXO construct to the corresponding TAL effectors, we 
first analyzed the relative fold-change in Xa27 mRNA 48 h after syringe inoculation of T2 leaves 
with Xoo PXO99A, the avrXa27-deficient mutant derivative ME1 (Gu et al.,  2005), Xoc   
BLS256, and  T3SS-deficient mutants  of PXO99A and BLS256. qPCR revealed significant (P < 
0.05) up-regulation of the transgene in the UXO-1 and UXO-3 lines when inoculated with 
PXO99A, ME1, or BLS256 relative to mock-inoculated tissue, but not when inoculated with 
either of the T3SS mutants (Fig. 2). By contrast, the gene in the RAN-1 and RAN-2 lines was 
not significantly up-regulated by any of the bacterial strains, unexpectedly including PXO99A, in 
spite of the AvrXa27 EBE present in the RAN construct. Inoculation of PXO99A to the  
 
 
Figure 2.  Type III secretion system (T3SS)-dependent and AvrXa27-independent activation of 
effector binding element (EBE)-amended Xa27 by Xanthomonas oryzae pv. oryzae (Xoo) PXO99
A
 and 
Xanthomonas oryzae pv. oryzicola (Xoc) BLS256.  Vertical bars represent fold-change in abundance of 
Xa27 mRNA in the UXO and RAN lines and in IRBB27 at 48 h after inoculation with the indicated bacterial 
strains, relative to mock-inoculated plants, measured by quantitative real-time reverse-transcriptase PCR 
(qPCR). Each is the average of three technical replicates of at least three biological replicates. Capped 
vertical lines show standard error. Asterisks indicate values significantly > 1.0 (dashed line) as determined 
by two-tailed, heteroscedastic t-tests. Relative fold-change was calculated by the 2
-∆∆Ct   
method. ME1 is an 
avrXa27-deficient PXO99
A
 derivative. 
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nontransgenic variety IRBB27, which carries the wildtype Xa27 gene, resulted in the expected 
activation, indicating that the failure of the RAN lines to respond was not the result of a defect in 
the PXO99A isolate. 
EBE-amended Xa27 is specifically activated by each TAL effector 
To assess the function of each EBE in the UXO construct, we measured the fold-change in 
Xa27 mRNA in leaves of T2 plants of the UXO-3 line 48 h after syringe infiltration with 
transformants of strain EB08 of the soybean pathogen Xag expressing each of the 
corresponding effectors individually. This strain on its own produces no visible response in rice. 
Xa27 in the UXO-3 plants was significantly (P < 0.05) up-regulated by all seven TAL effectors, 
that is (in the order of their EBEs) Tal4c, PthXo1, Tal2g, PthXo6, Tal4a, Tal9a, and AvrXa27, 
when compared with mock-inoculated tissue (Fig. 3).  The Xoo TAL effector AvrXa10 (Hopkins 
et al., 1992), and the Xoc TAL effector Tal1c (Bogdanove et al., 2011), for which UXO-3 
contains no EBEs, as well as Tal1c lacking its central repeat region, caused no significant up-  
 
 
Figure 3.  Specific activation of Xa27 in the UXO construct by each of the corresponding 
transcription activator-like (TAL) effectors individually.  Vertical bars represent relative abundance of 
Xa27 mRNA, measured by quantitative real-time reverse-transcriptase PCR (qPCR), in the UXO-3 line and 
in IRBB27 48 h after inoculation with Xanthomonas axonopodis pv. glycines EB08 expressing one of the 
seven corresponding Xanthomonas oryzae pv. oryzae (Xoo) or Xanthomonas oryzae pv. oryzicola (Xoc) 
TAL effectors, or as controls for specificity, the Xoo TAL effector AvrXa10, the Xoc TAL effector Tal1c, or 
Tal1c lacking its central repeat region (∆CRR), as indicated,  relative to mock-inoculated plants. Each is the 
average of three technical replicates of at least three biological replicates. Capped vertical lines show the 
standard error. Asterisks indicate values significantly > 1.0 (dashed line) as determined by two-tailed, 
heteroscedastic t-tests. Relative fold-change was calculated by the 2
-∆∆Ct
  method. Values for the seven 
corresponding effectors are shown in the order of their effector binding elements (EBEs) in UXO (left to right, 
5’ to 3’). 
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regulation (Fig. 3). Fold induction by the six targeted TAL effectors (Fig. 3) positively correlated 
with proximity of the corresponding EBE to an apparent TATA box immediately upstream of the 
native AvrXa27 EBE (Fig. 1; Spearman’s rank correlation coefficient = 0.8857, P < 0.01). The 
same pattern of induction of Xa27 by the individual TAL effectors was observed in the UXO-1 
line (Fig. S2). 
All six EBEs drive transcription of Xa27 primarily from a shared start site 
Previous studies reported start sites for TAL effector-induced transcription at positions 
distinct from the start site for basal level expression; these were generally located 42–54 
nucleotides downstream of the 3’ end of the EBE (Kay et al., 2007, 2009; Römer et al., 2009a;  
Römer et al., 2009b; Antony et al., 2010). To determine whether the position of the EBE for 
each TAL effector activating the UXO construct similarly defines the transcriptional start site 
(TSS), 5’ rapid amplification of cDNA ends (5’-RACE) was conducted on RNA collected for  the  
UXO-3  gene expression assays described earlier (Fig. 4).  Based on the 12–29 transcript  
sequences obtained per sample, despite the distinct positions of their corresponding EBEs, 
PthXo1, PthXo6, Tal9a, Tal4a, Tal4c, and  Tal2g each initiated transcription primarily at  a  
shared site, identical to  that of the majority of transcript sequences obtained from basal 
expression in the mock and AvrXa10-treated negative controls. The site, 60 bp upstream of the 
start codon of the Xa27 coding sequence, resides 27 bp downstream of the native, putative 
TATA box that immediately precedes the AvrXa27 EBE, which positions it only 10 bp 
downstream of the 3’ end of that EBE. Consistent with the observations to date that TAL 
effector-driven transcription initiates a minimum of 42 bp from the 3’ end of an EBE, none of the 
AvrXa27- generated transcripts initiated at that common site. Rather, they initiated further 
downstream, nearly all of them at a distance of 46 bp from the 3’ end of the AvrXa27 EBE, 24 
bp upstream of the Xa27 start codon. Xoo PXO99A- and Xoc BLS256-inoculated plants each 
exhibited a greater diversity of TSSs than was generated by any of the individually delivered 
effectors, including some TSSs not observed following individual TAL effector delivery.  
Conversely, however, some sites that were observed upon delivery of the TAL effectors 
individually were not detected following inoculation with the pathogen strains. The most 
common TSS in PXO99A-inoculated plants was the shared site at 60 bp upstream of the Xa27 
start codon. This was the second most common for BLS256-inoculated plants, the first being a 
unique site upstream, at -149 relative to the Xa27 coding sequence. Other apparent TSS 
locations for PXO99A- and BLS256-inoculated plants ranged as far upstream as -165 relative to 
the Xa27 translational start, with no discernible correlation to EBE positions. 
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Figure 4.  Xa27 transcriptional start sites observed in the UXO-3 plants in response to individual 
transcription activator-like (TAL) effectors, Xanthomonas oryzae pv. oryzae (Xoo) PXO99
A
, BLS256, 
or a mock inoculation.  Sequences obtained by 5’-RACE are represented by horizontal bars for each 
treatment, drawn to scale relative to the UXO construct, depicted below. The thickness of each bar reflects 
the relative frequency at which that sequence was obtained. The total number of sequences obtained for 
each treatment is given on the right. The numbers 1–4 indicate the four most common transcript initiation 
sites, mapped on the UXO promoter sequence at the bottom. 
 
EBE-amended Xa27 confers resistance to a broader spectrum of Xoo strains and to all 
tested Xoc strains 
 To assess the effectiveness of adding EBEs to Xa27 to broaden its functional specificity, we 
first carried out quantitative virulence assays  of ME1 and BLS256 in T2 plants of the UXO, 
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XOO, XOC, and RAN lines, as well as the HRB and AZY controls and IRBB27 (Fig. 5a,b). The  
extent of bacterial blight symptoms (length of leaf curling) following leaf clip inoculation 
(Kauffman et al., 1973) with ME1 was significantly (P < 0.01) and markedly reduced specifically 
in the UXO lines and the XOO line relative to the RAN, XOC, and HRB lines, and IRBB27. The 
single AZY line, for unknown reasons, showed an intermediate mean leaf curl length. Bacterial 
leaf streak lesions in the UXO and XOC lines following syringe inoculation (Schaad et al., 1996) 
with BLS256 were significantly (P < 0.01) and markedly reduced relative to all other lines. The 
patterns of resistance and susceptibility to ME1 and BLS256 in the EBE-amended and control 
lines correlate strictly with the patterns of Xa27 activation described earlier (Fig. 2), and 
demonstrate that the amendment resulted in a specific broadening of the resistance spectrum of 
Xa27 to include both bacterial blight and bacterial leaf streak. 
 
 
Figure 5.  Bacterial blight and bacterial leaf streak resistance in the effector binding element (EBE)-
amended Xa27 transgenic plants. (a) Length of leaf curl 14 d after leaf clip inoculation of T2 plants of the 
indicated lines with Xanthomonas oryzae pv. oryzae (Xoo) ME1, which lacks avrXa27. Different letters 
indicate a statistically significant difference between values (P < 0.01; UXO-3 and AZY values are different 
at P < 0.05). (b) Lesion lengths 10 d after syringe inoculation with Xanthomonas oryzae pv. oryzicola  (Xoc) 
BLS256. Statistically significant differences (P < 0.01) are indicated as in (a). (c) Extent of leaf curl on T2 
plants of UXO-1 or RAN-1 14 d following inoculation with Xoo strains isolated from several locations, as 
indicated  (Phils., Philippines; Thai., Thailand). An asterisk indicates significantly reduced length of leaf 
curling (P < 0.05) relative to that observed on the RAN line. (d) Lesion length 10 d after inoculation with Xoc 
strains isolated from several locations, as indicated (Malay., Malaysia; Chi., China; Ind., India). Each strain 
produced significantly shorter lesions (P < 0.01) on UXO-1 than on RAN-1. Two-tailed, heteroscedastic t-
tests were used to determine significance. Experiments were repeated at least twice with similar results. 
Error bars represent SD.   
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The distribution of the TAL effectors corresponding to the six EBEs in the UXO construct 
and of AvrXa27 in field populations of Xoo and Xoc is not yet known. Nonetheless, we sought to 
determine the effectiveness of the UXO construct against geographically diverse strains of both 
pathovars. Seven Xoo strains reported to be virulent (1947 from Africa, C4 and ZHE173 from 
China, K202 from Korea, and 2 from Thailand) or weakly virulent (JW89011 from Korea and 
PXO71 from the Philippines) on IRBB27 (Gu et al., 2004) were inoculated to UXO-1 and, for 
comparison, to RAN-1 by clip inoculation (Fig. 5c). C4 and ZHE173 caused significantly (P < 
0.05) and markedly reduced leaf curl lengths on UXO-1 relative to RAN-1. JW89011 caused 
significantly (P < 0.05) but less dramatically reduced leaf curl lengths on UXO-1. The remaining 
Xoo strains were not significantly less virulent on UXO-1 than on RAN-1. Ten geographically 
diverse strains of Xoc, each virulent toward wildtype Xa27 plants (data not shown), were 
inoculated to UXO-1 and RAN-1 by syringe infiltration. The strains differed in their virulence on 
RAN-1, but each showed significantly (P < 0.01) and markedly reduced relative virulence on 
UXO-1 (Fig. 5d).  Thus, EBE amendment to the Xa27 promoter broadened its functional 
specificity to include a diversity of Xoo and Xoc strains. 
The UXO EBEs contain sequences apparently under selection in rice promoters 
To assess whether the EBEs added to the Xa27 promoter in the UXO construct might 
contain cis regulatory elements, a condition that could prevent TAL effector-mediated activation 
or cause TAL effector-independent activation under certain environmental conditions or during 
development, we examined representation of the EBEs in the rice ‘promoterome’, the collection 
of sequences from 400 to 50 bases upstream of all annotated translational start sites. We chose 
this sequence space based on the observation that the EBEs in the UXO construct in their 
natural contexts occur from positions -362 (Tal4a) to -86 (AvrXa27) relative to the translational 
start site. We reasoned that any portions of EBE sequences corresponding to cis elements in 
the promoterome would be under selection and therefore occur at nonrandom frequencies. For 
every possible six-nucleotide fragment of each EBE in the UXO construct, we determined the 
number of instances of that sequence in the promoterome and in each of 5000 randomized  
promoteromes. Of the 97 six-nucleotide sequences contained in the EBEs, 40 occurred in the 
promoterome at lower frequencies than expected based on observed frequencies in the 
randomized promoteromes, and 54 occurred at higher-than-expected frequencies (P < 0.05, 
Fig. 6). To distinguish whether the large number of six-nucleotide sequences with nonrandom 
frequencies was a function of the EBE sequences or instead an artifact of the EBE nucleotide 
composition, we con- ducted the same test with six-nucleotide sequences from each of 100  
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Figure 6.  Effector binding element (EBE) sequence representation in rice promoters.  (a) 
Representation of the 97 sequences obtained from moving a six-nucleotide (nt) window through each EBE 
in the UXO construct. The number of occurrences of each sequence across all annotated rice gene 
promoters (from 400 to 50 bp upstream of the coding sequences) was determined. The numbers of 
sequences occurring at lower-than-expected (P < 0.05), expected, or higher-than-expected (P < 0.05) 
frequency relative to the distribution of frequencies found in 5000 sequence- randomized iterations of the 
promoter set are shown. (b–d) Examples of six-nt EBE sequences that are represented at a lower-than-
expected frequency (b), the expected frequency (c), or a higher-than-expected frequency (dashed lines) (d) 
relative to the distribution of their frequencies in the randomized set (gray bars). 
 
different internal randomizations of the EBEs. Based on the numbers of six-nucleotide 
sequences derived from these randomizations that occurred at higher- or lower-than-expected 
frequencies in the promoterome, we determined that the number of six-nucleotide sequences 
from the actual EBEs that occurred nonrandomly in the promoterome was significantly higher 
than expected to occur by chance (P < 0.01), meaning that those frequencies are indeed a 
function of the EBE sequences, and suggesting selection. Taken together, the data indicate a 
strong likelihood that the six EBEs added to the UXO gene configuration contain or overlap 
sequences likely to be cis regulatory elements. 
Discussion 
A resistance gene that recognizes an effector that otherwise contributes strongly to 
virulence can be relatively durable due to the fitness cost to the pathogen of losing or modifying 
that effector to evade detection (Leach et al., 2001). A striking example is bacterial blight 
resistance mediated by the rice Xa7 gene, which is triggered by AvrXa7, a major virulence 
factor in Xoo (Hopkins et al., 1992; Bai et al., 2000; Vera Cruz et al., 2000; Ponciano et al., 
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2003). However, a mutation that uncouples the virulence and avirulence (resistance-triggering) 
properties of an effector could result in defeat of the resistance gene. Also, because most 
resistance genes exhibit pathogen race specificity linked to recognition of a single effector, 
evolution or introduction of pathogen strains that use alternative effectors for virulence can 
render a resistance gene ineffective. Against pathogens that rely on TAL effectors for virulence, 
an executor gene engineered to respond to multiple TAL effectors important for virulence and 
conserved across a pathogen population could provide durable and broad-spectrum protection.  
Here, we established the feasibility of such an approach by adding EBEs to the promoter of 
the Xa27 gene for resistance to rice bacterial blight and demonstrating consequent broadening 
of its functional specificity to include Xoo strains virulent toward wild type Xa27-containing plants 
as well as strains of the bacterial leaf streak pathogen Xoc, for which no simply inherited 
resistance genes had been identified in rice. Without altering the coding sequence and by 
adding less than 200 bp of recombinant DNA to the gene promoter, EBE amendment resulted in 
a single gene with an effective recognition spectrum similar to that achieved by the arduous and 
time-consuming process of pyramiding multiple resistance genes. Our selection of EBEs was 
based on available data from one strain each of Xoo and Xoc. Systematic studies to catalog the 
diversity of TAL effectors in Xanthomonas field populations should enable the rational 
modification of executor genes to provide broad and durable resistance on a geographically 
specific basis. 
Importantly, each of the targeted TAL effectors individually activated the transgene in the 
UXO construct. Also, the observed patterns of resistance and susceptibility to Xoo ME1 and Xoc 
BLS256 across all transgenic lines were as expected based on the corresponding EBE and TAL 
effector content in each interaction, and they correlated directly with the patterns of Xa27 
activation. We used ME1 in addition to PXO99A for the gene expression assays and in place of 
PXO99A for the virulence assays to distinguish resistance due to the EBEs added to Xa27 from 
resistance mediated by the native AvrXa27 EBE. It should be noted that in addition to its 
deficiency in avrXa27, ME1 is also disrupted in pthXo6, which neighbors avrXa27; though 
AvrXa27 makes no measurable contribution to virulence, pthXo6 does (Sugio et al., 2007). The 
virulence reduction due to the disruption of pthXo6 in ME1 is slight, however, and did not mask 
the resistance conferred by the EBE-amended Xa27 constructs. The disruption of pthXo6 in 
ME1 did, though, limit the effectors in that strain expected to interact with EBEs in the UXO 
promoter to PthXo1 and Tal9a. Together, the results strongly suggest that activation of the 
transgene by the wildtype Xoo and Xoc strains is mediated by at least one and possibly each of 
the corresponding TAL effectors in those strains.  
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Each of the TAL effectors we chose from PXO99A plays a role in virulence. None of the ones 
we chose from BLS256 has been characterized with respect to virulence, but each has a well-
matched EBE in a putative target gene promoter in rice. The set of EBEs matching these 
effectors expanded the resistance spectrum of Xa27 to include not only the PXO99A mutant 
lacking AvrXa27, and BLS256, but two of seven additional, geographically diverse Xoo strains 
and each of ten additional, diverse Xoc strains tested. The wide resistance spectrum conferred 
by these EBEs against the Xoc strains and the narrower spectrum against Xoo strains suggests 
conservation of one or more of the BLS256 TAL effectors in the Xoc strains, and poor 
conservation of the PXO99A effectors in that group. This may reflect greater overall TAL effector 
diversity among Xoo strains, potentially due to diversifying selection exerted by the nearly 30 
known bacterial blight resistance genes in rice (Niño-Liu et al., 2006). As noted, no simply 
inherited genes for bacterial leaf streak resistance have been identified in rice [the only 
identified source of complete resistance is the Rxo1 gene from maize (Zhao et al., 2005)], and 
this might explain the apparently lesser TAL effector diversity across Xoc strains. To conclude 
with confidence whether a difference in TAL effector diversity truly exists between Xoo and Xoc, 
however, a more comprehensive and direct inventory across a broad collection of strains would 
be necessary. 
In light of the absence of major, native genes for resistance to bacterial leaf streak in rice, it 
is particularly promising that Xa27 was fully effective against Xoc. The only executor gene in 
rice cloned to date, Xa27 encodes a 113 amino acid product that has no similarity to functionally 
characterized proteins, but contains an amino-terminal signal-anchor-like sequence that 
mediates export to the apoplast and is required for bacterial blight resistance (Wu et al., 2008). 
Xoo colonizes rice xylem vessels, interacting with cells in the surrounding xylem parenchyma to 
cause bacterial blight. Xoc multiplies in the mesophyll parenchyma. The mechanism by which 
Xa27 confers resistance to bacterial blight is unknown. Its activation causes cell death, but it is 
yet unclear whether the death is programmed or due to toxicity of the Xa27 protein. Its 
effectiveness against bacterial leaf streak, demonstrated here, indicates that the mechanism is 
general and not restricted to cells in the xylem parenchyma. 
As noted earlier, weak constitutive expression of Xa27, though deleterious to the plant, 
conferred partial resistance to Xoc strain L8 (Tian & Yin, 2009). The complete resistance we 
observed is likely due to stronger, localized expression in response to one or more of the 
targeted TAL effectors delivered by Xoc. Fold induction of Xa27 in the UXO construct by each of 
the targeted Xoo and Xoc TAL effectors individually correlated positively with proximity of the 
EBE to a putative TATA box downstream and to the common start site of transcription. Although 
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differences in expression, delivery, or affinity of the TAL effectors may have contributed to this 
pattern, the strength and significance of the correlation of EBE position to fold induction suggest 
that there may be a limit to the number of EBEs that can be effectively added to a promoter, as 
those farthest upstream might drive expression only weakly or not at all. We also observed, 
unexpectedly, that PXO99A failed to activate Xa27 in the RAN lines, despite its ability to do so in 
IRBB27. The RAN construct maintains the native AvrXa27 EBE, differing from the UXO 
construct only in its internal randomization of the added EBEs. Thus, the randomized 
sequences in some way prevent activation by AvrXa27, or less likely, in both lines activation is 
blocked due to the positions at which the construct integrated. Though the TAL effector-DNA 
binding code enables prediction of TAL effector binding sites with relative confidence, the above 
observations highlight the fact that we still know little of the contextual requirements for 
functional EBEs, both with respect to promoter sequences as well as chromosomal location and 
chromatin status. Until more is known, successful placement of EBEs in a promoter may require 
some trial and error. 
Another complexity in EBE-amendment is the possibility of interaction among different TAL 
effectors binding to the same promoter. We sought to minimize this by spacing EBEs six bp 
apart and alternating those for Xoo with those for Xoc. Nonetheless, our 5’ RACE results 
comparing TSSs detected following individual TAL effector delivery to those detected following 
inoculation with the corresponding Xoo or Xoc strain provided evidence for such interaction. 
Some TSSs detected following inoculation with the pathogen strain were not detected on 
delivery of any of the corresponding individual effectors and, to a lesser extent, vice-versa. 
Thus, although the collection of transcript sequences may not have been saturating, the data 
suggest that both cooperative interaction to generate novel TSSs as well as interference that 
blocks initiation from some sites take place. 
Previous analyses showed TAL effector-initiated transcription to occur between 42 and 54 
nucleotides downstream of the 3’ end of the EBE, even when the EBE was moved out of 
context (Kay et al., 2007; Römer et al., 2007; Kay et al., 2009; Römer et al., 2009; Römer et al., 
2009; Antony et al., 2010). Our results differ. Most transcripts driven by each of the six non-
native TAL effector-EBE interactions on the Xa27 promoter in the UXO construct initiated at a 
site shared by all interactions, rather than at sites corresponding to the relative positions of the 
EBEs. Because this was the same site of transcript initiation observed in mock-inoculated 
leaves and leaves treated with the non-targeted negative control AvrXa10, it appears that in 
some configurations, and perhaps depending on the EBE, TAL effector induced transcript 
initiation can default to the primary site used for basal expression. The location of the common 
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TSS at 27 bp downstream of a putative TATA box suggests that presence of such an element 
might influence the location of TAL effector-driven transcript initiation. Some of the TAL effectors 
reported to dictate the TSS display a TATA box-like sequence within their EBE, which might 
explain that ability, but not all of them do. Indeed, the AvrXa27 EBE contains no TATA-like 
sequence, yet drives transcription from a site downstream of the common TSS, perhaps 
because it is too close to that TSS. In all, it appears that the site of TAL effector driven transcript 
initiation is influenced by position of the EBE and by other promoter features in a yet poorly 
understood way. 
We discovered that the EBEs we chose for the UXO construct contain sequences 
apparently under selection in rice promoters, suggesting coincidence with endogenous 
regulatory elements. These might include elements for gene activation in response to a 
particular environmental or developmental cue. Introduction of an EBE with such an element 
into the promoter of an executor gene could lead to TAL effector-independent cell death on that 
cue, with potentially disastrous consequences. We examined sequences from only six EBEs, so 
our findings may not be generalizable. However, TAL effectors might be expected typically to 
target endogenous regulatory elements in the host genome, by chance due to their localization 
in promoters, but also because such regulatory elements would likely be relatively immutable, 
and thereby confer selective advantage on any corresponding TAL effector. 
Though the lines included in this study were healthy and fertile under controlled growth 
conditions, we encountered difficulty retrieving viable, stably transformed lines for some 
constructs we made. In addition to the UXO construct, in which the EBEs are exactly those 
found in the rice genome and contain some nucleotides that do not match the RVD at that 
position in the corresponding TAL effector, we also made a construct containing analogous, 
perfectly matched EBEs. Plants with this construct were unhealthy, and no lines survived to T2. 
Also, we were unable to obtain plants transformed with wildtype Xa27. The latter observation, 
consistent with previous findings (Wu et al., 2008), suggests that the unmodified Xa27 promoter 
can drive expression of the executor gene and consequent cell death when outside of its native 
genomic context. Similarly, even with the terminator upstream, transformation events using the 
XOO construct only yielded one healthy line. Thus, in addition to the possibility that EBEs added 
to a promoter may contain regulatory elements that could drive TAL effector independent-
independent activation, synthetic sequences, sequences out of context, and position effects 
might also be problematic. 
In sum, though the results presented here establish the effectiveness of EBE amendment to 
expand the spectrum of pathogen genotypes against which an executor gene functions, multiple 
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alternative constructs may be necessary to obtain effective, stable transformants, and all lines 
should undergo testing under a variety of growth conditions and field environments prior to 
distribution or commercialization. Analysis of the representation of EBE sequences in the host 
promoterome might be a useful preliminary to selection of EBEs, in order to exclude those that 
contain sequences apparently under selection. Although beyond the scope of the work we have 
presented here, it might also be useful to determine whether any sequences that are over- or 
under-represented are found in promoters of genes of a particular functional class, in order to 
better predict conditions or processes in which the sequence might act as a regulatory element. 
Taking advantage of the degeneracy in the TAL effector-DNA binding code to generate non-
native EBE sequences may enable the rational design of a promoter recognized by a desired 
suite of TAL effectors without the inclusion of endogenous cis elements. Finally, making the 
promoter modifications in situ using engineered nucleases such as TALENs (Bogdanove & 
Voytas, 2011) may help guard against position effects on expression. 
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Supporting Information 
 Supplementary Fig. S1., which contains the complete sequences of the UXO, XOC, XOO, 
and RAN constructs, is available in the online version of the article. 
 
 
 
 
 
 
 
Figure S2.  Specific activation of Xa27 in UXO-1 plants by each of the corresponding TAL effectors 
individually. Vertical bars represent relative abundance of Xa27 mRNA, measured by qPCR, 48 hours after 
inoculation with Xag EB08 expressing one of the seven corresponding Xoo or Xoc TAL effectors, or as 
controls for specificity, the Xoo TAL effector AvrXa10 or the Xoc TAL effector Tal1c, as indicated, relative to 
mock inoculated plants. Each is the average of three technical replicates of at least three biological 
replicates. Capped vertical lines show standard error. Asterisks indicate values significantly greater than 1.0 
as determined by two-tailed, heteroscedastic t-tests. Relative fold-change was calculated by the 2
-∆∆Ct
 
method. Values for the seven corresponding effectors are shown in the order of their EBEs in UXO (left to 
right, 5’ to 3’). 
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Table S2.  Relative abundance of Xa27 mRNA in mock-inoculated transgenic lines compared to IRBB7. 
Line Fold difference1 P value2 
UXO-1 1.14 0.43 
UXO-3 1.28 0.00 
XOO 1.11 0.19 
RAN-1 6.01 0.01 
RAN-2 3.51 0.03 
XOC-2 7.79 0.04 
                            
 
 
 
1 
RNA was sampled at 48 hours after mock inoculation and Xa27 mRNA levels assessed by qPCR. 
Each value is the average of three technical replicates of at least three biological replicates and was 
calculated by the 2
-ΔΔCt
 method. 
2 
P values were determined by two-tailed, heteroscedastic t-tests. 
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CHAPTER 6.  THE ROLE OF TRYPTOPHAN 232 IN TAL EFFECTOR 
DNA BINDING 
 
A paper to be submitted to PLoS One 
 
Erin L. Doyle1, Colby G. Starker2, Zachary L. Demorest2, Aaron Hummel1, Dan Nettleton3, 
Phillip Bradley4, Barry L. Stoddard5, Daniel F. Voytas2, and Adam J. Bogdanove1,6 
Abstract 
TAL effectors are customizable DNA binding proteins that can easily be targeted to bind to 
almost any sequence of interest. Consequently, custom TAL effector-based constructs have 
rapidly become popular tools for targeted gene regulation and genome engineering. Naturally 
occurring TAL effector binding sites are nearly all directly preceded by a thymine (T) at the 5’ 
end of the binding site, and custom TAL effector constructs have typically been designed with 
this constraint.  Structural information suggests that the requirement for T is encoded by a 
tryptophan residue (W232) in the cryptic -1st repeat of the protein that exhibits Van der Waal’s 
contacts with the T.  We generated TAL effectors with all possible single amino acid 
substitutions for W232 and showed that many substitutions alter or relax the specificity for T at 
this position but also reduce the TAL effector’s activity and binding affinity.  We were unable to 
identify any substitutions with consistently better activity that W232 across different TAL 
effectors and in different types of assays, suggesting previously unknown complexity and 
context dependence of the interaction between this region of the protein and the DNA preceding 
the target site. TAL effectors with tryptophan or arginine at position 232 were predicted to have 
the most favorable DNA binding energies.  Notably, TAL effector-like proteins from Ralstonia 
solanacearum have and arginine at this position, suggesting that TAL effectors and Ralstonia 
TAL-like effectors have naturally selected the optimal residues at this position for binding.  
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Therefore, engineering enhanced TAL effectors with high activity levels that bind to sites not 
preceded by T may require altering portions of the TAL effector other than W232. 
Introduction 
Transcription activator-like (TAL) effectors from the plant-pathogenic bacterial genus 
Xanthomonas have generated considerable interest as tools for targeted control of gene 
expression and site-specific genome engineering.  In nature, TAL effectors function as trans-
kingdom transcriptional activators that are deployed by Xanthomonas spp. to manipulate host 
plant gene expression.  During infection, the TAL effectors are secreted from the pathogen into 
the host plant cell via the type three secretion system (T3SS) and localized to the nucleus.  
Once there, they bind to effector-specific DNA sequences to activate transcription of host plant 
genes necessary for bacterial multiplication and survival (1,2). Each TAL effector’s specific 
binding site is determined by its central repeat region (CRR), which is composed of a variable 
number of tandem repeats 34-35 amino acids in length.  The repeats are nearly identical with 
repeat-to-repeat variation occurring primarily at amino acids 12 and 13 (termed the repeat-
variable diresidue or RVD).  The sequence of RVDs corresponds directly to the DNA binding 
site, with each repeat/RVD forming base-specific contacts with single binding site nucleotide (3-
6).  Discovery of this TAL effector-DNA binding code has enabled prediction of binding sites and 
targets for individual TAL effectors (7).  It has also made it possible to engineer custom TAL 
effectors to bind to novel DNA sequences for a variety of applications. 
Custom TAL effector-based fusion proteins can be targeted to bind to novel sequences by 
assembling a CRR with the appropriate RVD sequence that corresponds to the intended target 
site.  Such custom TAL effectors have been used to activate transcription of specific genes, 
using either the native TAL effector activation domain or replacing it with the VP16 activation 
domain from herpes simplex virus or its tetrameric derivative VP64 (8-11).  Targeted gene 
repression using custom TAL effectors has also been demonstrated, either by simply removing 
the activation domain (yeast) or replacing it with a repressor domain (12-14).  The most widely 
used application of TAL effectors are TAL effector nucleases, or TALENs, which use TAL 
effector CRRs fused to the catalytic domain of the FokI endonuclease to create precisely 
targeted double strand breaks (DSBs) in the DNA (8,15-17).  In eukaryotic cells, the DSBs are 
subsequently repaired by one of two pathways.  Non-homologous end joining (NHEJ) frequently 
results in insertions or deletions, and can be used to disrupt a gene and created targeted gene 
knockouts.  Homologous recombination (HR) inserts a repair template of similar sequence at 
the break site.  By supplying a template encoding alterations to the targeted sequence, HR can 
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be used to create site-specific sequence modifications ranging from changing a few bases to 
inserting an entire gene (18-20).  TALEN-mediated NHEJ and HR have been demonstrated in a 
wide variety of cell types and organisms.  Additionally, custom TALENs have proven to be 
easier to design than other sequence-specific nucleases, and a variety of kits are readily 
available for their construction (reviewed in 21,22)).  Therefore, custom TAL effectors and 
TALENs have become key tools for genetic engineering and other biotechnology applications. 
Because the TAL effector repeats appear to behave modularly with no neighbor or context 
effects, and can therefore be assembled in any order, custom TAL effectors can be readily 
targeted to almost any sequence in the genome (5,6).  However, the design and targeting of 
custom TAL effectors and TALENs is constrained by a requirement for the TAL effector binding 
site to be directly preceded by a thymine (T) at the 5’ end (known as the 0th position).  The 0th 
position T is found in nearly all known TAL effector binding sites in nature (3,4).  The single 
exception is the target of TalC from Xanthomonas oryzae pv. oryzae (Xoo) strain BAI3, which is 
preceded by a 5’ cytosine at position 0 (23).  Replacing the 0th position T with another base has 
been shown to dramatically reduce or eliminate TAL effector-driven activation of reporter genes 
as well as DNA binding (4,24,25).  Functional TALENs targeting sites preceded by other 
nucleotides have been reported, but activity was not compared to equivalent targets with a T 
(8,26,27), and most custom TAL effectors have typically been designed to target binding sites 
preceded by a T. Thus, the presence of a T preceding the TAL effector binding site appears to 
be an important requirement for optimal TAL effector activity and represents a constraint on the 
design of custom TAL effectors and TAL effector based constructs. 
A structural explanation was revealed by the structure of Xoo TAL effector PthXo1 bound to 
its DNA target.  This structure included two previously unknown cryptic repeats (designated the 
0th  and -1st repeats) located N-terminal to the CRR   which were similar in structure but 
dissimilar in sequence to the canonical repeats encoding the binding site.  Residue 232 of the 
protein, a tryptophan located in the -1st repeat (tryptophan 232 or W232), was shown to be in 
close proximity to the 0th position T and to form energetically favorable, base-specific Van der 
Waal’s contacts with the methyl group of the T (5).  Additionally, W232 and its surrounding 
residues are highly conserved in Xanthomonas TAL effector sequences, consistent with W232 
playing a significant role by encoding the T at the 0th position of the binding site. TAL effector 
truncation studies have found that the presence of the -1st repeat is necessary for TAL effector 
binding and function (9,28).  Therefore, it is not possible to engineer TAL effectors that have no 
requirement for a T at the 0th position of the binding site by removing this portion of the protein.  
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Here we report a series of experiments testing if the requirement for the 0th position T is 
encoded by W232.  We also sought to enhance TAL effector-DNA targeting capacity by 
identifying substitutions for W232 that would relax or alter specificity for the 0th position T while 
retaining activity levels similar to wild-type TAL effectors.  We constructed a series of TAL 
effectors with single amino acid substitutions for W232 and tested their activity and binding 
affinities on targets preceded by A, C, G, or T.  None of the substitutions improved on the native 
W232 by consistently relaxing specificity for the 0th position T and having a high level of activity.  
We discovered an arginine in the analogous position of Ralstonia TAL-like effectors (RTLs) that, 
in the context of an RTL-TAL effector chimera, is similarly critical for DNA binding.  
Computational analysis predicted that TAL effectors with tryptophan or arginine at position 232 
had more favorable binding energies than other substitution variants.  This suggests that TAL 
effectors and RTLs have evolved at this position for optimal DNA binding. Although we found 
substitutions for W232 altered TAL effector activity and specificity for the 0th position T, these 
effects varied depending on the TAL effector repeat sequence, the N terminal portion of the TAL 
effector, and across assays.  These context –based effects suggest that the cryptic 0th repeat, 
other portions of the N terminus, and other regions of the protein may be involved in specifying 
the 0th position T. Therefore, development of TAL effectors with broader DNA targeting 
capacities will likely require re-engineering multiple positions in the cryptic repeats and the N 
terminus.  
Materials and Methods 
Construction of TAL effector -1 repeat variants 
To generate the PthXo1 TAL effector variants for GUS assays, the SphI fragment containing 
the repeat region of the gene encoding TAL effector PthXo1 (clone obtained from Bing Yang, 
Iowa State University) was ligated into the SphI site of plasmid pCS466 to create plasmid 
pAH103, which encodes a full length TAL effector with the PthXo1 CRR.  pCS466 is a Gateway 
entry plasmid containing a truncated form of the Xanthomonas oryzae pv. oryzicola (Xoc) tal1c 
gene, from which the SphI fragment containing the DNA binding domain has been removed 
(29).  To make single amino acid substitutions for W232, the region of pAH103 surrounding 
W232 was amplified via PCR using a forward primer p885 (5'-
GCGTCGGCAAACAGGCGTCCGGCGCACGC-3') crossing the NotI site, and reverse primers 
crossing the StuI site and introducing both a substitution for W232 and a silent XhoI site to 
facilitate screening (including arginine: 5’-
CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATCGCTGTTTGCCG-3’, asparagine: 5’-
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CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAATTCTGTTTGCCG-3’, glutamine:  5’-
CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATTGCTGTTTGCCG-3’, proline: 5’-
CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATGGCTGTTTGCCG-3’, and threonine: 5’-
CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATGTCTGTTTGCCG-3’).  The same 
forward primer was used for all substitutions.  Primers for all substitutions are listed in 
Supplementary Table 1.  PCR products carrying the W232 substitutions were digested with NotI 
and StuI (both New England Biolabs, Inc.) and ligated back into the pAH103 backbone between 
the NotI and StuI sites using standard techniques to create genes for full length TAL effectors 
with the PthXo1 repeat sequence and W232 substitutions. 
To generate pTAL868 variants, a TALEN containing the pTAL868 repeat sequence (Figure 
1) was constructed using our Golden Gate method (30), and digested with restriction enzymes 
StuI and AatII (both New England Biolabs, Inc.).  The 1.7kb fragment containing the repeat 
region was purified from an agarose gel.  pAH103 variants with W232 substitutions described 
above were digested with StuI and AatII and the 4.3kb backbone fragments containing the TAL 
effector N and C termini were recovered.  TAL868 repeats were ligated into these pAH103-
based backbones containing the W232 substitutions.  All TAL effectors (PthXo1 and TAL868 
variants) were recombined into the Gateway binary vector (31) pGWB5 using Gateway LR 
Clonase II (Life Technologies) according to the manufacturer’s instructions. 
Construction of chimeric TAL effector RScPthXo1 
The Ralstonia TAL-like effector N-terminal sequence was PCR-amplified with Phusion DNA 
polymerase (Thermo Fisher Scientific) from GMI1000 genomic DNA (gift of D. Gross, University 
of Georgia) with forward primer p1178 (5’-
TTGCATGTAAATAGGAGGTGCACCATGAGAATAGGCAAATCAAG-3’; which added sequence 
upstream of the start codon to match that of the Xanthomonas TAL effector expression 
constructs) and p1179 (5’-GAGACTCGTCTCGGCACGCGTGAGCTTCC-3’; which added a 
downstream Esp3I restriction site for cloning). This amplicon was tailed with 3’ adenine residues 
using Taq Polymerase (Thermo Fisher Scientific) and cloned into the pCR8/GW/TOPO TA 
vector (Life Technologies).  The resulting plasmid was digested with Esp3I and EcoRV 
restriction enzymes (both New England Biolabs, Inc.) and ligated to the BanI/EcoRV restriction 
enzyme fragment of pAH103 to produce the full-length, Ralstonia/Xanthomonas chimeric TAL 
effector in the Gateway entry vector, designated pAH410.  Each -1st  repeat amino acid 
substitution variant of the chimeric effector was generated by PCR-amplifying a portion of the 
Ralstonia N-terminus using forward primer P1178 and each of five reverse primers that 
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generated five different amino acid substitutions at the -1 repeat (asparagine: 5’- 
CGGGTAGCAGCGCTTGCAGCGCCAGGTCACCCGAATTCTGC-3’, glutamine: 5’- 
CGGGTAGCAGCGCTTGCAGCGCCAGGTCACCCGATTGCTGC-3’, proline: 5’- 
CGGGTAGCAGCGCTTGCAGCGCCAGGTCACCCGATGGCTGC-3’, threonine: 5’- 
CGGGTAGCAGCGCTTGCAGCGCCAGGTCACCCGATGTCTGC-3’, and tryptophan: 5’- 
CGGGTAGCAGCGCTTGCAGCGCCAGGTCACCCGACCACTGC-3’). PCR amplifications were 
done using Phusion DNA polymerase (New England Biolabs, Inc.)  Each amplicon was digested 
with AfeI and BsaI restriction enzymes (both New England Biolabs, Inc.) and cloned into the 
AfeI/BsaI restriction enzyme digested pAH410. The chimeric effector and amino acid 
substitution variants were transferred to the binary expression vector pGWB5 (31) via the 
Gateway LR II Clonase enzyme kit (Life Technologies) to create the final chimeric TAL effector 
construct and RScPthXo1 and -1 repeat variants for use in GUS assays. 
Construction of GUS reporter plasmids 
For GUS reporter constructs, a 343bp region of the Bs3 promoter was PCR amplified as 
previously described (24).  The PCR product was ligated into the Gateway vector 
pCR8/GW/TOPO TA vector (Life Technologies) and site-directed mutagenesis was used to 
introduce an AscI site upstream of the naturally occurring binding site for TAL effector AvrBs3.  
This modified promoter was recombined into the Gateway GUS reporter vector pGWB3 (31) 
upstream of the GUS gene using LR Clonase II (Life Technologies).  Single-stranded DNA 
oligos containing the naturally occurring binding site for PthXo1 (UptPthXo1) or the binding site 
corresponding to TAL868 (Upt868) directly preceded by A, G, C, or T at the 0th position and with 
AscI-compatible ends were annealed and ligated into the AscI site.  Oligos used were 5'-
CGCGTGCATCTCCCCCTACTGTACACCAC-3' and 5'-
CGCGGTGGTGTACAGTAGGGGGAGATGCA-3' for UptPthXo1 (T); 5'-
CGCGAGCATCTCCCCCTACTGTACACCAC-3' and 5'-
CGCGGTGGTGTACAGTAGGGGGAGATGCT-3' for UptPthXo1 (A); 5'-
CGCGCGCATCTCCCCCTACTGTACACCAC-3' and 5'-
CGCGGTGGTGTACAGTAGGGGGAGATGCG-3' for UptPthXo1 (C); 5'-
CGCGGGCATCTCCCCCTACTGTACACCAC-3' and 5'-
CGCGGTGGTGTACAGTAGGGGGAGATGCC-3' for UptPthXo1 (G);  5’-
CGCGTACGTTAATGGAAGCT-3’ and 5’-CGCGAGCTTCCATTAACGTA-3’ for Upt868 (T); 5’-
CGCGAACGTTAATGGAAGCT-3’ and 5’-CGCGAGCTTCCATTAACGTT-3’ for Upt868 (A); 5’-
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CGCGCACGTTAATGGAAGCT-3’ and 5’-CGCGAGCTTCCATTAACGTG-3’ for Upt868 (C); and 
5’-CGCGGACGTTAATGGAAGCT-3’ and 5’-CGCGAGCTTCCATTAACGTC-3’ for Upt868 (G). 
Quantification of GUS activity 
To measure TAL effector activity, TAL effector and reporter constructs were transformed into 
Agrobacterium tumefaciens GV3101.  Cells were grown overnight and diluted to OD600 = 0.8 in 
infiltration buffer (10mM MgCl2, 5mM MES pH 5.3, 200µM acetosyringone).  Cells carrying TAL 
effector constructs and cells carrying GUS reporter constructs were mixed 1:1 and infiltrated into 
the leaves of 6-8 week old Nicotiana benthamiana plants using a needleless syringe, and 
infiltrated areas were marked.  After 48 hours GUS measurements were carried out as 
described (32):  Infiltrated leaf disks were ground in 300µL extraction buffer (50mM sodium 
phosphate buffer pH 7.0, 10mM EDTA, 10mM β-mercaptoethanol, 0.1% Triton X-100, 0.1% 
SDS) and centrifuged at 3500rpm for 10 minutes. 10µL supernatant was mixed with 90µL assay 
buffer (extraction buffer supplemented with 10mM 4-methyl-umbelliferyl-β-D-glucuronide) and 
incubated at 37 C for 1 hour.  Following incubation, 10µL of the reaction was stopped by 
adding 90µL 0.2M sodium carbonate.  Fluorescence was read at 360nm (excitation) and 460nm 
(emission).  Protein amounts were quantified by Bradford assay (Biorad).   
Paired T-tests 
GUS assays were conducted in multiple independent experiments over several months.  
Because results varied across experiments, we used paired t-tests to identify significant 
differences in activity due to W232 substitutions and to estimate effect sizes.  Each TAL 
effector/target combination was considered to be a treatment.  GUS measurements for two 
treatments taken from the same plant on the same day were considered to be paired samples. 
To test for significant differences between two treatments, the log-transformed paired 
measurements were subtracted.  The set of paired differences for the two treatments were 
tested using the R function t.test to test the null hypothesis that the average difference between 
the two treatments was equal to zero.  Estimated effect sizes from the t.test function were 
converted to fold changes. 
Construction and testing of TALENs 
We used a yeast-based single-strand annealing assay for testing TALEN function that has 
been previously described (30,33)  Briefly, a mating-type cells containing TALEN expressing 
plasmid were mated to α mating-type cells containing target plasmids.  Cleavage of the target 
plasmid results in reconstitution of a functional lacZ gene, providing a quantitative measurement 
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of TALEN activity.  All data are normalized to a wild type N-terminus TALEN on the target with 
the 5’ thymine and are the result of two independent experiments with a minimum of five 
replicates. 
 Yeast expression vectors were made by amplifying a fragment of the N-terminus of the 
TAL effector present in pZHY500 with forward primer 5’-ggacgcaagtggttggtctagaatggtgg-3’ for 
all reactions and a reverse primer incorporating the desired changes (asparagine: 5’-
cctccagggcgcgtgcgccggaATTctgtttgccgacgcc-3’; proline: 5’-
cctccagggcgcgtgcgccggaTGGctgtttgccgacgcc-3’; glutamine: 5’-
cctccagggcgcgtgcgccggaTTGctgtttgccgacgcc-3’; arginine: 5’-
cctccagggcgcgtgcgccggaTCGctgtttgccgacgcc-3’; and threonine: 5’-
cctccagggcgcgtgcgccggaTGTctgtttgccgacgcc-3’).  PCR products were digested with XbaI, StuI 
and cloned into the XbaI, StuI sites of pZHY500 or pZHY501 (34).  DNA binding repeats were 
cloned into the resulting vectors as described (35). 
Expression and purification of recombinant TALE protein 
The bacterial expression vector pGEX6P2-TALE was created by ligating a Golden Gate 
compatible fragment with the NΔ152/C+63 architecture into pGEX6P2 (GE Healthcare). 
Variants with substitutions at W232 were created by site-directed mutagenesis (Quickchange II, 
Agilent) using the same primers described above for the TALEN yeast assays. An array of 15 
repeats with the RVD sequence [NI HD NN NG NG NI NI NG NN NN NI NI NN HD NG], 
designated as TAL868, was then cloned into each of these vectors using the Golden Gate 
method as previously described (30). Expression constructs encoding the TAL effector proteins 
were then transformed into Rosetta (DE3) pLysS cells (EMD Millipore) and selected on media 
containing carbenicillin (50 µg/ml) and chloramphenicol (30 µg/ml). 200 mL cultures were grown 
to log phase at 37°C before induction for 3 hours with 1 mM IPTG. The cells were pelleted by 
centrifugation and lysed in GST lysis buffer (25 mM HEPES pH 7.4, 150 mM NaCl, 5 mM MgCl2, 
130 µM CaCl2, 0.5% Triton X-100, 10% glycerol, 1 mM PMSF, 1 µg/mL Leupeptin, 100 nM 
Aprotinin, 1 µg/mL Pepstatin A). The lysates were treated with RNase A (20 µg/mL) and DNase 
I (10 U/mL), clarified by centrifugation (21,000× g, 10 minutes) and then loaded onto a column 
containing equilibrated Glutathione Sepharose (GE Healthcare). The columns were washed with 
GST lysis buffer and subsequently by cleavage buffer (50 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 
mM DTT, 10% glycerol). Elution of untagged purified TALE protein was performed by overnight 
incubation at 4°C with PreScission protease (GE Healthcare). Purified TALE proteins were 
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separated by electrophoresis and stained with Coomassie blue to determine the purity of the 
samples. 
Electrophoretic mobility shift assay (EMSA) 
Double stranded DNA substrates were prepared by annealing fluorescently tagged 
complementary oligos. Sequences for substrates used were 5′- AACGTTAATGGAAGCT-3’ for 
Upt868A, 5′- CACGTTAATGGAAGCT-3’ for Upt868C, 5′- GACGTTAATGGAAGCT-3’ for 
Upt868G, 5′-TACGTTAATGGAAGCT-3’ for Upt868T, and 5′- TCGACGCTCAGGCAAC-3’ for 
the scrambled target. The purified proteins were diluted into binding buffer (10 mM HEPES pH 
7.6, 10% glycerol, 100 mM KCl, 10 mM MgCl2, 100 µM EDTA, 500 µ M DTT, 15 ng/µL salmon 
sperm DNA, 30 ng/µL BSA) at varying concentrations with a fixed concentration of the labelled 
DNA substrate (20 nM). The reactions were incubated for 30 minutes at room temperature and 
then separated by electrophoresis on a 7% TBE-acrylamide gel. Detection of the labelled 
substrate was then performed on a fluorescent scanner (Storm 860, Molecular Dynamics). 
Structural predictions 
 DNA binding specificity calculations were performed for all 20 canonical amino acid 
substitutions at position W232 using the molecular modelling package Rosetta (36). The 
structure of the TAL effector PthXo1 bound to a natural target site (PDB ID: 3UGM) was used as 
a modelling template. We explored two levels of conformational sampling, either keeping the 
protein backbone completely fixed or allowing limited flexibility in the neighborhood of the 
mutation. Each mutant was simulated in complex with 16 different DNA target sites that 
sampled all possible DNA sequences at positions 0 (the canonical T position) and -1 (also 
contacted by W232 in the crystal structure). At the end of each simulation, we computed a 
binding energy for the final structure by taking the difference between the energy of the complex 
and the energies of the unbound partners, allowing limited conformational relaxation in the 
unbound state prior to computing the unbound energies. 
Results 
Single amino acid substitutions for W232 alter target specificity and activity of the TAL 
effector PthXo1 
To test whether W232 encodes TAL effectors’ specificity for T at the 0th position of the 
binding site, we generated full length TAL effector constructs containing the repeat region of 
Xanthomonas oryzae TAL effector PthXo1 (see Figure 1b) with the wild type W232 as well as all 
19 possible single amino acid substitutions at this position. We then tested the ability of the 
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PthXo1 W232 substitution variants to activate transcription of a GUS reporter gene containing a 
PthXo1 binding site (UptPthXo1, for up-regulated by TAL effector PthXo1) preceded by adenine, 
cytosine, guanine, or thymine in their promoters (UptPthXo1 (A), UptPthXo1 (C), UptPthXo1 
(G), and UptPthXo1 (T), respectively).  PthXo1 variants and reporter constructs were co-
delivered into Nicotiana benthamiana leaves using Agrobacterium and GUS activity was 
measured after 48 hours. 
For initial screening, each PthXo1 W232 substitution variant was tested in at least one 
experiment.  In each experiment, one to three TAL effector constructs were tested against each 
of the four corresponding UptPthXo1 target reporter constructs.  In addition, each experiment 
included UptTALPthXo1 (T) with no TAL effector as a negative control, and UptPthXo1 (T) co-
delivered with the PthXo1 W232 construct as a positive control.  During a single experiment, 
each sample (a control or a TAL effector and target) was inoculated onto five different N. 
benthamiana plants, for a total of five different measurements for the sample.  To facilitate 
comparisons across experiments, within each experiment data were normalized to the positive 
control.  Data for each experiment were reported as the average of three leaf discs (high and 
low measurements were thrown out). 
All 19 of the substitutions for W232 appeared to alter specificity for the 0th position T 
(indicated by having the highest activity on a target preceded by A, C, or G, or having nearly 
equal activity on all targets) (Supplementary Figure 1). These alterations in specificity provide 
the first experimental evidence that W232 is involved in encoding the requirement for T 
preceding the binding site. However, many of the substitutions, including aspartate (D), cysteine 
(C), glutamate (E), isoleucine (I), leucine (L), lysine (K), methionine (M), and valine (V), reduced 
activity to less than half of the activity level of PthXo1 W232 on the target UptPthXo1 (T).  
Because we were interested in identifying W232 substitutions that both altered or relaxed 
specificity for T at the 0th position and maintained relatively high levels of activity, we selected 
the arginine (R), asparagine (N), glutamine (Q), proline (P), and threonine (T) substitutions to 
characterize in greater detail other assays and contexts. 
The effects of W232 substitutions on TAL effector activity and specificity for T at the 0th 
position depend on the RVD sequence 
In our initial screening, we found that W232 substitutions altered the specificity for T 
preceding the binding site and the activity level of TAL effector PthXo1.  Next, we sought to 
determine whether the effects on specificity and activity depend on the TAL effector’s RVD 
sequence.  We constructed variants of a second TAL effector, TAL868 (see Figure 1), with W at 
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position 232 and five W232 substitutions and tested their ability to activate a GUS reporter gene 
driven by the corresponding target preceded by A, C, G, or T (Upt868A, Upt868C, Upt868G, 
and Upt868T, respectively).  As with our initial screening of PthXo1 mutants, one to three TAL 
effector constructs were tested against each of the four corresponding Upt868 target reporter 
constructs, and each experiment included both Upt868 (T) with no TAL effector and Upt868 (T) 
co-delivered with the TAL868 W232 construct as controls.  In a single experiment, each was 
inoculated onto five different N. benthamiana plants, for a total of five measurements for the 
sample.  Each TAL868 W232 mutation construct was tested in at least three experiments.  GUS 
assays were also repeated for the five W232 substitution variants of PthXo1. 
We used paired t-tests to identify differences in GUS activity due to W232 substitutions (see 
Materials and Methods).  For each TAL effector, we tested for significant differences between 
the wild type TAL effector (W232) on the target preceded by T and all other TAL effector-target 
combinations.  We converted the estimated effect sizes to fold changes relative to either PthXo1 
W232 or TAL868 W232 on the corresponding target preceded by T (Figure 1).  We also tested 
for significant differences between each of the W232 TAL effector variants on the target 
preceded by T and each of the other three targets to determine if specificity had been relaxed or 
altered.  Results of all t-tests are reported in Supplementary Table 2. 
In general, W232 substitutions relaxed or altered specificity for targets with a T at the 0th 
position. However, TAL effector context affected base preference for many of these (Figure 1 
and Supplementary Table 2).  For example, in the context of PthXo1, the W232R substitution 
shifted specificity for the position 0 base to A or C (p<0.05).  In contrast, the W232R substitution 
in the context of TAL868 appeared to relax specificity entirely (p<0.01).  W232P was the only 
substitution to relax specificity in both TAL effectors (activity on targets preceded by A, C, and G 
were not significantly different than activity on the target preceded by T, p < 0.05). Therefore, 
our findings suggest that the effect of W232 substitutions on TAL effector binding site specificity 
and activity may depend on the TAL effector’s RVD sequence.  None of the W232 substitution 
variants showed significantly higher activity on any of the targets than the wild type TAL effector 
on the target preceded by T. 
A chimeric RTL-TAL effector construct shows that effects of W232 substitutions depend 
on N terminus context 
To further examine the effects of context on the W232 substitutions, we tested the effects of 
single amino acid substitutions on the analogous position in Ralstonia TAL effector-like effectors 
(RTLs), which are found in the soil-borne bacterium Ralstonia solanacearum.  RTLs possess N  
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Figure 1. GUS activity of TAL effectors with single amino acid substitutions for W232 on targets 
preceded by A, C, G, or T at the 0th position. A.  Schematic of a TAL effector showing the -1
st
 repeat 
sequence.  -1, -1
st
 repeat.  0, 0
th
 repeat.  CRR, central repeat region.  W232 is shown in larger type.  B.  Fold 
changes in GUS activity for PthXo1 W232 substitution variants on targets preceded by A, C, G, or T.  Fold 
changes are relative to PthXo1 W232 on the target UptPthXo1 (T).  UptPthXo1 (A), UptPthXo1 (C), 
UptPthXo1 (G), and UptPthXo1 (T) indicate the PthXo1 target is preceded by adenine, cytosine, guanine, 
and thymine, respectively.   C.  Fold changes in GUS activity for TAL868 W232 substitution variants on 
targets preceded by A, C, G, or T.  Fold changes are relative to TAL868 W232 on the target Upt868 (T).  
Upt868 (A), Upt868 (C), Upt868 (G), and Upt868 (T) indicate that the TAL868 target is preceded by adenine, 
cytosine, guanine, and thymine, respectively.  Bars indicate the 95% confidence interval for the fold change. 
and C termini with type III secretion signals and acidic activation domains similar to those of 
TAL effectors, although with some amino acid sequences differences.  RTLs also possess a 
repetitive CRR composed of repeats 35 amino acids in length and differing in sequence from 
Xanthomonas TAL effector repeats (37,38).  Although the RTL repeats possess RVDs typically 
not found in Xanthomonas, the RVD sequence has been shown to encode the RTL’s DNA 
CRR 
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binding site (39).  Currently, no RTL-targeted genes have been identified, and their role in plant 
disease is unknown. 
Because of the many similarities between Xanthomonas TAL effectors and RTLs, we 
reasoned that the RTLs might possess cryptic repeats similar in structure and function to those 
of TAL effectors.  We identified three RTL sequences in Genbank with complete coding 
sequences that included both the CRR and the entire N-terminal region upstream of the repeats 
(Supplementary Figure 2).  Using ClustalW (40,41), we aligned the N terminal regions of the 
RTLs with the N terminal region of Xoo TAL effector PthXo1.  The multiple sequence alignment 
showed that the RTL N termini have high sequence similarity to the N terminal region of PthXo1.  
Tryptophan 232 is replaced by an arginine in the RTL sequences, but the residues immediately 
on either side are conserved (Supplementary Figure 2). To further assess the similarity of the 
cryptic repeats, we generated secondary structure predictions for the N termini of the RTLs and 
PthXo1.  For all of the proteins, the N termini form six helices, with four helices corresponding 
approximately to the -1st and 0th repeats of PthXo1.  W232 (PthXo1) and R232 (RTLs) are 
located on a short loop between the two helices that make up the -1st repeat in each protein 
context (Supplementary Figure 3).   
Because the sequence alignments and secondary structure predictions indicated that RTLs 
possess regions structurally similar to the -1st and 0th repeats of TAL effectors and present an 
arginine at the equivalent position to W232, we tested the effects of single amino acid 
substitutions for this arginine, which we refer to as R232 because it is located at the RTL 
position that aligns with W232, on the RTL’s specificity at the 0th position of the binding site.  
We constructed a chimeric TAL effector, RScPthXo1, by replacing the N terminal region 
immediately upstream of the CRR of our PthXo1 construct with the N terminal region of RTL 
RSc1815 (Figure 2).  The chimeric TAL effector was co-delivered with each of the four 
UptPthXo1 GUS reporter constructs into Nicotiana benthamiana, and GUS activity was 
measured after 48 hours. 
 We found that the chimeric TAL effector with the wild-type N terminal R232 had the highest 
activity on the target preceded by G, and overall activity was significantly lower than the activity 
of PthXo1 with W232 on the target UptPthXo1 (T) (Figure 2). The specificity of RScPthXo1 
R232 for targets preceded by G is different than the specificities observed for PthXo1 W232R or 
TAL868 W232R, suggesting that other N terminus amino acid sequence differences may affect 
the specificity for the 0th position T. 
 Next, we tested the activity of single amino acid substitution variants of RScPthXo1 on 
targets preceded by A, C, G, or T.  All substitutions for R232, including R232W, eliminated 
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Figure 2. GUS activity of chimeric TAL effector RScPthXo1 with single amino acid substitutions for 
R232 on targets preceded by A, C, G, or T at the 0th position. A. Schematic of the chimeric TAL effector 
RScPthXo1 showing the RSc1815 -1st repeat sequence. CRR, central repeat region. 0, 0
th
 repeat.  -1, -1
st
 
repeat.  The arginine (R) equivalent to W232 is shown in large bold font.  Numbers indicate positions relative 
to the PthXo1 sequence. The red portion of the TAL effector is from Ralstonia RTL 1815; the remainder is 
from PthXo1.  B.  Left: GUS activity for RScPthXo1 with the native arginine at position 232 and R232 
substitution variants.  Substitutions for R232 are indicated.  Right: The same plot, zoomed in to show 
differences in the activity of the RScPthXo1 R232 substitution variants.  Activity is normalized so that PthXo1 
+ UptPthXo1 (T) is equal to 1.0.  UptPthXo1 (A), UptPthXo1 (C), UptPthXo1 (G), and UptPthXo1 (T) indicate 
the PthXo1 target is preceded by adenine, cytosine, guanine, and thymine, respectively.  Error bars 
represent the mean of 5 replicates ± 1 s.d.  Experiments were repeated at least twice with similar results. 
activity almost entirely (Figure 2).  Therefore, the RTL amino acid at the position analogous to 
W232 of Xanthomonas TAL effectors also plays a critical role in determining the TAL effector’s 
binding site, and substitutions at this position dramatically decrease RTL activity.  However, the 
differences in specificities in the context of TAL effectors or RTLs suggests that sequence 
differences in other parts of the proteins’ N termini, also play a role in specifying a preferred 0th 
position nucleotide preceding the binding site. 
W232 substitutions alter TALEN activity and specificity for the 0th position T 
Next, we asked if the effects of W232 substitutions on TAL effector activity and specificity for 
the 0th position T would be the same in the context of TALENs.  We generated TALEN pairs with 
the same RVD sequence as TAL868 in each monomer (see Figure 1c), and created W232 
substitutions variants.  We tested their activity on targets preceded by A, C, G, or T in a yeast 
single-strand annealing assay (15).  The assay is based on a target plasmid containing a variant 
of the LacZ gene with an internal sequence duplication that is disrupted by the TALEN target 
CRR 
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sequence.  The yeast strain carrying the target plasmid is mated with a yeast strain carrying the 
TALEN, and cleavage of the target by the TALEN restores LacZ function through single-strand 
annealing.  Measured LacZ activity is used as a proxy for TALEN activity. 
 As expected, the TAL868 W232 TALEN had highest activity on the target Upt868 (T).  
Two of the W232 substitutions, W232P and W232R, each relaxed the preference for targets 
preceded by T, but also reduced TALEN activity to less than 60% of the W232 TALEN on 
Upt868 (T) (Figure 3).  The W232T and W232N substitutions altered specificity to prefer targets 
preceded by G and C/T, respectively.  Additionally, none of the W232 substitutions showed 
higher activity on any target than the wild type (W232) TALEN on Upt868 (T), although the 
W232Q TALEN had activity >85% (relative to W232 on Upt868 (T))on the targets preceded by 
C, G, or T. Overall, the effects of W232 substitutions on activity and specificity observed in 
TALENs were not consistent with the changes observed in the context of the GUS assay. 
Substitutions for W232 alter the TAL effector’s DNA binding affinity and specificity for 
targets preceded by A, C, G, or T 
We next asked if the effects of W232 substitutions on TAL effector and TALEN activity and 
binding site specificity are directly related to changes in TAL effector-DNA binding affinity.  We 
expressed and purified a TAL868 construct and five W232 substitution variants and tested their 
affinities for DNA targets preceded by A, C, G, or T in electrophoretic mobility shift assays 
(EMSAs) (Figure 4).  The protein with the wild type W232 showed the strongest affinity for  
 
 
Figure 3. Activity of TALENs with the TAL868 repeat sequence and W232 substitutions on targets 
preceded by A, C, G, or T at the 0th position. Upt868 (A), Upt868 (C), Upt868 (G), and Upt868 (T) 
indicate activity on the Upt868 target preceded by A, C, G, or T, respectively.  Data are normalized so that 
the TAL868 W232 + Upt868 (T) is equal to 1.0.  Error bars report the mean of all replicates ± 1 s.d.  N=8 for 
all TAL868 W232 variants on all targets except W232 (N=15) and W232P (N=7). 
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Figure 4. Relative binding affinities of TAL868 W232 substitution variants for targets preceded by A, 
C, G, or T at the 0th position. A.  Relative affinity of TAL868 (WT) and W232 substitution variants for the 
TAL868 target preceded by T, A, C, or G, or a scrambled target, demonstrated by electrophoretic mobility 
shift assay. For each TAL effector target combination, protein concentration increases from left to right. 
Bands across the bottom represent unbound DNA. The next bands up represent DNA bound by the TAL 
effector. The uppermost bands represent higher order complexes. DNA bound at lower protein 
concentrations indicates higher affinity.  B.  Relative affinity of TAL868 (WT) and W232 substitution variants 
for the TAL868 target preceded by T, A, C, or G, reported as the fraction of DNA bound by the protein.  
Fraction bound was estimated by band densitometric analysis of the images in Panel A. T, A, C, and G 
indicate the nucleotide at the 0
th
 position of the target site. Scr, scrambled target. 
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Upt868 preceded by a T.  The W232 substitution variants each showed a similar pattern, with 
the highest affinity for the Upt868 (T) target. However, their binding affinity for Upt868 (T) was 
reduced relative wild type TAL effector, and the preference for T was less pronounced.  Our 
results suggest that in the context of TAL868, substitutions for W232 lower the TAL effector’s 
DNA binding affinity and reduce the TAL effector’s specificity for targets preceded by T.  
However, the changes in binding affinity and specificity did not match the changes in activity 
and specificity observed in the GUS and TALEN assays.  We were unable to obtain sufficient 
soluble PthXo1 protein to assay effects of W232 substitutions on affinity in that context. 
Structural models of W232 substitutions predict W232 and W232R to have the most 
favorable binding energies 
We built structural models of all 20 amino acid substitutions at position W232, and 
calculated binding profiles to DNA target sites with all 16 nucleotide combinations at positions 0 
and -1 (representative models are depicted in Figure 5). As described in Materials and Methods, 
we explored two levels of conformational flexibility, either keeping the protein backbone 
completely fixed or allowing limited flexibility in the neighborhood of the mutation. In the fixed-
backbone simulations, the wild-type Tryptophan in complex with a T at position 0 yielded the 
highest predicted binding affinity overall (Figure 5a), followed by non-polar substitutions 
(isoleucine and valine) that maintained packing against the T0 methyl group. We did not see a 
strong dependence of binding energy on position -1, although some substitutions appeared to 
disfavor T at -1, likely due to steric clashes. We saw a different profile of binding energies in the 
flexible backbone simulations, with polar amino acids (arginine, followed by lysine, and 
glutamine) yielding the highest binding affinities, again generally preferring T at position 0. 
Examination of the structural models revealed that contacts to the DNA phosphate backbone 
predominated in these models, with protein backbone shifts allowing the mutated side chains to 
form hydrogen bonds to phosphate oxygens (Figure 5, panels B and D).  In addition, several of 
the models show that the side chains of the amino acids at position 232 are in close proximity 
to, and may interact with, the base preceding the 0th position T (designated the -1 position, see 
Figure 5). 
Discussion 
We tested the effects of single amino acid substitutions for W232 on TAL effector activity, 
preference for a 0th position binding site nucleotide, and binding affinity.  Located in the TAL 
effector’s cryptic -1st repeat, W232 packs tightly against the thymine residue that directly 
precedes most TAL effector binding sites in nature (at the so-called “0th position”)  and forms  
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Figure 5. Structural models for representative W232 substitutions. Models were built for 20 amino acid 
substitutions at position W232 with DNA target sites for all 16 nucleotide combinations at positions 0 and -1.  
Panels A, B, C, and D depict the models with W232, W232R, W232P, and W232Q, respectively.  The amino 
acid at position 232 is labeled.  The T at binding site position 0 is labeled T0.  The nucleotide at position -1 is 
also labeled.  Models shown include the -1 position nucleotide from the DNA target with the highest binding 
affinity for the corresponding W232 substitution. 
 
energetically favorable, base-specific Van der Waal’s contacts with this base (5). Therefore, 
W232 has been predicted to specify the 0th position T.  We found that single amino acid 
substitutions for W232 altered the TAL effector’s activity in a GUS reporter assay, and also 
altered the specificity of the TAL effector for targets preceded by T.  This general reduction in 
activity and changes to target specificity were also observed in the context of TALENs and were 
supported by reductions in binding affinity as measured in EMSAs.  Taken together, these 
results provide experimental evidence that W232 plays a role in encoding the requirement for T 
preceding the binding site. 
Although our experimental results generally agreed that substitutions for W232 lowered TAL 
effector activity or binding affinity, specificity results from different assays did not always agree.  
In GUS assays of TAL868 W232T we observed low activity (relative to TAL868 W232 on the 
A B
C D
W232
W232P
W232Q
W232R
T0 T0
T0
T0
A-1 T-1
A-1 A-1
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target Upt868 (T)) and a very slight preference for targets preceded by A and T, while in TALEN 
yeast assays TAL868 W232T had a preference for Upt868 (C) and high activity on that target.   
GUS assays also showed relaxed specificity and relatively high activity for TAL868 W232R.  
However, in the context of TALENs, the W232R substitution showed relaxed specificity but very 
low activity.  Additionally, EMSAs failed to detect any overall changes in target preference 
based on W232 substitutions, although the preference for targets preceded by T was less 
pronounced for all substitutions tested, suggesting some relaxation of target specificity. 
There are several factors that may explain the discrepancies between assays.  Despite 
careful standardization of conditions and leaf age, we found the GUS assay to be quite variable, 
both within experiments (across replicates) and across experiments performed on different 
days.  Although we attempted to account for this inherent variability by using paired T-tests to 
test for effects on activity levels, the variability may have been too subtle to accurately assess 
changes in target preference.  Another factor that may explain the differences in results across 
assays is that the W232 substitutions may in fact have differential effects on the different assays 
themselves.  While the GUS assay used a full-length TAL effector protein, the TALEN assay 
used a TAL effector-nuclease fusion with truncations at the N and C termini, and the EMSAs 
used a similarly truncated TAL effector.  The substitutions may have varying effects on the rates 
at which these slightly different proteins bind to and release their DNA targets.  Similarly, the 
substitutions may cause structural changes that affect the assay readouts differently.  For 
example, a W232 substitution might alter the TAL effector’s ability to interact with the host cell’s 
transcriptional machinery, affecting the outcome of the GUS assay but not the other assays. 
In addition to disagreements between assays, we found that the effects of the W232 
substitutions in the GUS assay varied depending on the TAL effector. These differences may be 
due to differences in the overall repeat sequence length and RVD sequence composition.  
Alternatively, the differences observed between array contexts may be due to specific 
differences in the repeat sequence near the cryptic -1st and 0th repeats.  These differences may 
also be due to the fact that we tested PthXo1 against its naturally occurring target sequence, 
which contains several mismatches (positions where the RVD is not aligned with its preferred 
nucleotide) whileTAL868 was tested on its perfect targets (no mismatches). One recent study 
found that the activity of TAL effector AvrBs3 (which contains several “non-standard” RVDs and 
has several mismatch positions) on its natural target was more sensitive to substitutions for the 
0th position T than an engineered TAL effector designed to match the target (42).  Therefore, the 
activity of TAL effector PthXo1, when paired with its natural target, may be more sensitive to 
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changes to W232.  Mismatches, especially those near the N terminus, may interfere with the 
ability of that portion of the protein to interact with and bind to the DNA. 
We also identified and studied the -1st cryptic repeat of RTLs from Ralstonia solanacearum.  
Although RTLs are highly similar to TAL effectors in structure, numerous amino acid sequence 
differences are present throughout the proteins.  These differences include an arginine at the 
analogous position to W232 in the RTL N terminus.  In our experiments, a chimeric TAL effector 
composed of the native RTL N terminus (with R232) and the PthXo1 CRR preferred targets 
preceded by G.  This differs from the Xanthomonas TAL effector W232R substitution variants, 
which had a preference for targets preceded by A or C (PthXo1) or no preference (TAL868) in 
GUS assays.  This suggests that the sequence differences between  the TAL effector and RTL 
N terminal regions surrounding W232 or R232 affect the specificity for the 0th position 
nucleotide, and that efforts to engineer TAL effectors with relaxed or altered 0th position 
specificities may require modifications throughout the entire TAL effector N terminus.   
We also observed that the chimeric TAL effector (R232) had significantly lower activity than 
PthXo1, and that substitutions for R232 in the RTL N terminus essentially eliminated activity.  
This may simply be due to sequence differences between the RTL and TAL effector N termini, 
as discussed above, which result in lower activity.  It is also possible that sequence and 
structure differences between the RTL and TAL effector N termini and CRRs caused the two 
pieces of the chimeric TAL effector to interact differently than an N terminus and CRR that are 
both derived from the same type of protein, potentially affecting the protein’s binding affinity or 
activity levels. 
Our goal for this study was to enhance TAL effector targeting capacity by identifying W232 
substitutions that would alter specificity to prefer sites preceded by a base (or bases) other than 
T while retaining overall affinity and activity.  Although a few substitutions showed high activity 
levels and relaxed specificities in a single assay, none of the substitutions tested behaved 
consistently in all assays.  We also failed to identify any substitutions that had consistently 
higher activity levels than the native W232.  Initially, we screened all 19 possible substitutions in 
a GUS assay, and then selected five substitutions to characterize more extensively, so 
substitutions we did not test might have met our criteria for high activity and broadened 
specificity.   However, our conclusion that TAL effectors with W232 have the highest activity 
level is supported by binding energy predictions in our computational simulations, which found 
that TAL effectors with tryptophan or arginine (depending on the conditions of the simulation) at 
position 232 have the highest binding affinity.  In nature, TAL effectors from Xanthomonas and 
Ralstonia TAL-like effectors have either a W (Xanthomonas) or R (RTLs) at this position, 
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suggesting that these two families of proteins have evolved to have the best possible affinities 
for their targets.  Therefore, it may not be feasible to engineer TAL effectors to have broader 
DNA binding capacities by altering W232 or other positions in the -1st repeat.   
Binding site specificity and activity may also depend on other regions of the -1st repeat, or on 
other cryptic repeats, whose role in DNA binding is still relatively unknown.  Examination of the 
crystal structure of TAL effector PthXo1 bound to its DNA target shows that the 0th and -1st 
repeats pack tightly together and the loop of the cryptic 0th repeat also appears to enter the 
major groove near the 0th position T (5).  Therefore, the 0th repeat may also be involved in 
stabilizing binding or specifying a preference for the 0th position T.  This specificity may depend 
on the 0th repeat directly, or on effects of the cryptic 0th repeat on the -1st repeat or on other 
regions of the N terminus.  The structure also shows that W232 makes specific contacts with the 
base preceding the T at binding site position 0 (5).  Therefore, it is possible that the preference 
for a 0th position T depends on specific interactions between the TAL effector and other 
nucleotides near the T.   
Thus, engineering TAL effectors to have robust, altered specificities may require changes at 
multiple positions to re-engineer the entire -1st repeat, changes to the cryptic 0th repeat and 
other regions of the TAL effector N terminus, or both.  The availability of more TAL effector 
structures will help to shed light on the increasingly complex picture of the role of the N terminus 
and the cryptic repeats on TAL effector-DNA binding.  Additionally, the development of more 
structures will improve computational modeling and structural predictions of TAL effector-DNA 
interactions, and will help to guide future efforts to engineer TAL effectors with broadened DNA 
binding capacities. 
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Supplementary Data 
Supplementary Table S1. Primers used for pAH236 tryptophan 232 substitutions. 
Mutation Primer Sequence1 
All
2 
p885 5'-GCGTCGGCAAACAGGCGTCCGGCGCACGC-3' 
W232A p886 5'-GCGTGCGCCGGACGCCTGTTTGCCGACGC-3' 
W232F p919 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAAAACTGTTTGCCG-3’ 
W232L p920 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATAACTGTTTGCCG-3’ 
W232I p921 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAAATCTGTTTGCCG-3’ 
W232M p922 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGACATCTGTTTGCCG-3’ 
W232V p923 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAGACCTGTTTGCCG-3’ 
W232S p924 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAAGACTGTTTGCCG-3’ 
W232P p925 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATGGCTGTTTGCCG-3’ 
W232T p926 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATGTCTGTTTGCCG-3’ 
W232Y p927 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAATACTGTTTGCCG-3’ 
W232H p928 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAATGCTGTTTGCCG-3’ 
W232Q p929 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATTGCTGTTTGCCG-3’ 
W232N p930 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAATTCTGTTTGCCG-3’ 
W232K p931 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATTTCTGTTTGCCG-3’ 
W232D p932 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAATCCTGTTTGCCG-3’ 
W232E p933 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATTCCTGTTTGCCG-3’ 
W232C p934 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGAACACTGTTTGCCG-3’ 
W232R p935 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATCGCTGTTTGCCG-3’ 
W232G p936 5’-CGTGAGCAAGGCCTCCAGGGCTCGAGCGCCGGATCCCTGTTTGCCG-3’ 
1 Codons introducing W232 substitutions are highlighted in grey.  The silent Xho1 site is underlined. 
2
 Used in all reactions along with one of the primers listed below in the table to produce the desired 
mutation.   
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Supplementary Table S2. Results of paired t-tests for significant effects of W232 substitutions on GUS 
activity. 
Treatment  1 Treatment 2 P-Value
1
 T Statistic DF
2
 Estimate
3
 95% CI
4
 FC
5
 
Upt868 (A) + 
TAL868 
Upt868 (T) + 
TAL868 0.000 -5.527 14 -0.519 
-0.720 to 
-0.317 0.595 
Upt868 (A) + 
TAL868 W232N 
Upt868 (T) + 
TAL868 0.005 -3.736 9 -0.355 
-0.570 to 
-0.140 0.701 
Upt868 (A) + 
TAL868 W232P 
Upt868 (T) + 
TAL868 0.001 -4.318 14 -0.383 
-0.574 to 
-0.193 0.682 
Upt868 (A) + 
TAL868 W232Q 
Upt868 (T) + 
TAL868 0.000 -5.481 14 -0.392 
-0.545 to 
-0.238 0.676 
Upt868 (A) + 
TAL868 W232R 
Upt868 (T) + 
TAL868 0.690 -0.405 19 -0.033 
-0.206 to 
0.139 0.967 
Upt868 (A) + 
TAL868 W232T 
Upt868 (T) + 
TAL868 0.000 -6.544 14 -0.429 
-0.570 to 
-0.289 0.651 
Upt868 (C) + 
TAL868 
Upt868 (T) + 
TAL868 0.000 -15.196 14 -0.978 
-1.116 to 
-0.840 0.376 
Upt868 (C) + 
TAL868 W232N 
Upt868 (T) + 
TAL868 0.000 -6.663 9 -0.584 
-0.782 to 
-0.386 0.558 
Upt868 (C) + 
TAL868 W232P 
Upt868 (T) + 
TAL868 0.001 -4.112 14 -0.422 
-0.643 to 
-0.202 0.656 
Upt868 (C) + 
TAL868 W232Q 
Upt868 (T) + 
TAL868 0.000 -8.369 14 -0.560 
-0.703 to 
-0.416 0.571 
Upt868 (C) + 
TAL868 W232R 
Upt868 (T) + 
TAL868 0.140 -1.542 19 -0.091 
-0.214 to 
0.032 0.913 
Upt868 (C) + 
TAL868 W232T 
Upt868 (T) + 
TAL868 0.000 -7.184 14 -0.752 
-0.977 to 
-0.527 0.471 
Upt868 (G) + 
TAL868 
Upt868 (T) + 
TAL868 0.000 -16.429 12 -0.960 
-1.087 to 
-0.832 0.383 
Upt868 (G) + 
TAL868 W232N 
Upt868 (T) + 
TAL868 0.158 -1.542 9 -0.235 
-0.579 to 
0.110 0.791 
Upt868 (G) + 
TAL868 W232P 
Upt868 (T) + 
TAL868 0.014 -2.844 13 -0.293 
-0.516 to 
-0.070 0.746 
Upt868 (G) + 
TAL868 W232Q 
Upt868 (T) + 
TAL868 0.007 -3.171 14 -0.257 
-0.431 to 
-0.083 0.773 
Upt868 (G) + 
TAL868 W232R 
Upt868 (T) + 
TAL868 0.905 0.121 19 0.010 
-0.166 to 
0.186 1.010 
Upt868 (G) + 
TAL868 W232T 
Upt868 (T) + 
TAL868 0.000 -5.804 14 -0.755 
-1.035 to 
-0.476 0.470 
Upt868 (T) + 
TAL868 W232N 
Upt868 (T) + 
TAL868 0.120 -1.715 9 -0.152 
-0.354 to 
0.049 0.859 
Upt868 (T) + 
TAL868 W232P 
Upt868 (T) + 
TAL868 0.000 -5.227 14 -0.464 
-0.655 to 
-0.274 0.628 
                                                          
1
 P value for the t-tests testing the null hypothesis that the expected value of ln(Treatment 1) - 
ln(Treatment 2) = 0 
2
 Degrees of freedom 
3
 Estimate of the average difference ln(Treatment 1)-ln(Treatment 2).  Estimate < 0 indicates that the 
GUS activity of Treatment 1 is lower than the GUS activity of Treatment 2.  Estimate > 0 indicates that the 
GUS activity of Treatment 1 is higher than the GUS activity of Treatment 2. 
4
 95% Confidence Interval for the Estimate. 
5
 Fold Change of Treatment 1/Treatment 2.  FC = e^Estimate.  FC = 1 indicates the two treatments have 
equal GUS activity.  FC > 1 indicates that Treatment 1 has higher GUS activity that Treatment 2.  FC < 1 
indicates that Treatment 2 has higher GUS activity that Treatment 1.   
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Supplementary Table S2. Continued. 
Treatment  1 Treatment 2 P-Value
1
 T Statistic DF
2
 Estimate
3
 95% CI
4
 FC
5
 
Upt868 (T) + 
TAL868 W232Q 
Upt868 (T) + 
TAL868 0.020 -2.615 14 -0.170 
-0.310 to 
-0.031 0.843 
Upt868 (T) + 
TAL868 W232R 
Upt868 (T) + 
TAL868 0.549 0.610 19 0.050 
-0.121 to 
0.220 1.051 
Upt868 (T) + 
TAL868 W232T 
Upt868 (T) + 
TAL868 0.000 -5.140 14 -0.418 
-0.592 to 
-0.244 0.658 
Upt868 (A) + 
TAL868 W232N 
Upt868 (T) + 
TAL868 
W232N 0.054 -2.209 9 -0.203 
-0.410 to 
0.005 0.817 
Upt868 (C) + 
TAL868 W232N 
Upt868 (T) + 
TAL868 
W232N 0.002 -4.309 9 -0.431 
-0.658 to 
-0.205 0.650 
Upt868 (G) + 
TAL868 W232N 
Upt868 (T) + 
TAL868 
W232N 0.555 -0.613 9 -0.082 
-0.386 to 
0.221 0.921 
Upt868 (A) + 
TAL868 W232P 
Upt868 (T) + 
TAL868 
W232P 0.353 0.962 14 0.081 
-0.100 to 
0.262 1.084 
Upt868 (C) + 
TAL868 W232P 
Upt868 (T) + 
TAL868 
W232P 0.709 0.380 14 0.042 
-0.196 to 
0.280 1.043 
Upt868 (G) + 
TAL868 W232P 
Upt868 (T) + 
TAL868 
W232P 0.115 1.688 13 0.195 
-0.055 to 
0.445 1.216 
Upt868 (A) + 
TAL868 W232Q 
Upt868 (T) + 
TAL868 
W232Q 0.000 -4.869 14 -0.221 
-0.319 to 
-0.124 0.801 
Upt868 (C) + 
TAL868 W232Q 
Upt868 (T) + 
TAL868 
W232Q 0.000 -11.768 14 -0.390 
-0.461 to 
-0.319 0.677 
Upt868 (G) + 
TAL868 W232Q 
Upt868 (T) + 
TAL868 
W232Q 0.151 -1.519 14 -0.087 
-0.209 to 
0.036 0.917 
Upt868 (A) + 
TAL868 W232R 
Upt868 (T) + 
TAL868 
W232R 0.163 -1.452 19 -0.083 
-0.203 to 
0.037 0.920 
Upt868 (C) + 
TAL868 W232R 
Upt868 (T) + 
TAL868 
W232R 0.038 -2.227 19 -0.141 
-0.273 to 
-0.008 0.869 
 
                                                          
1
 P value for the t-tests testing the null hypothesis that the expected value of ln(Treatment 1) - 
ln(Treatment 2) = 0 
2
 Degrees of freedom 
3
 Estimate of the average difference ln(Treatment 1)-ln(Treatment 2).  Estimate < 0 indicates that the 
GUS activity of Treatment 1 is lower than the GUS activity of Treatment 2.  Estimate > 0 indicates that the 
GUS activity of Treatment 1 is higher than the GUS activity of Treatment 2. 
4
 95% Confidence Interval for the Estimate. 
5
 Fold Change of Treatment 1/Treatment 2.  FC = e^Estimate.  FC = 1 indicates the two treatments have 
equal GUS activity.  FC > 1 indicates that Treatment 1 has higher GUS activity that Treatment 2.  FC < 1 
indicates that Treatment 2 has higher GUS activity that Treatment 1.   
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Supplementary Table S2. Continued. 
Treatment  1 Treatment 2 P-Value
1
 T Statistic DF
2
 Estimate
3
 95% CI
4
 FC
5
 
Upt868 (G) + 
TAL868 W232R 
Upt868 (T) + 
TAL868 
W232R 0.485 -0.712 19 -0.040 
-0.156 to 
0.077 0.961 
Upt868 (A) + 
TAL868 W232T 
Upt868 (T) + 
TAL868 
W232T 0.861 -0.179 14 -0.011 
-0.149 to 
0.126 0.989 
Upt868 (C) + 
TAL868 W232T 
Upt868 (T) + 
TAL868 
W232T 0.000 -5.278 14 -0.334 
-0.470 to 
-0.198 0.716 
Upt868 (G) + 
TAL868 W232T 
Upt868 (T) + 
TAL868 
W232T 0.008 -3.066 14 -0.338 
-0.574 to 
-0.101 0.714 
UptPthXo1 (A) + 
PthXo1 
UptPthXo1 
(T) + PthXo1 0.757 -0.312 29 -0.031 
-0.236 to 
0.173 0.969 
UptPthXo1 (A) + 
PthXo1 W232N 
UptPthXo1 
(T) + PthXo1 0.006 -3.158 17 -0.617 
-1.029 to 
-0.205 0.540 
UptPthXo1 (A) + 
PthXo1 W232P 
UptPthXo1 
(T) + PthXo1 0.313 -1.027 30 -0.067 
-0.201 to 
0.066 0.935 
UptPthXo1 (A) + 
PthXo1 W232Q 
UptPthXo1 
(T) + PthXo1 0.089 -1.793 19 -0.416 
-0.901 to 
0.070 0.660 
UptPthXo1 (A) + 
PthXo1 W232R 
UptPthXo1 
(T) + PthXo1 0.562 0.594 14 0.084 
-0.220 to 
0.388 1.088 
UptPthXo1 (A) + 
PthXo1 W232T 
UptPthXo1 
(T) + PthXo1 0.000 -4.350 30 -0.576 
-0.847 to 
-0.306 0.562 
UptPthXo1 (C) + 
PthXo1 W232N 
UptPthXo1 
(T) + PthXo1 0.033 -2.305 18 -0.555 
-1.062 to 
-0.049 0.574 
UptPthXo1 (C) + 
PthXo1 
UptPthXo1 
(T) + PthXo1 0.013 -2.657 29 -0.280 
-0.496 to 
-0.064 0.755 
UptPthXo1 (C) + 
PthXo1 W232P 
UptPthXo1 
(T) + PthXo1 0.114 -1.629 30 -0.113 
-0.256 to 
0.029 0.893 
UptPthXo1 (C) + 
PthXo1 W232Q 
UptPthXo1 
(T) + PthXo1 0.098 -1.739 19 -0.323 
-0.712 to 
0.066 0.724 
UptPthXo1 (C) + 
PthXo1 W232R 
UptPthXo1 
(T) + PthXo1 0.970 0.038 14 0.005 
-0.276 to 
0.286 1.005 
UptPthXo1 (C) + 
PthXo1 W232T 
UptPthXo1 
(T) + PthXo1 0.000 -4.589 30 -0.673 
-0.973 to 
-0.374 0.510 
UptPthXo1 (G) + 
PthXo1 
UptPthXo1 
(T) + PthXo1 0.053 -2.020 29 -0.227 
-0.456 to 
0.003 0.797 
UptPthXo1 (G) + 
PthXo1 W232N 
UptPthXo1 
(T) + PthXo1 0.902 -0.125 18 -0.020 
-0.363 to 
0.322 0.980 
                                                          
1
 P value for the t-tests testing the null hypothesis that the expected value of  ln(Treatment 1) - 
ln(Treatment 2) = 0 
2
 Degrees of freedom 
3
 Estimate of the average difference ln(Treatment 1)-ln(Treatment 2).  Estimate < 0 indicates that the 
GUS activity of Treatment 1 is lower than the GUS activity of Treatment 2.  Estimate > 0 indicates that the 
GUS activity of Treatment 1 is higher than the GUS activity of Treatment 2. 
4
 95% Confidence Interval for the Estimate. 
5
 Fold Change of Treatment 1/Treatment 2.  FC = e^Estimate.  FC = 1 indicates the two treatments have 
equal GUS activity.  FC > 1 indicates that Treatment 1 has higher GUS activity that Treatment 2.  FC < 1 
indicates that Treatment 2 has higher GUS activity that Treatment 1.   
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Supplementary Table S2. Continued. 
Treatment  1 Treatment 2 P-Value
1
 T Statistic DF
2
 Estimate
3
 95% CI
4
 FC
5
 
UptPthXo1 (G) + 
PthXo1 W232P 
UptPthXo1 (T) + 
PthXo1 0.469 -0.734 30 -0.109 
-0.411 to 
0.194 0.897 
UptPthXo1 (G) + 
PthXo1 W232R 
UptPthXo1 (T) + 
PthXo1 0.011 -2.913 14 -0.439 
-0.763 to 
-0.116 0.644 
UptPthXo1 (G) + 
PthXo1 W232T 
UptPthXo1 (T) + 
PthXo1 0.022 -2.425 30 -0.447 
-0.823 to 
-0.071 0.640 
UptPthXo1 (T) + 
PthXo1 W232N 
UptPthXo1 (T) + 
PthXo1 0.003 -3.509 17 -0.532 
-0.852 to 
-0.212 0.587 
UptPthXo1 (T) + 
PthXo1 W232P 
UptPthXo1 (T) + 
PthXo1 0.001 -3.645 30 -0.635 
-0.990 to 
-0.279 0.530 
UptPthXo1 (T) + 
PthXo1 W232Q 
UptPthXo1 (T) + 
PthXo1 0.012 -2.789 19 -0.644 
-1.128 to 
-0.161 0.525 
UptPthXo1 (T) + 
PthXo1 W232R 
UptPthXo1 (T) + 
PthXo1 0.023 -2.556 14 -0.456 
-0.838 to 
-0.073 0.634 
UptPthXo1 (T) + 
PthXo1 W232T 
UptPthXo1 (T) + 
PthXo1 0.000 -4.193 29 -0.803 
-1.195 to 
-0.412 0.448 
UptPthXo1 (A) + 
PthXo1 W232N 
UptPthXo1 (T) + 
PthXo1 W232N 0.580 -0.564 18 -0.129 
-0.611 to 
0.352 0.879 
UptPthXo1 (C) + 
PthXo1 W232N 
UptPthXo1 (T) + 
PthXo1 W232N 0.397 -0.867 18 -0.206 
-0.704 to 
0.292 0.814 
UptPthXo1 (G) + 
PthXo1 W232N 
UptPthXo1 (T) + 
PthXo1 W232N 0.019 2.574 18 0.370 
0.068 to 
0.673 1.448 
UptPthXo1 (A) + 
PthXo1 W232P 
UptPthXo1 (T) + 
PthXo1 W232P 0.001 3.713 30 0.568 
0.255 to 
0.880 1.764 
UptPthXo1 (C) + 
PthXo1 W232P 
UptPthXo1 (T) + 
PthXo1 W232P 0.002 3.360 30 0.521 
0.204 to 
0.838 1.684 
UptPthXo1 (G) + 
PthXo1 W232P 
UptPthXo1 (T) + 
PthXo1 W232P 0.000 5.775 30 0.526 
0.340 to 
0.712 1.692 
UptPthXo1 (A) + 
PthXo1 W232Q 
UptPthXo1 (T) + 
PthXo1 W232Q 0.270 1.137 19 0.229 
-0.192 to 
0.649 1.257 
UptPthXo1 (C) + 
PthXo1 W232Q 
UptPthXo1 (T) + 
PthXo1 W232Q 0.047 2.128 19 0.321 
0.005 to 
0.637 1.379 
UptPthXo1 (G) + 
PthXo1 W232Q 
UptPthXo1 (T) + 
PthXo1 W232Q 0.005 3.165 19 0.577 
0.195 to 
0.958 1.780 
UptPthXo1 (A) + 
PthXo1 W232R 
UptPthXo1 (T) + 
PthXo1 W232R 0.012 2.905 14 0.540 
0.141 to 
0.939 1.716 
UptPthXo1 (C) + 
PthXo1 W232R 
UptPthXo1 (T) + 
PthXo1 W232R 0.035 2.335 14 0.461 
0.038 to 
0.884 1.585 
UptPthXo1 (G) + UptPthXo1 (T) + 0.857 0.184 14 0.016 -0.175 to 1.017 
                                                          
1
 P value for the t-tests testing the null hypothesis that ln(Treatment 1) - ln(Treatment 2) = 0 
2
 Degrees of freedom 
3
 Estimate of the average difference ln(Treatment 1)-ln(Treatment 2).  Estimate < 0 indicates that the 
GUS activity of Treatment 1 is lower than the GUS activity of Treatment 2.  Estimate > 0 indicates that the 
GUS activity of Treatment 1 is higher than the GUS activity of Treatment 2. 
4
 95% Confidence Interval for the Estimate. 
5
 Fold Change of Treatment 1/Treatment 2.  FC = e^Estimate.  FC = 1 indicates the two treatments have 
equal GUS activity.  FC > 1 indicates that Treatment 1 has higher GUS activity that Treatment 2.  FC < 1 
indicates that Treatment 2 has higher GUS activity that Treatment 1.   
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Supplementary Table S2. Continued. 
Treatment  1 Treatment 2 P-Value
1 
T Statistic DF
2 
Estimate
3 
95% CI
4 
FC
5 
UptPthXo1 (A) + 
PthXo1 W232T 
UptPthXo1 (T) + 
PthXo1 W232T 0.255 1.161 30 0.180 
-0.137 to 
0.497 1.197 
UptPthXo1 (C) + 
PthXo1 W232T 
UptPthXo1 (T) + 
PthXo1 W232T 0.606 0.521 30 0.080 
-0.235 to 
0.396 1.084 
UptPthXo1 (G) + 
PthXo1 W232T 
UptPthXo1 (T) + 
PthXo1 W232T 0.000 4.686 30 0.419 
0.237 to 
0.602 1.521 
1 
P value for the t-tests testing the null hypothesis that the expected value of  ln(Treatment 1) - 
ln(Treatment 2) = 0 
2 
Degrees of freedom 
3 
Estimate of the average difference ln(Treatment 1)-ln(Treatment 2).  Estimate < 0 indicates that the GUS 
activity of Treatment 1 is lower than the GUS activity of Treatment 2.  Estimate > 0 indicates that the GUS 
activity of Treatment 1 is higher than the GUS activity of Treatment 2. 
4 
95% Confidence Interval for the Estimate. 
5 
Fold Change of Treatment 1/Treatment 2.  FC = e^Estimate.  FC = 1 indicates the two treatments have 
equal GUS activity.  FC > 1 indicates that Treatment 1 has higher GUS activity that Treatment 2.  FC < 1 
indicates that Treatment 2 has higher GUS activity that Treatment 1.   
 
 
 
 
 
 
Supplementary Figure S1.  GUS activity for PthXo1 variants with all 19 possible single amino acid 
substitutions for W232. W232 is the wild-type PthXo1 with W at position 232.  Substitutions to other amino 
acids are indicated as W232X.  UptPthXo1 (A), UptPthXo1 (C), UptPthXo1 (G), and UptPthXo1 (T) indicate 
that the target UptPthXo1 is preceded by an adenine, cytosine, guanine, or thymine, respectively.  To 
facilitate comparison across multiple experiments, activity within each experiment was normalized so that 
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the activity of PthXo1 + UptPthXo1 (T) is equal to 1.0.  Values are the mean of three replicates.  Error bars 
indicate s.d.   Horizontal lines at bottom group constructs that were tested on the same day in the same 
experiment. 
 
Supplementary Figure S2. ClustalW multiple sequence alignment of N terminal sequences of 
Ralstonia TAL-like effectors (RTLs) and PthXo1. RSc1815, Genbank ID CAD15517.1 from Ralstonia 
solanacearum strain GMI1000(1). Hpx17, Genbank ID AB178011.1 from strain RS1085(2).  RscCAQ18687, 
Genbank ID CAQ18687.1 from strain MolK2 (direct Genbank submission by Genoscope -,C.E.A.).  PthXo1, 
Genbank ID ACD58243.1 from Xanthomonas oryzae strain PXO99A (3). 
 
CLUSTAL 2.1 multiple sequence alignment 
 
 
RSc1825          MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDTPRT 60 
hpx17            MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDTPRT 60 
RScCAQ18687      --------------------------------------------MRRRTAVGRVPGASRS 16 
PthXo1           ------------------------------------------------------------ 
                                                                              
 
RSc1825          EARSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPAVSSPRFSAGSSAAITDPFPSLP-- 118 
hpx17            GARSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPFSSLP-- 118 
RScCAQ18687      GTSPLVLSQPLSRVSASPQPARS-----------SAISSPNFSAGNPTAFANPSPSLPPT 65 
PthXo1           ------------------------------------------------------------ 
                                                                              
 
RSc1825          ----PTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACP 174 
hpx17            ----PTPVLYAMARELKALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACP 174 
RScCAQ18687      PVLPPTPVLYAMARELEELHNATWQPAVPLTAEPLADARRDNTVVDGGSGSSPAIASARP 125 
PthXo1           -----------------------MQSGLRAADDPPPTVR-------------VAVTAAR- 23 
                                         *..:  . :* . .*              .:::*   
 
RSc1825          QAFASPPRAPRSARARRARTGGDAWPAPTFLS-RPSSS-------RIGRDVFGKLVALGY 226 
hpx17            QAFASPPRAPRSARARRARTGGDAWPAPTFLS-RPSSS-------RIGRDVFGKLVALGY 226 
RScCAQ18687      QAFAGPPRAPRSARARRARTAGDAWPAPAYLGPSPSPSPSPSPSPRIAPDLSGKLAALGY 185 
PthXo1           -----PPRAKPAPRRRAAQPS-DASPA-----------------------AQVDLRTLGY 54 
                      ****  :.* * *:.. ** **                          .* :*** 
 
RSc1825          SREQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPEL 286 
hpx17            SREQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPEL 286 
RScCAQ18687      SREQIRKLKQESLAEVAKYHATLAGQGFTHADICRISRRWQSLRVVANNYPELMAALPRL 245 
PthXo1           SQQQQEKIKPKVGSTVAQHHEALVGHGFTHAHIVALSRHPAALGTVAVKYQDMIAALPEA 114 
                 *::* .*:* :  : :*::* :*.*:*****.*  :**:  :* .** :* :: ****.  
 
RSc1825          TRAHIVDIARQRSGDLALQALLPVATALTAAPLRLSASQIATVAQYGERPAIQALYRLRR 346 
hpx17            TRAHIVDIARQRSGDLALQALLPVATALTAAPLRLSASQIATVAQYGERPAIQALYRLRR 346 
RScCAQ18687      TTAQIVDIARQRSGDLALQALLPVAAALTAAPLGLSASQIATVAQYGERPAIQALYRLRR 305 
PthXo1           THEDIVGVGKQWSGARALEALLTVAGELRGPPLQLDTGQLVKIAKRGGVTAVEAVHASRN 174 
                 *  .**.:.:* **  **:***.**  * ..** *.:.*:..:*: *  .*::*::  *. 
 
RSc1825          KLTRAPLH 354 
hpx17            KLTRAPLH 392 
RScCAQ18687      KLTRAPLG 313 
PthXo1           ALTGAPLN 182 
                  ** ***                                        
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Supplementary Figure S3.  Secondary structure predictions for PthXo1 and Rsc1815 N terminal 
regions. Left: PthXo1, ACD58243.1 from Xanthomonas oryzae strain PXO99A (3). Right: RSc1815 
(GenBank protein CAD15517.1) from Ralstonia solanacearum strain GMI1000 (1). 
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CHAPTER 7.  GENERAL CONCLUSIONS. 
General Discussion 
In this dissertation, I describe computational and experimental approaches for studying TAL 
effector-DNA binding, and I have apply the results to TAL effector design and target prediction 
and to answer questions about the role of TAL effectors in plant disease.  In Chapter 3, I 
analyzed known TAL effector-DNA binding site pairs to develop a series of design guidelines for 
custom TAL effectors and TAL effector nucleases (TALENs).  I reasoned that naturally occurring 
TAL effectors would have evolved to have high levels of activity on their targets. Out of 15 
TALEN pairs designed according to these guidelines, 14 were active, suggesting that following 
the guidelines aided in designing active TALENs. 
 However, more recent research suggests that conformation to the design guidelines did not 
boost TAL effector/TALEN activity.  For example, the guidelines advise selecting targets with a 
high percentage of A’s (corresponding to the RVD NI) and relatively few G’s (corresponding to 
the RVD NN).  However, the solved structures of two TAL effectors bound to their respective 
DNA targets showed that the NI-A interaction was weaker than other RVD-nucleotide pairs 
(1,2).   Experimental data has subsequently confirmed NI has significantly lower affinity for A 
than HD for C or NN for G (3,4).   Although we found evidence supporting our design guidelines 
in the activity of intermediate constructs, close review of those data show that the constructs 
with the highest activity also had high percentages of HD-C pairs. Additionally, the TALEN pair 
that was not active had one TALEN monomer in which 9 of 23 positions were NI-A’s (5).  
Analysis by Reyon et al. (6) found that adherence to any of the guidelines did not significantly 
improve TALEN activity in the context of human cell-based reporter assay (they also did not test 
the guidelines in the context of gene activation by single TAL effectors).  It is possible that the 
positional biases observed at the ends of TAL effector RVD sequences are due to lack of 
recombination at the ends of the repeat region rather than an evolutionary adaptation for binding 
affinity or activity.  Therefore, although the design guidelines have not been systematically 
tested in a variety of cell types and using TALENs targeting endogenous genes, designing 
TALENs to target GC-rich sites is likely the best way to ensure their activity,. 
I subsequently updated the TALEN design software tool described in Chapter 3 to reflect 
this changing knowledge. The newer version, described in Chapter 4, was made available as 
part of the TAL Effector-Nucleotide Targeter website (TALE-NT 2.0).  Instead of design 
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guidelines, the updated TALEN design tool allowed users to design TALENs optimized for their 
specific application and to specify the approximate location of the TALEN cut site. 
In addition to the updated TALEN design tool, I also created a software tool for TAL effector 
target prediction, called Target Finder.  Because RVD-nucleotide binding specificity is not 
absolute (7), custom TAL effectors and TALENs may bind to sequences other than their 
intended target.  Custom TAL effector transcription factors can activate the transcription of non-
target genes with promoter sequences similar to the intended target (8). The potential for such 
off-target activity is a critical problem in TALEN-based applications, where off-target binding 
could result in the cleavage and disruption of non-target genes.  Target Finder uses a 
mathematical scoring function to predict candidate binding sites for a TAL effector in a user-
selected genome.  In addition to allowing researchers to quickly assess the off-target binding 
potential of a TAL effector, it can be used to identify candidate TAL effector-targeted genes for 
natural TAL effectors in plant disease (an example of this is described in detail in the Appendix). 
Because the tool only searches for sites for one TAL effector at a time, identifying off-target 
sites for TALENs requires running searches for each TALEN monomer and then identifying 
opposing sites with the proper orientation and spacing (this has since been updated, see 
Significance, below).  Another weakness of the tool is the score cutoff used to predict binding.  
Although the cutoff is based on experimental data for predicted and verified TAL effector target 
sites (see Appendix), it likely misses some sites that are just above the cutoff and also identifies 
a high number of false positive sites scoring below the cutoff.  Nevertheless, the Target Finder 
tool provides a relatively simple way for researchers to estimate and compare the off-target 
potential of custom TAL effectors or TALENs.  Improvements to the tool will require better 
understanding the importance of binding site context and of the individual contributions RVD-
nucleotide to binding affinity (see Recommendations for Future Research, below). 
In Chapter 5, I present a case study in engineering disease resistance in rice by stably 
inserting multiple TAL effector EBEs into the promoter of a naturally occurring R gene.  One 
potential pitfall to this mode of engineered resistance is that inserted EBEs might overlap cis-
regulatory elements.  The insertion of such elements into the promoter of the executor R gene 
might cause the gene to be activated during development, in certain tissues, or under certain 
environmental conditions in the absence of any TAL effector, ultimately leading to cell death and 
the death of the plant.  To assess this possibility, I analyzed the inserted TAL effector EBEs for 
evidence of potential regulatory elements.  I discovered that the EBEs contained sequences 
under selection, suggesting that TAL effectors might have evolved specifically to target these 
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regulatory sequences in host plants.  It is possible that the positional biases observed in TAL 
effector targets discussed in Chapter 3 reflect this evolution.  
Finally, in Chapter 6 I explored the role of the cryptic -1st repeat in TAL effector DNA binding.  
Although the role of RVDs in specifying the binding site has been well established, it is not clear 
how the TAL effector specifies the thymine (T) directly preceding the repeat-specified binding 
sites of almost all TAL effectors in nature (7).  Replacing this T with another nucleotide 
preceding the binding site dramatically lowers or even eliminates TAL effector activity (9,10), so 
custom TAL effectors and TALENs have typically been designed to target sites preceded by T.  
Understanding how this 0th position T is specified could enable engineering of TAL effectors with 
an altered or relaxed specificity for this position. The solved crystal structure for TAL effector 
PthXo1 bound to its DNA target revealed that tryptophan 232 (W232), located in the “cryptic” -1st 
repeat appeared to make base-specific, energetically favorable contacts with the 0th position T 
(1).  Although we found that single amino acid substitutions for W232 altered TAL effector 
activity and specificity for the 0th position T, the effects of individual substitutions varied 
depending on the assay, the TAL effector repeat sequence, and other portions of the N 
terminus.  These context-based effects suggest that other portions of the TAL effector, such as 
the N terminus and the cryptic 0th repeat, may also be involved in specifying the 0th position T.   
 A weakness in our approach was that we did not test the effects of the W232 substitutions 
on stability of the TAL effector N terminus.  Loss of N terminal stability could affect the N 
terminal’s ability to nucleate TAL effector DNA binding.   The observed lower TAL effector 
activity would be due to the reduced binding affinity and not to changes in specific interactions 
between the 0th position T and the amino acid at position 232.  Therefore, the effect of W232 
substitutions on N terminal stability must be determined before it can be definitively stated that 
W232 is or is not involved in specifying the preference for the 0th position T.  It is also feasible 
that W232 does specify this preference, and that W232 substitutions also destabilize the N 
terminus.  If this proves to be the case, the creation of enhanced TAL effectors with broadened 
targeting capacity will require substantial reengineering of the entire N terminus.  In addition, 
understanding the role of TAL effector context on specificity for the 0th position T, especially the 
role of the RVD sequence and mismatches, may help to improve the target prediction tools 
described in Chapter 3 (for example, in cases where bases other the T might be tolerated at the 
0th position. 
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Significance 
The design of maximally efficient and highly specific custom TAL effectors and TALENs is 
becoming increasingly important as TAL effector-based constructs are adapted for a variety of 
research and biotechnology applications.  Although TAL effector repeats appear to behave 
modularly, meaning they can be assembled in any order with no effects on activity or specificity, 
custom TAL effectors and TALENs exhibit varying levels of activity.  As noted above, 
differences in activity level may be due to RVD sequence composition, with RVD sequences 
containing more strong-binding RVDs having higher activity.  However, other factors, such as 
binding site context may also play a role (see Recommendations for Future Research).  The 
software tools for TAL effector/TALEN design described in Chapters 3 and 4 were some of the 
first TAL effector/TALEN design tools available.  More importantly, they were the first TALEN 
design tools to recognize that designing active TAL effector-based constructs might depend on 
selecting RVD and target sequences with specific features, rather than simply assembling a 
string of RVDs with no attention to context or composition.  The manuscript in Chapter 3, which 
describes an early version of these tools, as well as a method for TAL effector/TALEN 
construction, has been cited 94 times. 
 The TAL effector target prediction tool Target Finder, which was described in Chapter 4, 
is also unique.  It is the only existing tool for predicting binding sites that allows mismatches 
between the TAL effector and target sequence.  Since the publication of that manuscript, the 
TALE-NT 2.0 website has been updated to include a new target prediction tool, based on Target 
Finder, which searches for paired TAL effector binding sites for TALENs.  Paired Target Finder 
allows users to perform off-target site searches for TALENs in one search instead of searching 
for sites for each monomer individually.  Recently, we integrated Paired Target Finder with 
TALEN Targeter, allowing users to design TALENs and receive predicted off-target site counts 
in a single step.  Addition of these features to the TALEN 2.0 website dramatically increased 
user traffic, with the website as a whole processing 1300+ queries per week.  Currently, the 
TALEN design tool (with integrated off-target site counting) processes an average of 760+ 
queries per week, and the manuscript presented in Chapter 4 has already been cited 12 times.  
Usage of these tools will likely remain high, because the flexibility of the TALE-NT 2.0 website 
interface and code makes it simple to update these tools in response to changing knowledge of 
TAL effector-DNA binding.  Additionally, the use of these tools to predict targets of natural TAL 
effectors in host plants will continue to grow as more Xanthomonas genome sequences become 
available and their TAL effectors are inventoried.  Publication of the study reported in the 
Appendix, which describes the first successful attempt at in silico genome-wide prediction of 
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TAL effector targets, will increase interest in using target prediction tools to study the role of TAL 
effectors in plant disease by providing a roadmap for future similar studies. 
 The work described in Chapter 5 addresses the role of TAL effectors in plant pathology 
from the angle of disease resistance.  Although it had been previously shown that introducing an 
EBE into a gene’s promoter made that gene responsive to the corresponding TAL effector (9), 
this study, spearheaded by Aaron Hummel, was the first to show that such a mechanism could 
be used to engineer and broaden resistance by making an executor R gene responsive to 
multiple TAL effectors from multiple Xanthomonas strains.  This was also the first study to report 
that TAL effectors may target sequences under selection, including potential cis-regulatory 
elements (my contribution).  The introduction of TAL effector binding sites into gene promoters 
might introduce regulatory sequences that could cause activation the R gene under specific 
conditions and lead to the death of the plant.  This potential pitfall to engineering TAL effector-
responsive executor R genes had not been discussed in the literature. 
 Finally, the manuscript in Chapter 6 adds to the understanding of the basic biology of 
TAL effector-DNA interactions.  Although the crystal structure of TAL effector PthXo1 bound to 
its target indicates that amino acid W232 in the cryptic -1st repeat interacts with and specifies 
the required T preceding the TAL effector binding site (1), the -1st repeat region is not well 
resolved in the other published structure of artificial TAL effector dHAX3 (2).  Previously, it was 
thought that the cryptic -1st repeat specified the 0th position T through interactions between a 
single amino acid (W232) and a single nucleotide, much like the interactions between the 
canonical repeats and binding site nucleotides.  However, our study of W232 substitutions found 
numerous context effects, suggesting that the cryptic repeats may rely on interactions with each 
other, other regions of the protein, and even multiple nucleotides in the target DNA to specify 
the 0th repeat and nucleate DNA binding.  Therefore, this study revealed previously unknown 
complexities in TAL effector DNA binding, and will pave the way for additional studies of the 
structure and function of the TAL effector N terminus.  Overall better understanding of the TAL 
effector-DNA binding mechanism may also enhance custom TAL effector design and inform 
target prediction models. 
Recommendations for Future Research 
 Better understanding of TAL effector DNA-binding will be needed to continue to improve 
custom TAL effector design and target prediction.  Currently, the effect of binding site context on 
TAL effector-DNA binding is not well understood.  Other site-specific DNA binding proteins are 
sensitive to local features such as chromatin status and methylation (11), and TAL effector 
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transcriptional activators are not able to overcome epigenetic gene silencing (12).   Other 
features like regulatory elements may also affect TAL effector binding and activity.  
Understanding the effects of such features will allow researchers to target sites that will not be 
negatively affected by local context, or to design TALENs that overcome such context-imposed 
limitations. For example, TAL effectors can be designed to target methylated cytosines by using 
non-standard RVDs (13).  Similarly, the discovery of new, highly specific RVDs, such as NH to 
target G, may improve TAL effector specificity (14).   
 Designing highly specific TAL effectors also depends on accurately predicting off-target 
binding sites. The method of target prediction presented in Chapter 4 uses as scoring function 
that relies on observed RVD-nucleotide association frequencies to approximate the individual 
contributions RVD-nucleotide pairs to binding affinity.  Replacing these frequencies with actual 
binding affinity data would likely improve prediction accuracy.  In addition, the effects of 
mismatches on binding affinity are not well understood.  There is some evidence that 
mismatches at the 5’ end of the binding site are more detrimental to binding than mismatches at 
the 3’ end (3), and the distribution of mismatches may also be important.  Systematic study of 
the effects of mismatches on binding would enable the development of a target prediction 
function that accurately accounts for these complexities.  The scoring function might also be 
improved by giving higher weights to strong-binding RVDs and lower weights to weak binding 
RVDs (3,4).  Such improvements would enhance our ability to predict off-target binding sites for 
custom TAL effectors /TALENs and to identify TAL effector-targeted genes involved in plant 
disease.  
 Successful deployment of the method of engineered disease resistance presented in 
Chapter 5 depends on the selection of appropriate TAL effectors and their corresponding EBEs.  
It is important to choose TAL effectors that are present in a large number of Xanthomonas 
strains to ensure broad resistance.  Therefore, it will be necessary to inventory the TAL effector 
complement of as many Xanthomonas strains as possible.  This may require the development 
of new sequencing technologies, as current technologies are unable to sequence through the 
repetitive DBD.   Identification of novel R and S genes as described in the Appendix will also 
require sequencing TAL effectors from diverse populations of Xanthomonas. 
 Finally, understanding the complexities involved in TAL effector-DNA binding, as 
described in Chapter 6, will be crucial for optimizing TAL effectors and TALENs for 
biotechnology applications and for studying the role of TAL effectors in plant disease.  The 
current understanding of TAL effector-DNA binding is based on the crystal structures of two TAL 
effectors bound to their targets.  Additional structures for TAL effectors with a variety of RVD 
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sequences and target mismatches will be necessary to begin sorting out the complex 
interactions between the TAL effector N terminal and the DNA target.  Structure-function studies 
and a solved structure for a Ralstonia TAL-like effector, with its slightly different amino acid 
sequence, would also allow for comparisons of specific interactions between the two proteins 
and their targets.  In light of the complexities in TAL effector-DNA binding and binding site 
specificities, future attempts to alter TAL effector target specificity or activity levels by 
engineering the N terminus will likely require mutations at multiple positions. These efforts will 
need to be guided by structure modeling and binding affinity predictions to pinpoint useful 
combinations of mutations to characterize. 
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APPENDIX: DE NOVO PREDICTION OF TAL EFFECTOR TARGETS 
IDENTIFIES A NOVEL SUSCEPTIBILITY GENE FOR BACTERIAL LEAF 
STREAK OF RICE 
Summary 
This appendix contains data from a larger study entitled “High-throughput identification of 
TAL effector targets in bacterial leaf streak of rice reveals striking differences from bacterial 
blight and a new class of susceptibility gene1” that is currently in preparation for publication.  
The data presented here represent a case study in combining TAL effector target prediction with 
transcriptomics data for the high-throughput identification of previously unknown TAL effector 
targets and the discovery of previously unknown plant disease susceptibility (S) genes. 
 Transcription-activator like (TAL) effectors of Xanthomonas spp. induce expression of 
targeted S genes which aid in bacterial spread and multiplication and symptom development 
during host plant infection.  Following injection into the host plant cell, TAL effectors localize to 
the nucleus where they bind to specific DNA sequences and activate target gene expression. In 
this work we focused on X. oryzae pv. oryzicola (Xoc), the causal agent of rice bacterial leaf 
streak (BLS). Xoc is closely related to the rice bacterial blight (BB) pathogen X. oryzae pv 
oryzae (Xoo).  Although the role of many Xoo TAL effectors in disease has been characterized, 
the role of most Xoc TAL effectors remains unknown. Therefore, we combined microarray 
analyses, computational predictions and experimental validations to pinpoint a novel set of Xoc 
TAL effectors targets. Follow-up experiments confirmed that 19 of 36 predicted candidate 
targets of Xoc TAL effectors were induced by TAL effectors. Our list of confirmed targets 
included two genes targeted by Xoc TAL effector Tal2g, which we identified as an important 
virulence factor for BLS. To determine which Tal2g target was the biologically relevant S gene, 
we used designer TAL effectors (dTALEs) to specifically activate each target.  We found that 
complementation with the dTALE activating the sulfate transporter gene was able to restore 
virulence to a mutant strain of BLS256 lacking the tal2g gene, and identified the sulfate 
transporter as an S gene.  Thus, combining TAL effector target predictions with transcriptomics 
data allowed us to discover a previously unknown set of host genes induced by Xoc TAL 
effectors, and identify a key S gene for BLS of rice. 
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Introduction 
Xanthomonads are widely distributed plant pathogens that affect numerous plant species, 
including the economically important crops rice, cotton, citrus, cassava, and tomato (1). 
Bacterial leaf streak (BLS) and bacterial blight (BB) diseases of rice (Oryza sativa) are caused 
by Xanthomonas oryzae pv. oryzicola (Xoc) and Xanthomonas oryzae pv. oryzae (Xoo), 
respectively. Although BLS is less important and more sporadic than BB, both cause 
considerable reductions of crop yield in the major rice-producing countries.  During infection, 
Xoo colonizes the vascular system of rice leaves, while Xoc is limited to the non-vascular 
mesophyll tissue. The determinants for this difference in host tissue specificity are unknown (2).  
The virulence of both Xoc and Xoo depends on a type-three secretion system (T3SS), which 
injects a variety of effectors from the bacterium into the host plant cells.  Included in this T3SS-
delivered effector cocktail are transcription-activator like (TAL) effectors (3,4). Upon injection 
into the plant cell, TAL effectors localize to the nucleus and induce expression of specific host 
genes by binding to effector-specific DNA sequences called effector binding elements (EBEs).  
In BB, induction of susceptibility (S) genes by Xoo TAL effectors is necessary for pathogen 
multiplication and spreading as well as the occurrence of disease symptoms (5-10). Recent 
reports have shown that many of the major TAL effector-targeted genes on which Xoo 
pathogenicity relies are sugar transporters that are presumably involved in sucrose phloem 
loading (7,11-13). Despite the fact that the sequenced genome of Xoc strain BLS256 encodes 
an unusually high number of TAL effectors, 26 (14), the role of TAL effectors in Xoc virulence 
have not been characterized, and the majority of BLS256 TAL effectors have unknown targets. 
Each TAL effector’s specific DNA target is determined by its central repeat domain, which is 
composed of a variable number of nearly identical, tandem repeats of 34-35 amino acids in 
length. Repeat-to-repeat variation occurs primarily at residues 12 and 13 of each repeat (known 
as the repeat-variable diresidue or RVD), with each RVD forming base-specific contacts and 
specifying a single binding site nucleotide (15-17). The most commonly occurring RVDs are HD, 
NG, NI, and NN, and they associate preferentially with the DNA bases C, T, A, and G/A, 
respectively. This simple TAL effector-DNA binding code has made it possible to identify the 
specific EBEs of Xoo TAL effectors in the promoters of TAL effector-targeted genes (18). 
However, the tolerance for multiple mismatches (positions where an RVD is aligned with a non-
preferred nucleotide) between TAL effectors and their targets, as well as the existence of rare 
RVDs whose specificities have not been characterized, make the de novo prediction of TAL 
effector targets a challenging task. 
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To test whether it is possible to predict in silico the TAL effector targets of a non-
characterized strain, we undertook whole genome transcriptional profiling and combined it with 
computational prediction and experimental validation to comprehensively identify TAL effector 
target genes that may function as S genes for BLS.  By combining microarray analysis with 
computational predictions, we identified 34 candidate target genes for Xoc TAL effectors.  
Experimental validations later confirmed that 19 of the 34 were TAL effector targets.  Using a 
library of BLS256 TAL effector mutants, we identified Tal2g as a major TAL effector virulence 
factor of Xoc.  Our computational analysis and experimental verification revealed that two 
genes, a monocopper oxidase and a sulfate transporter, were directly targeted and induced by 
Tal2g.  We used designer TAL effectors (dTALEs) to selectively activate the expression of each 
gene, revealing that the sulfate transporter was the relevant target for Xoc virulence. These 
results demonstrate the utility of high-throughput identification of TAL effector targets by 
combining computational predictions with transcriptomics.  Such analysis could be easily 
extended to other important crops affected by Xanthomonas spp. 
Results 
X. oryzae pv. oryzicola and X. oryzae pv. oryzae induce very different gene expression 
changes in rice leaves 
To examine host gene expression changes associated with BLS and BB, we compared 
transcript profiles in rice leaves over time after infection with Xoc BLS256 or Xoo PXO99A 
(14,19).  We focused our statistical analyses of gene expression on the kinetics of the infection 
instead of looking at a particular time point. Therefore, we identified genes whose average 
pattern of expression over time was different during the host interaction with Xoo or Xoc relative 
to the control. A total of 517 genes were differentially regulated (q ≤ 0.3) in the different 
treatment comparisons. Eighty-seven and ninety-nine genes were induced uniquely in response 
to Xoc or Xoo, respectively. Only five genes were commonly regulated by both Xoc and Xoo 
(Figure 1).  Among the Xoo-induced genes, we identified genes previously reported to be TAL 
effector-targeted S genes for Xoo infection, including the sugar transporter, Os8N3 (7), the 
transcription initiation factor TFIIAI, and the bZIP transcription factor OsTFXI (20). Functional 
ontology enrichment of Xoc- and Xoo-upregulated genes revealed that different host signaling 
pathways appear to be involved in the plant susceptibility response to Xoc and Xoo.  Our data 
indicated that the Xoc-induced genes are potentially involved in reactive oxygen species 
detoxification and redox status control. These experiments demonstrate that Xoc and Xoo 
induce broadly distinct sets of genes in rice. 
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Appendix Figure 1. Rice transcriptional responses to Xanthomonas oryzae pv. oryzicola BLS256 
(Xoc) or X. oryzae pv. oryzae PXO99A (Xoo). Distribution of genes differentially expressed over a 96 h 
time course in response to either strain relative to a mock inoculation is shown. Each circle of the Venn 
diagram represents a different pairwise comparison of treatments, as indicated. Results are based on mixed 
linear model analysis using four biological replicates for each time point of the study at a false discovery rate 
(q) of 0.3 or lower. The intersections represent the genes differentially expressed uniquely in response to the 
indicated treatments. Note that differentially expressed uniquely in response to mock means differentially 
expressed similarly in Xoc and Xoo relative to mock, and differentially expressed uniquely in response to all 
three treatments means differentially expressed differently in Xoc and Xoo relative to mock. 
Many up-regulated genes are predicted to be targets of TAL effectors 
We used the TAL effector–target scoring function developed previously (17,21) to scan in 
silico nearly 60,000 rice gene promoters for candidate binding sites for Xoc and Xoo TAL 
effectors.  For each TAL effector, we identified all sites in the promoterome scoring below a 
computed cutoff score for that TAL effector.  Candidate TAL effector binding sites were required 
to be directly preceded by a T at the 5’ end.  The lists of candidate sites scoring below the cutoff 
were correlated with the microarray data to identify putative effector binding elements (EBEs) in 
the promoters of genes induced during infection.  We identified thirty-six genes significantly 
induced by Xoc that contain putative EBEs for twenty different Xoc TAL effectors (Table 1). In 
addition, our analysis identified thirty Xoo-induced genes (Table 2) containing putative EBEs for 
Xoo TAL effectors, including those previously reported for PthXo1, PthXo6 and PthXo7 
(7,20,22). We refer to these as candidate TAL effector-targeted genes. Eight and four of the 
candidate TAL effector-targeted genes induced by Xoc and Xoo, respectively, contain putative 
EBEs for more than one TAL effector, suggesting a partial redundancy among effector 
specificity. 
The number of identified candidate TAL effector-targeted genes for a particular TAL effector 
was variable. In the case of Xoc, we identified up to five putative EBEs on different promoters  
for Tal3b and Tal6 and only one putative EBE for each of Tal2c, Tal2f, Tal5a, Tal8, Tal9b and 
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Tal11b (Table 1). Exceptionally, we found three overlapping candidate EBEs of different Xoc 
TAL effectors (Tal2a, Tal11b and Tal1c) on the promoter of gene 06g14750. No other 
overlapping EBEs for Xoc TAL effectors were found in the analysis. For Xoo TAL effectors, we 
found seven potentially targeted genes for TAL effector PthXo6 and only one targeted gene for 
each of PthXo1, PthXo7, Tal6a and Tal7a/7b (Table 2).  Overlapping of putative EBEs on the 
promoter of 07g11510 was also identified for Xoo TAL effectors (Table 2). Finally, we also 
identified potential EBEs on three genes (03g03034, 07g06970 and 02g15290) that are 
commonly regulated by Xoc and Xoo (Table 2), suggesting that some of the commonly 
regulated genes are targeted by different TAL effectors from both strains.  The majority of genes 
identified as significantly up-regulated in the microarray experiments were not predicted to be 
TAL effector targets. 
Experimental validation yields 19 confirmed TAL effector targets for X. oryzae pv. 
oryzicola TAL effectors 
We chose to focus our subsequent investigations on targets of Xoc TAL effectors since 
nothing is yet known about their role in BLS.   For each of the predicted Xoc TAL effector-
targeted genes, we used semi-quantitative RT-PCR to test whether or not they were induced by 
an Xoc BLS256 mutant lacking the corresponding TAL effector. We also tested the ability of the 
corresponding cloned TAL effector gene to complement the mutation and restore induction. 
Additionally, we expressed each of the cloned TAL effectors in the non-host pathogen X. 
axonopodis pv. glycines (Xag), strain EB08, which elicits neither symptoms nor hypersensitive 
reaction when inoculated onto rice, and tested whether delivery of the individual TAL effector by 
Xag led to induction of the candidate target gene. In all, 19 out of the 45 predicted candidates 
were experimentally validated as TAL effector targets (Table 1).   
Comparison of validated and un-validated predicted TAL effector binding sites reveal 
characteristics that may be useful for future TAL effector target prediction 
Comparison of validated and un-validated candidate TAL effector binding sites revealed a 
few differing characteristics.  Direct comparison of binding site scores for different TAL effectors 
was impossible, because TAL effectors with more repeats and longer binding sites will always 
have higher scores.  To facilitate comparing scores across multiple TAL effectors, we developed 
the concept of a “score ratio”. The score ratio is calculated as the actual score for a TAL 
effector-target alignment divided by the perfect score (the hypothetical score for the TAL effector 
aligned with its perfect match target).  Because score ratios account for the different numbers of 
repeats, they can be used to compare binding site scores for multiple TAL effectors.  We found 
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that the validated binding sites typically had score ratios ranging from 1.22-2.8, while unverified 
sites had score ratios ranging from 1.7-3.18.  When the binding sites for each TAL effector were 
ranked by score, verified sites typically had lower (better) ranks, with 15 of 19 verified sites 
having ranks less than 150.  Conversely, 20 of 27 unverified sites had ranks higher than 200, 
suggesting that rank may be more useful than score or score ratio for separating functional and 
nonfunctional sites.  Finally, we compared the contexts of the functional and non-functional 
sites, and found that 18 of the 19 verified sites were located within 150bp of the native 
transcriptional start site (TXS), and many were near TATA boxes.  For un-verified sites, only 6 
were within 150bp of the TXS.  Because our initial lists of predicted sites were quite long, 
filtering out sites that do not meet some of the characteristics described above may prove to be 
a useful way to filter the predicted binding site lists. 
The sulfate transporter gene targeted by Tal2g is a major S gene for bacterial leaf streak 
We previously identified mutant M27 from a library of BLS256 TAL effector mutants as 
having a mutation in its tal2g gene. The M27 mutant showed a significant loss in virulence (as 
measured by lesion length) relative to the wild type bacteria which was restored by 
complementation with the tal2g gene (Figure 2).  In comparisons of rice inoculated with wild 
type BLS256 and mutant M27, the rice inoculated with the mutant strain showed less bacterial 
exudate on the inoculated leaf surfaces (data not shown).  Similarly, isolation and quantification 
of surface bacteria 7 days after inoculation found 400-fold fewer bacteria on the surface of the 
M27-inoculated leaves (Figure 2).  Thus Tal2g is a major virulence factor in BLS that contributes  
 
 
Appendix Figure 2.  Virulence contribution of X. oryzae pv. oryzicola BLS256 TAL effector Tal2g. (A) 
Lengths of lesions caused by X. oryzae pv. oryzicola BLS256 (WT), the tal2g knockout derivative M27 
carrying an empty plasmid vector (ev), and M27 carrying the vector with the cloned tal2g gene, measured 10 
days after infiltration. The asterisk indicates a significant difference relative to WT (P<0.01). Error bars 
represent standard deviation (N≥10). (B) Total and surface (exudate) bacterial populations of leaves 7 days 
after inoculation with the strains in panel A. The asterisk indicates a significant difference relative to WT 
(P<0.01). (P<0.01) between the treatments. Error bars represent standard deviation (N≥6). Experiments 
were repeated three times with consistent results. 
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both to lesion expansion and bacterial egress to the leaf surface. 
Our microarray and target prediction analysis identified two candidate TAL effector-targeted 
genes for Tal2g, Os06g46500 and Os01g52130 (Table 1).  Both genes were found to be 
genuinely induced by Tal2g.  To distinguish which of these is a biologically relevant target, i.e., 
an S gene, we engineered designer TAL effectors (dTALes) to specifically activate each of the 
targets and tested whether the dTALEs restore virulence to M27. dTALE434 was designed to 
specifically induce Os06g46500, which encodes a monocopper oxidase. Both dTAL436 and 
dTAL437 were designed to induce Os01g52130, a sulfate transporter (Figure 3A). When 
transformed individually into M27, all three dTALEs restored induction of their targets to levels 
similar to induction by Tal2g (Figure 3B). Virulence assays conducted with each dTALE-
transformed M27 strain revealed that the induction Os01g52130, but not Os06g46500, is 
sufficient to restore the wild type virulence in M27 (Figure 3C). These data point to 
Os01g52130, which encodes a sulfate transporter induced by Tal2g, as a principal susceptibility 
gene candidate for BLS. 
Discussion 
The work presented here represents the first study to attempt high-throughput, in silico 
prediction of TAL effector targets.  We show that by combining TAL effector target site 
predictions with microarray data and experimental validation, we were able to identify a 
previously unknown set of TAL effector target genes.  Significantly, our approach led to the 
discovery of a previously unknown S gene for BLS.   
Although our method was successful at identifying a set of TAL effector targeted genes, it is 
unclear how many TAL effector-targeted genes were missed.  To construct our initial lists of 
candidate target genes, we relied on a somewhat arbitrary scoring cutoff.  Although this cutoff 
seemed reasonable, it is unlikely that it captured all TAL effector targets.  Additionally we relied 
on microarray analysis to filter our initial lists of predicted targets, which limited us to discovering 
TAL effector targets that were represented on the Gene Chip used.  Similar analysis using RNA-
seq transcriptomics data would likely have yielded more candidate targets. 
The TAL effector-target scoring function used in this analysis also yields high rate of false 
positives, identifying hundreds of candidate sites per TAL effector in the rice genome.  
Therefore, filtering the predicted lists based on transcriptomics or other biological data is 
essential.  Filtering the lists of predicted sites by characteristics such as score, rank, and  
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Appendix Figure 3. Determination of Os01g52130 as the relevant target of Tal2g using designer TAL 
effectors.  (A) DNA sequence of the promoter regions of Tal2g induced genes 06g46500 and 01g52130 in 
rice cv. Nipponbare. The effector binding elements (EBEs) for Tal2g are in bold. The EBEs for designer TAL 
effectors dT434 targeting 06g46500 and dT436 and dT437 targeting 01g52130 are underlined and labeled 
above. Short arrows indicate transcriptional start sites and italics indicates the translational start site per the 
Rice Genome Annotation Project (Release 7, http://rice.plantbiology.msu.edu). (B) Activation of 06g46500 
and 01g52130 by Tal2g and specific activation of 06g46500 and 01g52130 by dT434, and dT436 or dT437, 
respectively. Shown are the results of semi-quantitative RT-PCR of leaf RNA isolated 48 h after inoculation 
by infiltration with X. oryzae pv. oryzicola BLS256 (WT), the tal2g knockout derivative M27 carrying an 
empty plasmid vector (ev), M27 carrying the vector with the cloned tal2g gene, or M27 carrying the vector 
with coding sequences for dT436, dT436, or dT437 as indicated. An actin gene was used to equalize cDNA 
amounts. (C) Rescue of the virulence defect of M27 by dT436 or dT437 but not dT434, revealing 
Os01g52130 as the relevant target of Tal2g. Lesion lengths were measured 10 days after inoculation with 
the indicated strains. Values labeled with the same letter are not significantly different (P>0.01). Error bars 
represent standard deviation (N≥10). Experiments were repeated twice with consistent results. 
proximity to the transcriptional start site may also help separate functional TAL effector binding 
sites from false positives. 
A weakness in our comparison of functional and non-functional TAL was that we did not 
distinguish between non-functional sites at which the TAL effector failed to bind the DNA and 
non-functional sites at which the TAL effector bound the DNA target but did not activate 
transcription.  Therefore, dividing predicted sites into functional or non-functional categories 
based on binding site characteristics may be useful for applications in which TAL effectors are 
used to activate transcription or for identifying TAL effector targets in nature.  However, these 
characteristics might not extend to identifying TAL effector targets in other contexts, such as 
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TAL effector nucleases or TALENs, where proximity to a TATA box or transcriptional start site is 
less important.  It is unclear if features such as rank or score ratio will be useful in other 
applications. 
Overall, we anticipate that our approach will be useful for studying the role of TAL effectors 
in a variety of Xanthomonas-host plant systems.  One bottleneck in this approach is the 
characterization and sequencing of TAL effectors from Xanthomonas populations.  Sequencing 
of TAL effector repeat regions is difficult, as next-generation sequencing technologies do not 
produce reads long enough to sequence through a TAL effector’s repeats.  However, as 
sequencing improves and more complete Xanthomonad genomes become available, the 
approach described here should prove extremely valuable for identifying TAL effector targets 
and understanding host-bacterial disease interactions. 
Materials and Methods 
Plant materials 
Rice (Oryza sativa L.) plants were grown in LC-1 soil mixture (SunGRO, Bellevue, WA, 
U.S.A.) in a growth chamber under cycles of 12 h of light (28°C) and 12 h of dark (25°C). 
Fertilizer (Peters Professional, St. Louis) and iron chelate micronutrient (Becker Underwood, 
Ames, IA, U.S.A.) were applied twice a week during watering at 0.25 and 4.5 g/l-1, respectively. 
Bacterial strains and preparation of inoculum 
Xoo strain PXO99A and Xoc strain BLS256 were used. For each, a single colony from a 
glucose yeast extract (GYE; 20 g glucose, 10 g yeast extract per liter) agar plate was 
transferred to 5 ml of GYE liquid medium and incubated for 24 h at 28ºC with constant shaking 
at 250 r.p.m. Subsequently, 2 ml of this culture were transferred to 300 ml of fresh GYE liquid 
medium and incubated as above for an additional 18 h. Cells were pelleted by centrifugation at 
4000 r.p.m. for 10 min, washed twice and resuspended in sterile 10 mm MgCl2 to an OD600 of 
0.5, yielding 7 liters of inoculum. Tween-20 was added to a final concentration of 0.5%. 
Bacterial inoculation: vacuum infiltration method 
Fourteen days after sowing, and 2 h after the beginning of the light period, flats of seedlings 
were inverted into inoculum and vacuum infiltrated at 500mm Hg for two minutes, two 
consecutive times, in a custom-made chamber.  A total of three flats were used; each flat was 
inoculated with one of Xoo, Xoc or mock inoculum (sterile 10 mm MgCl2, 0.5% Tween-20).  
Following inoculation, plants were returned to the growth chamber. During growth, plants were 
cycled weekly in the same order through three growth chambers. In this way all plants could be 
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incubated in the same final chamber following inoculation. For each replicate, position of the 
flats in the growth chamber (from left to right, used also for the order of inoculation and harvest) 
was determined by a split-plot design. 
Tissue collection 
Within flats, assignment of pots for the harvest of inoculated tissue at 2, 4, 8, 24 and 96 h 
was made using a separate randomized complete block design. Tissue was harvested from 
plants in four pots (approximately 2 g fresh weight) for each time point per inoculum per 
replication. Harvested tissue was immediately frozen in liquid nitrogen and stored at -80ºC until 
processing. 
RNA Isolation and processing for microarray experiments 
Total RNA was isolated from frozen whole plant tissue, purified using RNeasy spin columns 
(Qiagen), and adjusted to a final concentration of 1 µg/µL. Probe synthesis, labeling, and 
hybridization were performed at the Iowa State University GeneChip Core facility, according to 
their standard protocols. GeneChips (the Affymetrix Rice Genome Array) were washed and 
stained with streptavidin-phycoerythrin using the fluidics script EukGE-WS2v5_450 in the 
Affymetrix GeneChip Fluidics Station 450. Stained chips were immediately scanned with the 
Affymetrix GeneChip Scanner 3000 7G. 
Microarray data scaling and normalization 
The hybridization data were processed using Affymetrix GeneChip Operating Software 
(GCOS v1.4.0.036). Scanned images were examined for any visible defects and satisfactory 
image files were analyzed to generate raw data files using the default settings of GCOS from 
Affymetrix. Signal measures on each GeneChip were scaled to a target intensity of 500, a 
normalization value of 1, and the default parameter settings for the Rice Genome Array were 
used. The raw microarray data were uploaded to the Plant Expression Database (PLEXdb, 
http://plexdb.org/); experiment name OS3. 
Microarray analysis 
The microarray experiment was analyzed as a split-plot design with four replications. The 
four replications were obtained on four separate occasions at 1-week intervals using a single 
growth chamber. Within each replication, one tray of plants was used for each of the three 
treatments (Mock, Xoc, and Xoo). The five collection timepoints were randomly assigned to 
rows of plants within each tray. Thus, an experiment’s treatment and time serve as the whole-
plot and split-plot treatment factors, respectively. 
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A mixed linear model was fit separately to RMA-normalized data from each gene. Each 
mixed linear model included fixed effects for replications, treatments, times, and treatment-by-
time interaction, as well as random effects for the trays serving as whole-plot experimental units. 
As part of our mixed linear model analysis for each probe set, we tested for a difference in the 
pattern of expression over time between Mock and Xoc, between Mock and Xoo, and between 
Xoc and Xoo. These tests are designed to detect genes whose changes in expression across 
time differed between treatments. The 57,381 p-values from each of these three tests were 
converted to q-values (23). Genes with q-values less than 0.30 were identified as significantly 
differentially expressed. This method controls that false discovery rate (FDR) at approximately 
30% for each comparison. 
Cloning TAL effector genes of X. oryzae pv. oryzicola  
Two micrograms of genomic DNA of X. oryzae pv. oryzicola strain BLS256 were digested 
with BamHI and separated in 1% agarose by electrophoresis. DNA fragments corresponding 
from 2 to 5 kb were gel purified and ligated into pBlueScript SK(-) (Agilent Technologies) 
previously digested with BamHI. The ligation was transformed into E. coli TOP10 cells and 
colonies encoding TAL effector genes were identified by colony PCR using oligos P270 (5’-
GCCAAGTCCTGCCCGCG-3’) and P271 (5’-CCTCCAGGGCGCGTGC-3’), which target a 
conserved N-terminus region of Xanthomonas oryzae TAL effectors. The corresponding SphI 
fragments of each Xoc TAL effector encoding the repeat region were cloned into the entry 
vector pCS466 and confirmed by 5’ and 3’ sequencing with oligos p235 (5’-
GGAGGCCTTGCTCACGGATGC-3’) and p236 (5’-GGCCGGTGACAGCACGATCCG-3’), 
respectively. In the particular cases of tal2g, tal4a and tal8, we used BamHI fragments instead, 
because those genes have only one of the SphI sites. Xoc TAL effectors in pCS466 were 
recombined to the broad host-range destination vector pKEB31 using Gateway LR Clonase 
(Invitrogen) (24). 
Determination of bacterial virulence and growth in rice leaves 
Virulence tests of Xoc BLS256 and TAL effector mutants were conducted on 3 to 4 week-old 
leaves of rice cv. Nipponbare. The lesion lengths were recorded as the sum of water-soaked 
expansions in both directions from the infiltration site.  Lesion lengths were measured 10 to 14 
days after bacterial infiltration. 
To measure the multiplication of wild type BLS256 and TAL effector mutants in planta, three 
leaves per treatment at defined time-points were collected. Leaf sections corresponding to five 
centimeters on either side of the initial infiltration site were sliced into small pieces and ground in 
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2 ml of water. Samples were diluted serially in sterile water and spread on peptone sucrose 
agar (PSA) supplemented with cephalexin at 20 mg/L. Plates were incubated at 28°C until 
appearance of single colonies, and colonies were counted. The results are displayed as the 
mean and standard deviation of 8 replicates for this experimental procedure. For bacterial 
counting on the leaf surface, the water-soaked leaf areas (approximately 1 cm2) were washed 
thoroughly two times with 50 μl of sterile water and then diluted into 1 ml of water. Viable counts 
were determined by serial dilution as described before. Bacterial counting experiments were 
repeated at least three times with consistent results. 
Computational prediction of TAL effector targets 
Promoter sequences (defined as 1000 bases upstream of the start codon) for approximately 
60,000 rice genes were downloaded from the MSU Rice Genome Annotation Project 
(http://rice.plantbiology.msu.edu/).  For each of the approximately 40 Xoo and Xoc TAL 
effectors, we used our previously published TAL effector-target scoring model (21) to identify 
the best-scoring site for the TAL effector in each of the 60,000 promoter sequences.  Based on 
the list of best-scoring sites, an outlier score cutoff was computed for each TAL effector.  The 
cutoff was defined as the 25th percentile – 1.5*Interquartile range.  Promoters were rescanned 
for each TAL effector to identify all sites scoring below the TAL effector’s cutoff (a lower score 
indicates better binding affinity).  All identified candidate binding sites were required to be 
directly preceded by a T at the 5’ end.  The lists of candidate binding sites for each TAL effector 
were cross-referenced to the lists of up-regulated genes from the microarray experiments.  Sites 
scoring below the cutoff for an Xoc TAL effector in promoters of genes differentially expressed 
in the Xoc-mock comparison were identified as candidate targets for Xoc TALs.  Similarly, sites 
scoring below the cutoff for an Xoo TAL effector in promoters of genes differentially expressed 
in the Xoo-mock comparison were identified as candidate targets for Xoo TALs. Genes 
possessing such sites were considered candidate TAL effector-targeted genes. 
RNA extraction and RT-PCR analyses 
RNA was prepared from leaf tissue collected at 48 h after infiltration using the RNeasy Mini 
Kit (Qiagen). The RNA was subjected to in-column DNase treatment with the RNase-Free 
DNase Set (Qiagen). 2µg of total RNA were reverse-transcribed using SuperScript III 
(Invitrogen) and standard oligo dT20. For the semi-quantitative RT-PCR analysis, 1 mL (5%) of 
the RT-PCR reaction was used as a template with Phire Hot Start II DNA polymerase (Thermo 
Scientific) together with the gene-specific oligos.  Cycling parameters were 30 s at 98°C; 23 
cycles of 10 s at 98°C, 5 s at 60°C, and 10 s at 72°C. 
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Designer TAL effectors 
To design TAL effectors targeting the promoter regions of Os01g52130 and Os06g46500, 
we used the TAL Effector Nucleotide Targeter 2.0 website (21). dTALes were first assembled 
into an entry vector (25)  and subsequently transferred to pKEB31 destination vector by 
Gateway LR Clonase (Invitrogen) to generate dT434, dT436 and dT437.  
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Appendix Table 1. Predicted X. oryzae pv. oryzicola BL256 TAL effector targets in rice and target verification. 
TAL 
effector Locus ID 
EBE 
location
1
 
EBE 
score
2
 
EBE 
score 
ratio
3
 
EBE 
rank
4
 
TAL 
knock-
out
5
 Xag
6
 Description 
Tal1c LOC_Os07g06970 -24 5.97 1.22 0 - + HEN1 
Tal2c LOC_Os03g03034 -114 19.55 1.83 0 - + Flavonol synthase/ 
flavanone 3-
hydroxylase 
Tal2d LOC_Os04g49194 -26 8.22 1.26 0 - + Naringenin,2-
oxoglutarate 3-
dioxygenase 
Tal2g LOC_Os01g52130 -58 15.60 1.78 77 - + Sulfate transporter 
Tal2g LOC_Os06g46500 -59 15.73 1.8 117 - + Monocopper 
oxidase 
Tal3b LOC_Os05g27590 -33 11.40 1.88 2 - + Wound-induced 
protein WI12 
Tal3b LOC_Os02g34970 -29 15.33 2.53 75 - + No apical meristem 
protein 
Tal3b LOC_Os07g36430 -31 15.78 2.6 108 - + Expressed protein 
Tal3c LOC_Os02g47660 63 10.93 1.92 53 - + Basic helix-loop-
helix 
Tal3c LOC_Os03g07540 -99 12.33 2.17 350 - + bHLH family protein 
Tal4a LOC_Os03g37840 -151 15.58 1.52 0 - + Potassium 
transporter 
Tal4b LOC_Os09g32100 -84 8.15 1.5 16 - + Expressed protein 
Tal4c LOC_Os06g37080 -39 14.64 1.78 0 - + L-ascorbate 
oxidase precursor 
Tal5a LOC_Os02g15290 -30 23.32 1.88 107 - + VQ domain 
containing protein 
 
                                                          
1
 Location relative to the start codon 
2
 Score calculated as in (21) 
3
 Score divided by Best Possible Score (the score for the TAL effector on its perfect target 
4
 EBE rank is out of the collection of all sites in the promoterome scoring below the cutoff for the TAL 
effector 
5
 + and – indicate that the corresponding TAL effector mutant induced or failed to induce the gene, 
respectively.  ND, no data. 
6
 + and – indicate that delivery of the corresponding TAL effector by Xag induced or failed to induce gene 
expression.  ND, no data. 
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Appendix Table 1.  Continued. 
TAL 
effector Locus ID 
EBE 
location
1
 
EBE 
score
2
 
EBE 
score 
ratio
3
 
EBE 
rank
4
 
TAL 
knock-
out
5
 Xag
6
 Description 
Tal6 LOC_Os12g42970 -30 16.84 2.14 139 - + GATA zinc finger 
domain containing 
protein 
Tal6 LOC_Os09g29100 83 17.00 2.13 167 - + Cyclin 
Tal6 LOC_Os01g31220 19 18.75 2.38 685 - + Expressed protein 
Tal9b LOC_Os01g51040 -47 14.07 2.81 275 - + Transmembrane 
protein 16K 
Tal1c LOC_Os06g14750 -521 12.00 2.44 256 + - Phosphatidylinosito
l-4-phosphate 5-
Kinase family 
protein 
Tal2a LOC_Os02g43760 22 15.87 1.75 21 + + Ubiquitin carboxyl-
terminal hydrolase, 
family 1 
Tal2a LOC_Os06g14750 -527 17.59 1.94 88 + - Phosphatidylinosito
l-4-phosphate 5-
Kinase family 
protein 
Tal2d LOC_Os01g51040 -315 14.32 2.19 324 + - Transmembrane 
protein 16K 
Tal3a LOC_Os05g12450 -818 16.07 2.01 294 + - hydroquinone 
glucosyltransferase 
Tal3a LOC_Os07g06970 -567 16.21 2.03 354 + - HEN1 
Tal3b LOC_Os03g03034 -142 16.73 2.76 258 + - Flavonol 
synthase/flavanone 
3-hydroxylase 
Tal4a LOC_Os09g20220 -152 28.93 2.83 280 + - glutathione S-
transferase 
Tal4a LOC_Os01g27210 -310 29.22 2.85 341 + - glutathione S-
transferase 
Tal4c LOC_Os02g47660 -30 24.73 3.01 434 + - Basic helix-loop-
helix 
Tal4c LOC_Os07g29750 -610 25.09 3.05 557 + - glycosyl hydrolases 
family 16 
Tal6 LOC_Os07g47790 8 13.38 1.7 8 + - AP2 domain 
containing protein 
Tal6 LOC_Os02g14770 -30 18.48 2.35 569 + - phosphoenolpyruva
te carboxylase 
Tal7 LOC_Os03g25490 -341 16.32 2.01 494 + - cytochrome P450 
72A1 
Tal7 LOC_Os02g43760 -560 16.45 2.03 547 + - Ubiquitin carboxyl-
terminal hydrolase, 
family 1 
 
                                                          
1
 Location relative to the start codon 
2
 Score calculated as in (21) 
3
 Score divided by Best Possible Score (the score for the TAL effector on its perfect target 
4
 EBE rank is out of the collection of all sites in the promoterome scoring below the cutoff for the TAL 
effector 
5
 + and – indicate that the corresponding TAL effector mutant induced or failed to induce the gene, 
respectively.  ND, no data. 
6
 + and – indicate that delivery of the corresponding TAL effector by Xag induced or failed to induce gene 
expression.  ND, no data. 
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Appendix Table 1.  Continued. 
TAL 
effector Locus ID 
EBE 
location
1 
EBE 
score
2 
EBE 
score 
ratio
3 
EBE 
rank
4 
TAL 
knock-
out
5 
Xag
6 
Description 
Tal8 LOC_Os06g37080 -191 19.92 2.32 605 + - L-ascorbate 
oxidase precursor 
Tal9a LOC_Os12g01490 -621 19.71 2.56 205 + - MYB family 
transcription factor 
Tal9a LOC_Os11g01480 -653 19.71 2.56 206 + - MYB family 
transcription factor 
Tal11a LOC_Os03g05370 -422 17.39 2.74 307 + - Expressed protein 
Tal11a LOC_Os02g15290 -195 20.15 3.18 582 + - VQ domain 
containing protein 
Tal11b LOC_Os06g14750 527 12.44 2.77 129 + - Phosphatidylinosito
l-4-phosphate 5-
Kinase family 
protein 
Tal11a LOC_Os06g47950 -506 16.20 2.55 19 ND ND tetratricopeptide-
like helical 
Tal2d LOC_Os09g23560 -64 14.19 2.17 288 ND ND dehydrogenase 
Tal3b LOC_Os01g53220 -151 17.72 2.92 611 ND ND HSF-type DNA-
binding domain 
containing protein 
Tal4b LOC_Os07g34510 -951 8.88 1.63 33 ND ND retrotransposon 
protein, 
unclassified 
Tal7 LOC_Os02g15710 -243 15.75 1.94 265 ND ND plastocyanin-like 
domain containing 
protein 
1
 Location relative to the start codon 
2
 Score calculated as in (21) 
3
 Score divided by Best Possible Score (the score for the TAL effector on its perfect target 
4
 EBE rank is out of the collection of all sites in the promoterome scoring below the cutoff for the TAL 
effector 
5
 + and – indicate that the corresponding TAL effector mutant induced or failed to induce the gene, 
respectively.  ND, no data. 
6
 + and – indicate that delivery of the corresponding TAL effector by Xag induced or failed to induce gene 
expression.  ND, no data. 
 
Appendix Table 2.  Predicted X. oryzae pv. oryzae PXO00A TAL effector targets in rice 
TAL 
effector Locus ID 
EBE 
location
1
 
EBE 
score
2
 
EBE score 
ratio
3
 
EBE 
rank
4
 Description 
PthXo1 LOC_Os08g42350 -78 15.84 1.95 0 nodulin MtN3 
family protein 
PthXo6 LOC_Os01g52610 -64 22.66 1.65 197 peroxidase 
precursor 
PthXo6 LOC_Os06g48010 -32 17.16 2.08 2 peroxidase 
precursor 
 
                                                          
1
 Location relative to the start codon 
2
 Score calculated as in (21) 
3
 Score divided by Best Possible Score (the score for the TAL effector on its perfect target 
4
 EBE rank is out of the collection of all sites in the promoterome scoring below the cutoff for the TAL 
effector 
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Appendix Table 2.  Continued. 
TAL 
effector Locus ID 
EBE 
location
1
 
EBE 
score
2
 
EBE score 
ratio
3
 
EBE 
rank
4
 Description 
PthXo6 LOC_Os07g11510 50 21.24 1.72 54 RAL6 - Seed 
allergenic protein 
RA5/RA14/RA17 
precursor 
PthXo6 LOC_Os08g44220 -654 22.50 1.66 169 GLTP domain 
containing protein 
PthXo6 LOC_Os09g29820 -30 15.61 2.33 1 bZIP transcription 
factor domain 
containing protein 
PthXo6 LOC_Os10g28240 -51 22.32 1.67 148 calcium-
transporting 
ATPase, plasma 
membrane-type 
PthXo6 LOC_Os11g42950 -690 23.80 1.60 460 expressed protein 
PthXo7 LOC_Os01g73890 -29 15.34 2.04 1 transcription 
initiation factor IIA 
gamma chain 
PthXo7 LOC_Os01g73890 -441 25.93 1.43 561 transcription 
initiation factor IIA 
gamma chain 
PthXo7 LOC_Os03g03034 -267 32.39 1.32 763 flavonol synthase/ 
flavanone 3-
hydroxylase 
PthXo7 LOC_Os06g03080 -356 32.17 1.32 420 unknown 
PthXo7 LOC_Os07g17460 -301 32.24 1.32 330 OsFBL36 - F-box 
domain and LRR 
containing protein 
Tal2a LOC_Os01g01840 -709 11.12 2.18 142 helix-loop-helix 
DNA-binding 
domain containing 
protein 
Tal2a LOC_Os07g11510 46 10.04 2.50 32 RAL6 - Seed 
allergenic protein 
RA5/RA14/RA17 
precursor 
Tal2a LOC_Os08g26620 -99 12.38 1.95 482 unknown 
Tal4 LOC_Os01g58240 -449 11.25 2.36 72 OsSub6 - Putative 
Subtilisin 
homologue 
Tal4 LOC_Os02g43360 -366 11.94 2.19 166 cytochrome b5-like 
Heme/Steroid 
binding domain 
containing protein 
Tal4 LOC_Os04g27020 -598 12.14 2.15 213 cytochrome P450 
Tal4 LOC_Os06g29730 -369 10.47 2.63 26 RALFL28 - Rapid 
ALkalinization 
Factor RALF family 
protein precursor 
 
                                                          
1
 Location relative to the start codon 
2
 Score calculated as in (21) 
3
 Score divided by Best Possible Score (the score for the TAL effector on its perfect target 
4
 EBE rank is out of the collection of all sites in the promoterome scoring below the cutoff for the TAL 
effector 
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Appendix Table 2.  Continued. 
TAL 
effector Locus ID 
EBE 
location
1 
EBE 
score
2 
EBE score 
ratio
3 
EBE 
rank
4 
Description 
Tal5a LOC_Os07g09190 162 13.98 1.66 578 transketolase 
Tal5a LOC_Os07g11510 65 14.43 1.62 803 RAL6 - Seed 
allergenic protein 
RA5/RA14/RA17 
precursor 
Tal5a LOC_Os09g27580 -303 13.73 1.68 501 potassium 
transporter 
Tal5a LOC_Os11g42950 -38 11.21 1.98 32 expressed protein 
Tal6a LOC_Os09g29210 -31 16.86 1.97 91 purine permease 
Tal7a/8a LOC_Os01g68740 409 9.14 5.33 0 keratin, type I 
cytoskeletal 9 
Tal7b/8b LOC_Os01g40290 -31 12.55 1.95 2 expressed protein 
Tal7b/8b LOC_Os10g32700 232 18.49 1.49 279 hypersensitive-
induced response 
protein 
Tal9a LOC_Os06g39120 246 17.01 1.50 103 expressed protein 
Tal9a LOC_Os07g06970 2 7.81 3.71 0 HEN1 
Tal9b LOC_Os01g58194 -239 27.52 1.56 259 protein disulfide 
isomerase 
Tal9b LOC_Os03g03034 16 26.59 1.59 130 flavonol 
synthase/flavanone 
3-hydroxylase 
Tal9d LOC_Os04g01470 -696 9.36 1.92 691 O-
methyltransferase 
Tal9d LOC_Os11g28740 -637 9.33 1.92 626 unknown 
Tal9e LOC_Os02g15290 -30 23.52 2.14 104 VQ domain 
containing protein 
1
 Location relative to the start codon 
2
 Score calculated as in (21) 
3
 Score divided by Best Possible Score (the score for the TAL effector on its perfect target 
4
 EBE rank is out of the collection of all sites in the promoterome scoring below the cutoff for the TAL 
effector 
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